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Abstract 
 
The  main  focuses  of  this  research  were  to  examine  the  capabilities  of  solution 
techniques  to  attempt  to  monitor  the  nucleation  process  in  crystallisation,  and  to 
investigate  structural  outcomes  of  crystallisation  processes,  with  reference  to 
polymorphism and intermolecular interactions.   
 
To achieve this, work on the investigation of nucleation and early-stage crystallisation 
was carried out at the Department of Pharmaceutical Sciences at the University of 
Strathclyde  and  also  at  the  central  synchrotron  facility  of  Station  2.1  at  the  SRS 
Daresbury.  Small angle X-ray scattering (SAXS) was carried out on solutions of 
methyl-4-hydroxybenzoate (pMHB) and 2-bromobenzoic acid.  These studies were 
carried out after developing solution methods to enable us to determine the point at 
which  crystals  emerged  from  solution.    This  was  achieved  using  Focussed  Beam 
Reflectance  Measurements.  Structural studies  were also carried out on pMHB to 
examine  its  polymorphic  behaviour  and  crystal  structures  were  solved  at  various 
temperatures  from  100K  to  300K.    The  crystal  structure  of  methyl-2,5-
dibromobenzoate  was  also  solved  at  100K  after  discovering  it  sublimes  at  room 
temperature.  This structure could only be solved from a twinned crystal and indicated 
the appearance of interesting halogen interactions occurring. 
 
Structural studies have also been carried out using the bromanilic acid molecule as a 
focus to generate a number of co-crystal complexes to examine their halogen bonding 
capability and to determine any structural significances in their formation. 
 
Co-crystal complexes of bromanilic acid and a variety of molecules were made in 1:1 
and  1:2  ratios  to  see  if  any  additional  halogen  interactions  could  be  observed  or 
induced, in addition to the expected hydrogen-binding interactions.  The co-crystals 
included a range of picolines and lutidines as well as bromo-substituted pyridines to 
attempt to induce halogen interactions.  This generated a number of new compounds 
whose  structures  were  determined  using  single  crystal  X-ray  diffraction  and  the 
interactions were monitored to observed whether any defined patterns with regards to 
the tendency of bromanilic acid co-crystallisations to produce predictable patterns of 
intermolecular interactions could be determined.  
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Chapter 1. Introduction 
 
1.1: Polymorphism 
 
Polymorphism in molecular crystals is defined as the ability of a substance to exist in 
different  molecular  arrangements  or  different  molecular  conformations  within  the 
lattice under similar external conditions.  The wide range of molecules that exhibit 
polymorphism can be explained by Ostwald’s law of stages, which states that “when 
leaving an unstable state, a system does not seek out the most stable state, rather the 
nearest  metastable  state  which  can  be  reached  with  loss  of  free  energy”
1.    This 
describes the idea that when crystallisation occurs the molecules, as they assemble, 
will simply fall to the nearest minimum energy state with a loss in free energy and can 
then continue to seek out the most stable form.  This can ultimately result in changes 
in the polymorphic form adopted even after an apparently stable structure appears to 
be found.  The co-crystal structure of carbamazepine and isonicotinamide shows that 
through a solvent mediated transformation the initial needles produced (form II) will 
be replaced with plate like crystals of form I over time
2. 
 
Polymorphism can generally be traced back to the work of Mitscherlich in the early 
1800s and he is widely credited with the first recognition of the phenomenon from his 
studies  on  crystals  of  certain  phosphates  and  arsenates
3.    Since  this  discovery 
polymorphism has become an area of huge study and of critical importance in many 
areas, including the food and speciality chemicals industries, however arguably the 
most  significant  of  these  would  be  the  pharmaceutical  industry.    This  can  be 
highlighted in many major studies including that of Ritonavir
1, a drug developed for 
the treatment of HIV.  The discovery of a second more thermodynamically stable 
form of Ritonavir, changing the physical properties and characteristics and making the 
original formulated form disappear from the production process, led to a complete 
stop  on  production  and  ultimately  cost  the  manufacturer  (Abbot  Laboratories) 
millions of dollars in lost sales and in R&D for reformulation.  It should be mentioned 
that even after a polymorphic form ‘disappears’ it can be possible to generate this 
initial form again but a different route will have to be found.  There are many other 
examples  of  disappearing  polymorphs
4,5,6,  causing  a  great  deal  of  concern  among 2 
 
researchers in the field as this finding shows that an apparently ‘simple’ process such 
as crystallisation in fact could not be controlled.   
 
Another  common  example  of  polymorphism  in  pharmaceuticals  is  the  case  of 
paracetamol, a widely used analgesic that has for a long time been known to have two 
distinct crystal forms in which single crystals can be produced.  Form I, the common 
form, is monoclinic
7, while form II is known to be orthorhombic
8.  Subsequent studies 
using variable temperature x-ray diffraction, on Form II,
9 and neutron diffraction, on 
Form I,
10 have been carried out to characterise the structures fully.  Form I is the 
thermodynamically stable modification
9 at room temperature, whereas form II is the 
metastable  form  under  ambient  conditions.    This  is  a  rather  simple  example  of 
polymorphism where the two forms that can be solved by single crystal diffraction 
have unique crystal systems (Figure 1.1.1). 
 
 
 
Figure 1.1.1: The packing motifs of the two polymorphs of paracetamol 
 
There are also several more complicated instances of polymorphism, many of which 
have been widely studied over the course of many years.  One of these is the heavily 
studied  anticonvulsant  drug  carbamazepine  (Figure  1.1.2).    There  are  four  known 
polymorphs of carbamazepine
11,12,13,14, however solvates and hydrates are also known 
to exist and in one particular automated parallel crystallisation study Forms I-III were 
found along with one hydrate form and no fewer than 8 organic solvates
15.   
 3 
 
N
O
H2N
 
Figure 1.1.2: Structure of carbamazepine 
 
Due to the significant polymorphism present in this material computational studies 
have also been carried out as there are clear advantages in being able to predict any 
occurrence of polymorphism.  The computational studies carried out were concerning 
the predictability of forms II-IV, as current computational prediction models do not 
permit  the  study  of  structures  where  Z’  is  greater  than  1.    The  two  monoclinic 
polymorphs forms III and IV were found to be the most stable structures alongside a 
third, currently unobserved structure.  Forms I and II were 6 and 8 kJ/mol above the 
global minimum, where the energy for Form I was generated from the known crystal 
structure,  and  along  with  many  other  potential  structures  in  the  energy  landscape 
would  have  been  unlikely  to  be  suggested  as  possible  polymorphs
16.    This  study 
emphasises how important it is to develop computational techniques further, with the 
aim of benefiting crystal structure prediction. 
 
The material with the most known polymorphs is 5-methyl-2-[(2-nitrophenyl)amino]-
3-thiophenecarbonitrile  (ROY;  Figure  1.1.3)).   This  is  known  as  ROY  due  to the 
characteristic  colours  of  the  distinguishable  polymorphs  that  are  known  to  exist.  
These  forms are orange  needles,  yellow prisms, red prisms, orange plates,  yellow 
needles and orange-red plates
17. 
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Figure 1.1.3: Molecular structure of ROY 
 
The six polymorphs mentioned above are all available in single crystal forms from 
recrystallisation from solvents, with no solvates known.  This is a unique case and 
makes ROY the organic compound with the most available polymorphs from simple 
recrystallisation.    There  are  also  now  three  further  polymorphs  that  have  been 
discovered  from  less  studied  routes
18,19.    This  goes  to  show  the  importance  of 
alternative  approaches  to  polymorph  screening  to  include  not  only  solvent 
crystallisations, but also allowing for the discovery of further polymorphs via unusual 
routes. 
 
The terminology surrounding polymorphism is a major area of ambiguity with many 
terms relating to small subtle changes in the crystal structure, which may or may not 
be  evidence  of  a  new  polymorph  being  produced.    These  include 
pseudopolymorphism and conformational polymorphism
1.  The first of these relates to 
the formation of solvates and hydrates of which there are many in a wide range of 
studied compounds as highlighted by Jacco van de Streek
20.  The second is a much 
more complicated term as any small changes in crystal structures, with reference to 
changing temperature or pressure, etc, of a specific study could be described by the 
author  as  an  incidence  of  conformational  polymorphism.    The  potentially  narrow 
scope  of  this  field  in  trying  to  attribute  the  occurrence  of  polymorphism  can  be 
identified in the study of methyl 4-hydroxybenzoate where a stable crystal structure 
was known to exist
21.  Further work was carried out on the crystal structure and a 
reported  conformational  polymorph  was  discovered
22.    The  small  changes  with 
reference to the original crystal structure, solved at room temperature, were largely 
due to a torsion angle change of less than 6
o.  This prompted further discussion and 5 
 
disagreement
23, illustrating how an apparent polymorphic transition can sometimes be 
defined at the authors’ discretion. 
 
The relationship between polymorphs and their most stable forms can be described as 
monotropic  or  enantiotropic
24.    If  the  polymorphs  are  related  monotropically, 
transformation from the metastable form to the stable form is irreversible independent 
of the physical processes that are applied to the structure – a return to the metastable 
crystal  structure  will  not  occur.    If  the  polymorphs  are  related  enantriotropically 
however, the transformation is reversible.  In this case a transition point exists, where 
the  free  energies  are  identical,  and  at  temperatures  above  this,  one  form  is  more 
thermodynamically  stable  than  the  other,  whereas  this  is  the  opposite  at  lower 
temperatures.  There are two proposed mechanisms for such transitions, solid state 
transitions (SST) and solution mediated transformations (SMT)
25.  SST are influenced 
by the environment of the crystal, such as pressure and temperature, and also by the 
presence of crystal defects and impurities.  SMT typically occur in solvent and can be 
driven  by  the  change  in  solubility  between  the  two  forms,  however  at  higher 
temperatures it is also possible for a second, less stable, state to be accessed due to the 
increase in energy as a result of heating.   
 
The massive increase in the study of polymorphism has given rise to a significant 
improvement in techniques for monitoring the modifications in crystal structure.  The 
instrumentation available for the detection, characterisation and identification of new 
polymorphs has increased at a significant rate in terms of both in-situ techniques and 
also off-line techniques.   
 
With regards to off-line techniques that are used most regularly these can typically be 
subdivided into four areas; crystallographic, spectroscopic, microscopic and thermal.  
Crystallographic  techniques  include  both  single  crystal  diffraction  and  powder 
diffraction, from both X-ray and neutron sources.  The significant increase has come 
increasingly  in the powder diffraction side with  it now becoming routine to solve 
crystal  structures  to  a  publishable  standard  using  the  quality  of  powder  data  and 
structure solution programs now widely available.  Spectroscopic techniques include 
infrared spectroscopy and Raman spectroscopy, and while not able to solve structures 
in terms of the 3-dimensional connectivity, these can give quick analysis of samples 6 
 
to indicate similarities and changes from the starting materials.  Microscopic analysis 
is  used  to  examine  the  optical  properties  of  crystals  for  example  using  electron 
microscopy.  Thermal techniques include differential scanning calorimetry (DSC) and 
thermal gravimetric analysis (TGA) and these are routinely carried out together to 
examine changes in the physical properties of the compounds. 
 
X-ray powder diffraction (XRPD) is still the most routinely used and arguably the 
most important technique for quick determination of products.  It is now possible in 
high throughput labs to produce hundreds of samples each day and using XRPD to 
carry out analysis quicker than ever.  However these techniques require preparation of 
appropriate samples and especially in the example of XRPD, grinding of the samples 
into a fine powder is sometimes able to in itself produce enough energy to produce a 
new polymorph
26,27. 
 
1.2: Nucleation 
 
Crystal  nucleation  is  generally  viewed  as  essentially  a  two-step  process,  which 
involves the initial formation of clusters followed by the organisation of these clusters 
into  ordered  crystalline  arrangements
28.    These  clusters  are  determined  to  be  at 
nucleation when the critical nuclei size is reached.  This point is unique for every 
system investigated and even for polymorphic forms of the same molecule this can be 
different. 
 
Homogeneous nucleation,  in which  nucleation will occur spontaneously with only 
molecules  of  the  crystallising  materials  present,  will  very  rarely  occur  in  large 
volumes of solution as these are highly difficult to prepare without the presence of 
impurities.    It  is  believed  that  homogeneous  nucleation  can  be  controlled 
experimentally  by  many  variables  including  solubility  and  temperature
2.  
Precipitation  in  small  volumes  has  been  used  to  study  homogeneous  nucleation 
processes.    An  example  of  this  is  the  generation  of  the  metastable  polymorph  of 
nabumetone via capillary based crystallisation
29.  Due to the increased evaporation 
time this can also promote the growth of larger crystals in an environment much more 
likely  to  induce  homogeneous  nucleation  than  that  of  the  common  sample  vial.  
Further  studies  include  the  use  of  emulsion  systems  to  study  homogeneous 7 
 
nucleation, this involves the separation of heteronuclei in the dispersion of a melt and 
from  the  remainder  of  the  drop  homogeneous  nucleation  can  occur
30,31.    This 
technique  was  carried  out  on  meta-chloronitrobenzene  (m-cnb)  from  2  solutions 
containing a mixture including para-chloronitrobenzene (p-cnb).  This also involved 
seeding with m-cnb and the resulting crystallisation resulted in a highest purity of 
99.7% for both of the solutions prepared. 
 
Heterogeneous  nucleation  processes  are  significantly  more  important  in 
pharmaceutical systems since extra surfaces can act as nucleation points to promote 
the crystallisation of different crystal structures.  This process can occur via many 
pathways from scratching of the walls of the vessel to accidental nucleation by dust or 
a strand of hair.  This sensitivity to environment is what makes the nucleation process 
so hard to define.  In laboratory and large-scale crystallisations it is often found that 
the nucleation process appears to originate in one section of the reaction vessel.  This 
can be at different areas such as at a cooling spot or the surface of a liquid.  It can also 
be found that a particular spot on the vessel wall or the stirrer can also be the centre 
around which nucleation occurs, this is generally due to faults in the glassware, which 
are impossible to avoid.  In the case where the same glassware is being used for 
another  experiment,  there  may  be  a  seed  left  behind  that  will  lead  to  erroneous 
results
32.  
 
Whilst  thermodynamic  models  are  available  to  predict  polymorphism 
computationally,  they  do  not  currently  accommodate  kinetic  factors  such  as 
nucleation and crystal growth resulting in an inclination to overestimate the tendency 
to  form  polymorphs
15.    There  are  three  well  defined  regions  associated  with 
crystallisation  (Figure  1.2.1).    The  first  is  a  stable,  unsaturated,  zone  where 
crystallisation  is  impossible.    The  second  is  the  metastable  zone  between  the 
solubility and supersolubility curves, where crystallisation is improbable, however if 
seeds were to be implanted in a metastable solution then growth would occur on it
33.  
This is the preferred region to carry out controlled crystallisations as this helps to 
prevent  any  unwanted  nucleation  from  occurring
34.    Crystallisation  within  the 
metastable zone is not common due to the stability of the solution and beyond this 
metastable  zone  the  system  is  said  to  be  labile,  and  this  is  where  spontaneous 
nucleation can occur.  Tuning the cooling rate of a supersaturated solution until the 8 
 
first indications of crystallisation can be seen, can control the onset of nucleation.  
This is referred to as the nucleation point.  
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Figure 1.2.1: Illustration of the metastable zone incorporating solubility curve and 
supersolubility curve. 
 
In many cases the best way to control the crystallisation product is to add seeds from 
previously  grown  crystals
35,36  thus  being  able  to  control  the  final  product  of  the 
crystallisation.    Seeding  can  be  carried  out  either  intentionally  or  unintentionally, 
which  leads  to  the  idea  of  homogeneous  and  heterogeneous  nucleation.    The 
effectiveness of crystal seeding in controlling crystallisation outcomes relies on the 
potential of solid surfaces to promote heterogeneous or secondary nucleation, while 
avoiding  heterogeneous  nucleation  mediated  by  unknown  contaminants.    Roger 
Davey, through the simple example of brown sugar, highlights this theory where just 
one granule is used to produce numerous others of a uniform size and shape
37. 
 
 
1.3: Small angle x-ray scattering (SAXS) 
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X-ray and also neutron small angle scattering are both powerful probing techniques 
that  can  be  used  in-situ  to  study  the  growth  of  particles  and  monitor  solution 
changes
38,39.    SAXS  is  widely  used  to  analyse  low  resolution  structure  and 
conformational changes of native biological  macromolecules  in solution
40 and  has 
come a long way since A. Guinier developed the main principles behind the technique 
during  his  studies  of  metallic  alloys
39.    Progress  in  these  fields  have  led  to  the 
manufacturing of significant high – flux dedicated x-ray synchrotron radiation beams, 
such as station 2.1 at the SRS, Daresbury Laboratories, which was used to collect 
some of the data presented in Chapter 4 and 5.  Such a beamline can generate huge 
amounts  of  data  during  in-situ  experiments,  though  the  analysis  of  these  can  be 
difficult and time-consuming. 
 
Low angle scattering can  be  important for studying the onset of crystallisation  in 
solution as at the onset of crystallisation there is no crystallinity, merely the start of 
ordering of molecules in solution.  This allows larger d-spacings to be investigated.  
Such  studies  are  hugely  important  and  could  in  principle  be  used  to  aid  in  the 
prediction of polymorphism if ever a reliable kinetic profile of crystallisation can be 
produced.  SAXS can also be used as a complementary technique with wide angle x-
ray  diffraction  (WAXS)  which  can  also  be  used  to  study  structural  changes  in 
solution.  When used together they provide complementary methods for determining 
size,  size  distribution,  structural  profile  and  ‘order’  in  the  solution  state.    SAXS 
focuses on the low scattering angles, <10
o, and WAXS from 3/4-60
o.  
 
SAXS measurements typically are concerned with scattering angles <10
o. As dictated 
by Bragg's Law (nλ=2dsinθ), the diffraction information about structures with large d-
spacings lies in this region.  In Bragg’s law, n is an integer, λ is the wavelength of the 
incident and diffracted beam, d is the spacing between the planes in the crystal and θ 
is the scattering angle.  Therefore the SAXS technique is commonly used for probing 
large  length  scale  structures  such  as  high  molecular  weight  polymers,  biological 
macromolecules  and  self-assembled  superstructures.    When  used  in  the  study  of 
proteins  and  other  macromolecules  it  routinely  provides  information  on  the  size, 
shape and the radius of gyration of the sample under study.  SAXS measurements are 
technically challenging because of the small angular separation of the direct beam 
(which is very intense) and the scattered beam.  Large specimen-to-detector distances 10 
 
and high quality collimating optics are used to achieve good signal-to-noise ratio in 
the SAXS measurement.  This relies on the availability of SAXS programs which can 
reveal significant signal from the scattering region at low scattering angles.   
 
SAXS has been used in conjunction with Raman spectroscopy in the study of fibrillin 
rich microfibres
41.  This enabled the packing of the microfibres contained in the tissue 
and the organization to be monitored.  A combination of these techniques enabled 
changes within the microfibrils to be noted on a macromolecular and submolecular 
level to be noted when the tissue was extended and strained.  With the development of 
SAXS it is possible to carry out experiments such as this and determine the overall 
change in structure on such small scales. 
 
Amorphous carbon films have also been studied using SAXS to develop the technique 
away from purely biological science, and be applied to determine their porosity.  The 
films  studied  were  produced  by  plasma  enhanced  chemical  vapour  deposition 
(PECVD)
42, which deposits films at varying argon pressure.  As SAXS probes the 
whole structure, the changes in pore size were able to be determined using GNOM
43.  
This  enabled  8nm  pores  to  be  detected  in  carbon  films  produced  at  high  argon 
pressure.  With such determination at small sizes the possibilities for the technique are 
very wide ranging. 
 
SAXS has also been used to monitor solution structures.  This can lead to significant 
prospects with regards to molecular binding in the body.  Glyceraldehyde-3-phosphate 
dehydrogenase  (GAPDH)  was  studied  in  relation  to  the  method  by  which  it 
transported into the cell surface where glycolytic enzymes are not routinely found
38.  
Crystallographic studies found that GAPDH formed dimers whereas all other GAPDH 
type structures formed tetrameric structures.  Through SAXS studies, however, it was 
noted that the protein was in fact tetrameric in solution but it is the arrangement of the 
dimers that alters from previous studies.  Using SAXS it was also possible to monitor 
the impact of the structure upon binding to NAD+, which contracted significantly.  
 
A further study involving solution structures was carried out on the human natural 
killer inhibitory receptor Irp60
40.  SAXS data was able to determine that Irp60 is 
monomeric in solution with distinct molecular shape.  This is even though there is no 11 
 
crystallographic data available for this specific protein, showing that in the absence of 
such data SAXS is still able to determine shape in solution. 
 
 
1.4: Studies in the Solid State 
 
Crystal engineering is the design and production of molecular solid state structures 
based upon their functional group capabilities.  This can be done with the aim of 
controlling subsequent physical properties that the molecules will possess.  Crystal 
engineering has become an area of wide scale study and has been developed widely in 
terms of predictability of interactions that are likely to occur. Being able to predict 
structures is still proving a great challenge, including computationally, so there is still 
a lot of knowledge to be gained before crystal engineering will result in confident 
predictions.  This area is open to a great deal of ongoing work and relies on a lot of 
experimental trial and error before reliable predictions will ever be made. 
 
The basic technology project; CPOSS (Control and Prediction of the Organic Solid 
State)  project  was  set  up  to  try  and  combine  the  theoretical  prediction  of 
polymorphism with the practical side of growing polymorphs to push the boundaries 
of polymorph prediction, which would ultimately lead to the ability to confidently 
predict the lowest energy conformation of a specific compound, and the number of 
polymorphs present.  The project, led from University College London, reaches out to 
experimentalists  carrying  out  high  throughput  XRPD  and  monitoring  early  stage 
polymorph formation using solid state NMR and links in with computational studies.  
These computational studies produce energy landscapes to show what is predicted to 
be the lowest energy polymorph.  There have been occasions that this has been able to 
generate the most stable polymorph even taking into account hydrates
44, however the 
kinetics behind crystal growth are not well enough understood to be incorporated into 
the calculations and for this reason relative energies of known polymorphs are not 
always predicted correctly, and many possible polymorphs are missed. 
 
The progress incorporated in such a research activity can be measured when both 
experimental data and computationally predicted structures are combined such as in 
the case of the 5-substituted uracils
45.  This approach compared the experimentally 12 
 
produced  crystal  structures  of  twelve  uracils  substituted  at the  5-position  and  the 
energy predictions associated with the most likely forms.  The computational studies 
in this work calculated the experimentally produced crystal structures to be within 3kJ 
mol
-1  of  the  global  minimum.    This  implies  that  these  structures  produced  were 
indeed within reasonable range of the computationally produced global minimum and 
are determined to be thermodynamically feasible.  
 
The computational methods currently in place still rely purely on energy calculations 
but through computational program development, crystal structure prediction is now 
able to study compounds with Z’>1, more flexible compounds and now co-crystals.  
There  are  obvious  limitations  in  the  reliability  of  polymorph  prediction  using  the 
current  techniques,  however  there  has  been  progress  in  terms  of  crystal  structure 
prediction  and  a  way  to  evaluate  this  is  via  the  four  blind  tests  carried  out  so 
far
46,47,48,49.   These  blind  tests, organised  by  the  Cambridge  Crystallographic  Data 
Centre, are on compounds without widely  available structural data and  in  fact an 
independent figure holds the structural data for the compounds in the tests.  Each of 
the groups that takes part is allowed three predictions, ranked, for each molecule.  For 
the first time in blind test 4 it has been possible for a group (Neumann, Leusen and 
Kendrick)  to  predict  all  four  molecules  correctly  and  as  their  top  ranked  guess, 
however  the  technique  used  requires  a  great  degree  of  computational  time.    This 
however proves that significant progress has been made since the first blind test where 
from  many  attempts  only  seven  guesses  were  ‘classified  as  correct’  though  with 
numerous structures available around the global minimum even this was inconclusive.  
For this reason it is essential that efforts to improve crystal structure energy prediction 
continue and that inclusion of kinetic factors is developed to aid with the difficulties 
that lie within polymorph prediction. 
 
 
1.5: Pre-Nucleation Studies and Crystallisation Within the Metastable Zone 
 
Pre-nucleation studies are fundamental with respect to increasing knowledge about 
how crystallisation occurs.  Using focussed beam reflectance measurements (FBRM) 
and  particle  vision  and  measurement  (PVM)  it  has  been  possible  to  monitor  a 
polymorphic transition of mannitol
50,51.  These techniques enable in-situ monitoring of 13 
 
particle changes without sampling and whilst FBRM records the changes in the chord 
length  distribution,  PVM  enables  visual  monitoring.    This  can  have  benefits  with 
regards to monitoring dissolution and recrystallisation to examine the forms as they 
are being produced.  This also eliminates the need for supplementary techniques to 
examine whether a change has occurred such as XRPD, which as mentioned above in 
itself can sometimes promote a polymorphic transition due to the grinding necessary. 
 
FBRM has also been used to monitor the particle size changes in solution
52,53.  The 
FBRM  probe  has  a  measurement  range  of  1-1000µm  and  can  collect  data 
measurements every five seconds and transfer them to chord length distribution plots 
(CLD).  Making use of this with an imaging technique such as process video imaging 
(PVI)  provided  evidence  that  below  1µm  the  FBRM  was  not  highly  sensitive 
signifying that although the FBRM probe generates an idea of what is in solution it is 
not sufficiently sensitive to provide any evidence on crystallisation kinetics. 
 
Other  techniques  involved  in  solution  studies  include  the  use  of  attenuated  total 
reflectance ultra-violet (ATR-UV).  This is another in-situ technique that has been 
successfully developed to monitor concentration changes of an organic compound
54.  
The UV absorption data acquired can be simply transformed to concentration using 
the Beer Lambert law for the absorbance 
 
A = e c l.   
 
where A is the absorption coefficient, e is the molar absorptivity of the absorber, c is 
the concentration and l is the path length. 
 
The  metastable  zone  refers  to  the  region  of  supersaturation  where  spontaneous 
nucleation cannot occur and a seed of the crystal is required to initiate growth.  The 
width of the metastable zone indicates the stability of the solution, the larger the zone 
width the more stable the solution
33. 
 
A solute is maintained in solution until a sufficiently high level of supersaturation has 
been  developed;  this  in  turn  encourages  spontaneous  nucleation  to  occur.    It  is 14 
 
important to characterize the metastable zone width (MZW) under a specific set of 
operating  conditions,  which  relate  closely  to  the  conditions  of  the  final  scale 
crystallisation.  The polythermal technique
55 involves cooling a saturated solution at a 
fixed  rate  until  nucleation  occurs.    This  is  repeated  several  times  at  a  variety  of 
cooling rates until a reliable MZW can be determined.  The MZW can be considered 
to be characteristic for each crystallisation system as each is unique.  The induction 
period of nucleation is defined as the time that elapses between the instant when the 
supersaturated state is generated and the point of time at which solid phase particles 
become detectable.  This includes the time required for the generation of a critical 
nucleus in supersaturation and the growth to a detectable range, which can be as low 
as 1µm in the FBRM
56. 
 
Understanding the MZW is of fundamental importance in being able to control crystal 
growth  and  is  widely  studied  in  this  field
1.    In  depth  solubility  studies  and 
supersolubility studies of a single compound are needed and temperature control is 
crucial.  Reliable dissolution profiles can be determined and these are fundamental in 
the pharmaceutical industry in particular.  This is due to the increase in discovery of 
new polymorphic  forms of  molecules  and the corresponding changes  in their key 
physical properties such as solubility.  For this reason it is vitally important to be able 
to carry out these experiments  in a clean and controlled environment as even the 
smallest contaminant such as a speck of dust can be known to initiate nucleation. 
 
 
1.6: Experimental Structure and Hydrogen Bonding in Molecular Crystals 
 
Hydrogen  bonding  is known to be the strongest non-bonding  interaction with the 
strongest being similar in strength to that of some conventional covalent bonds.  It is 
proven  to  be  vitally  important  in  both  structural  chemistry  and  biology  where 
hydrogen  bonds  provide,  for  example,  vital  interactions  in  the  structure of  DNA.  
Hydrogen  bonds  are  known  to  affect  the  smallest  of  molecules,  such  as  ice  and 
essentially  provide  the  glue  that  holds  a  structure  together.    Techniques  such  as 
infrared spectroscopy and NMR can be used to monitor the dynamics and strengths of 
hydrogen bonding systems, however crystallography can tell us precise information 15 
 
about the atomic positions in specific crystal systems and hence about the detailed 
geometry of hydrogen bonds.   
 
From a crystallographic perspective, hydrogen bonding interactions are known to be 
the strongest non covalent interactions with energies ranging from 0.5 – 40 kcal mol
-1.  
Pauling  first  freely  used  the  term  hydrogen  bond  in  1935  to  account  for  the 
interactions in ice
57, though the prospect of hydrogen bonding had been advanced 
previously by Latimer and Rodebush (1920)
58 and Huggins (1922)
59 and has been 
progressively used since.  Pauling stated that in a hydrogen bonding system, X-H- - - 
A,  only  if  X  and  A  were  highly  electronegative  would  there  be  an  electrostatic 
interaction between H and A that would in turn be sufficiently high to be termed a 
hydrogen  bond
60.    This  theory  however  restricts  the  phenomenon  of  hydrogen 
bonding to interactions where X and A are any of; F, O, Cl, N, Br or I.  This has led 
to further quantification and led Steiner and Saenger in 1993 to put forth their own 
definition that ‘any cohesive interaction X-H- - - A where H carries a positive and A a 
negative charge and the charge on X is more negative than on H’ can be deemed to be 
a hydrogen bond
60.  This definition still holds value today. 
 
Hydrogen bonding is routinely split into three types according to their energy: weak < 
4 kcal mol
-1, moderate 4-15 kcal mol
-1 and strong 15-40 kcal mol
-1  61.  Unusually 
activated donors and acceptors, often in an intramolecular situation, form very strong 
hydrogen bonds
60.  Most often they are formed between an acid and its conjugate 
base,  X-H-  -  -  X
-,  or  between  a  base  and  its  conjugate  acid,  X
+-H-  -  -  X.   The 
distinctive  characteristic  of  such  interactions  is  that  their  bonding  is  covalent  in 
character, for example the X-H and H-A distances are comparable.  An energy range 
of 15-40 kcalmol
-1 is to be found for this category.  The main examples include [F- - - 
H- - - F]
- and [N- - - H- - - N]
+.   
 
The moderate region with regards to hydrogen bond strength is the most common and 
is  frequently  observed  in  organic  compounds.    Many  functional  groups  that  have 
hydrogen bonding capabilities are to be found in this region.  This area of hydrogen 
bonding represents a change from the almost covalent nature of the bonding involved 
in the very strong hydrogen bonds, towards the electrostatic character that is typical 
of hydrogen bonding systems.  These systems are also known to be most common for 16 
 
undergoing hydrogen transfer between donor and acceptor compounds and have been 
widely studied
62,63.  For example Schmidtmann et al. studied hydrogen transfer in 
pentachlorophenol – dimethylpyridine (lutidine) complexes
64.  By matching the pKa 
of these compounds they could examine how a change in which lutidine isomer was 
used would affect the hydrogen atom position, since even though the lutidine isomers 
are from the same family, their pKas are not identical.   
 
Weak hydrogen bonds are numerous throughout most crystal structures but are not 
widely studied due to the presence of stronger interactions, which are common in 
many  crystal  structures.    The  strongest  of  these  bonds  such  as  O-H-  -  -  π,  are 
electrostatic in nature and have energies that are comparable to a bond such as O-H- - 
- O-H.  The energy of these interactions typically lies in the 2-4 kcal mol
-1 range.  
This is in contrast to the weakest of the interactions containing C-H donors, which are 
barely stronger than dipole-dipole interactions or dispersion forces
60. 
 
Hydrogen  bonds are  long range and directional  interactions and  because of this a 
group X – H can be bonded to more than one acceptor at the same time.  In a situation 
where there are two acceptors, A1 and A2, this is called a bifurcated hydrogen bond 
(Figure 1.6.1). 
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Figure 1.6.1 a and b: An example of a bifurcated hydrogen bond donor and 
acceptor 
 
The term bifurcated can also be used to describe the action of an acceptor molecule.    
This has mainly been observed for systems containing weak hydrogen bonds or in 
organometallic compounds.  This is because organometallic systems can be donor rich 
when  weak  donors  are  taken  into  account  and  in  these  circumstances  bifurcated 
acceptors can occur frequently depending on the ligands surrounding the metal centre.  
This is not a new discovery and in fact can be found to exist in important compounds 
such as glycine
65, while a study of tetrachlorohydroquinone also discovered bifurcated 17 
 
hydrogen bonding
66.  The three angles associated with a bifurcated hydrogen bond can 
also be used to give an example of the environment of the hydrogen.  That is to say 
that  if  the  three  angles  add  up  to  360
o, the  hydrogen  will  lie  in  the  plane  of  the 
hydrogen bonds, however the smaller the angle becomes the more raised above the 
plane the hydrogen atom becomes.  In the literature it is often noted that a bifurcated 
hydrogen  bond  is written as X-H- - - A1(A2)
60.  This  is due to the presence of a 
dominant hydrogen bond and in many cases the weaker bond will be ignored.  It is 
very  rarely,  if  at  all,  seen  that  the  hydrogen  atom  will  lie  equidistant  from  both 
acceptor atoms.  The dominant interaction will always have the shorter bond distance 
and the angle associated will lie closer to 180
o.  This will become apparent in the co-
crystallisation work carried out in Chapter 7 with bromanilic acid. 
 
 
1.7: Crystal engineering and the importance of halogen bonding 
 
Hydrogen  bonding  has  always  been  recognised  as  the  strongest  intermolecular 
interaction due to its directionality resulting in strong crystal networks.  In this regard 
conventional strong hydrogen bonds such as O-H- - - O and N-H- - - O can form a 
predictable  network  of  interactions  and  are  routinely  used  in  terms  of  crystal 
engineering building blocks.  These interactions are not the only ones currently being 
studied in terms of crystal engineering and there are currently a lot of investigations 
into trying to use weaker interactions such as X- - - O, X- - - N and even X- - - X 
where X represents a halogen atom.  These interactions are considered to be similar in 
strengths to moderate hydrogen bonds, with energies in the region of 4-15 kcal mol
-1. 
 
It is known that the halogens Cl,  Br and I  form short non-bonded  interactions  in 
crystal  structures
60.    These  close  contacts  between  halogens  are  deemed  to  be 
potentially significant in stabilising a structure based on the distance between them 
being less than the sum of their respective van der Waals radii.  These contacts are 
also of high  importance  in crystal engineering as they  form the  basis of the  “4Å 
chloro rule” described by Schmidt for planar dichloroaromatic compounds
67.  This 
rule in itself is however questionable and the nature of the interactions is the cause for 
some  debate.    Price  et  al
68  believe  that  these  short  contacts  are  the  result  of 
anisotropy, whereas Desiraju
69 believes that there are special attractive forces present 18 
 
between halogen atoms in the crystal lattice.  Atomic polarisation is an important 
factor as this induces directional interactions formed by the halogens with O and N 
atoms and has been studied in terms of crystal engineering
70.  Halogens can give rise 
to a variety of interactions depending on their size and environment where it is most 
likely that fluorine and chlorine atoms will interact mainly in terms of C – H- - - X 
and less in terms of X- - - X, while bromine and iodine atoms tends towards X- - - O 
interactions
60.  This is likely to be due to the increased polarisability of the heavier 
halogen atoms giving more directionality. 
 
Whilst halogen bonds, X- - - O, N, have been found to exhibit orientation preferences 
this  is  not true  for  halogen  –  halogen  interactions.    It  is  recognised  that  halogen 
bonding  may  be  strong  enough  to  be  of  prime  importance  in  the  arrangement  of 
molecules in a crystal lattice, however this is certainly not true of halogen – halogen 
interactions.  Nyburg and Faerman
71 found the sum of van der Waals radii of the 
halogens varies as a function of the direction of the interaction, i.e. head-on or side-
on.  The values are noticeably higher in the side-on position indicating the importance 
of anisotropy of the electron density of the atom.  Halogen bonding has been studied 
with regards to four p-phenyl-substituted cis-9,10-diphenyl-9,10-dihydroanthracene-
9,10-diols,  with  the  para  substituent  being  either  chloro,  bromo,  iodo  or  methyl 
substituted
72.  This study showed that the O-H- - - O hydrogen bond was present 
throughout, however the methyl substituted compound was found to crystallise in the 
monoclinic P21/c space group whereas the other three halogen containing compounds 
were  discovered  to  crystallise  in  the  P-1  space  group  each  containing  competing 
halogen  –  halogen  interactions.    This  also  provides  further  evidence  against  the 
existence of a chloro-methyl exchange rule. 
 
Christer Aakeröy et al. have studied the effect of combining hydrogen bonding and 
halogen  bonding  interactions  in  terms  of  developing  supramolecular  strategies  to 
generate  target  molecules.    This  was  done  via  a  series  of  co-crystallisation 
experiments between a molecule containing two sites with possibilities of hydrogen 
or  halogen  bonding  and  a  secondary  molecule  containing  a  weak  and  a  strong 
hydrogen bond donor and a potential halogen bond donor, where bromo, chloro and 
iodo substitutions were all attempted in this secondary molecule
73.  These co-crystal 
studies proved that the strong hydrogen bond interactions, in this case oxime dimers, 19 
 
are always formed.  Only in the iodine-containing secondary molecule was a halogen 
bond  formed,  for the chloro and  bromo substituted molecules the weak  hydrogen 
bond was formed (figure 1.7.1).   
 
 
 
Figure 1.7.1 a and b:  The crystal structures of the iodo and bromo substituted co-
crystal compounds studied by Aakeröy
73. 
 
Figure 1.7.1 a shows the I- - - N halogen bond formed alongside the F- - - F halogen – 
halogen interactions.  In the bromo substituted analogue only Br- - - F halogen – 
halogen interactions are found to exist, these link the molecules in three dimensions. 
 
Further  work  has,  however,  led  to the  successful  generation  of  halogen  bonds  to 
supplement the presence of strong hydrogen bonds in co-crystal compounds
74. 
 
 
1.8: Co-crystallisations 
 
Co-crystallisations are becoming more widely used with regards to trying to develop 
complexes with specific physical properties, and there is a large market for this in the 
pharmaceutical industry in particular.  An example of this is where a co-crystal can be 
formed to encourage the formulation of an active pharmaceutical ingredient in a form 
that will be taken up in the body, for example with favourable solubility properties.  
In crystallography terms the terminology surrounding co-crystals can still be slightly 20 
 
contentious, especially with regards to co-crystals involving hydrogen transfer where 
these  may  be  more  accurately  referred  to  as  salts.    Co-crystals  are  commonly 
described as ‘structurally homogeneous crystalline materials that contain two or more 
neutral building blocks’
75.  This definition however can lead to ambiguity as any co-
crystal that shows hydrogen transfer should be described as a salt.  Problems can then 
arise if studying the hydrogen transfer as a function of temperature as the hydrogen 
atom has sometimes been shown to migrate towards an acceptor atom as a function of 
temperature, meaning originally the two were neutral, however as temperature has 
changed this is no longer the case.  During the work presented here, these will be 
referred to as co-crystals to remove any ambiguity with regards to situations where 
hydrogen transfer occurs and others where hydrogen transfer does not occur.   
 
Co-crystals are often produced in an attempt to generate a specific interaction and to 
determine how reliable such an interaction is in a family of related molecules.  The 
production of such an interaction may not ultimately be successful, however it is still 
important  to  try  and  determine  which  interactions  occur  and  are  therefore  more 
dominant.  A lot of this chemistry is however trial and error with regards to crystal 
engineering, however there is more progress being noted in this field also.  A crystal 
engineering approach was recently undertaken with caffeine to attempt to produce a 
co-crystal that is stable at high relative humidities
76.  Caffeine was co-crystallised 
with a series of dicarboxylic  acids  and a predicted intermolecular  hydrogen  bond 
motif was produced.  
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Chapter 2: Theory 
 
2.1 Crystallography 
 
Crystallography is the best way of obtaining detailed atomic structural information 
from a well ordered solid material.  This allows analysis of crystalline solids most 
commonly  by  use  of  X-ray  or  neutron  diffraction.    These  techniques  allow  the 
examination of a wide range of materials and provide precise information about the 
location of atoms in the structure.  X-ray diffraction is the most commonly used and is 
the  most  widely  available  especially  in  terms  of  in-house  equipment.    Neutron 
diffraction is less widely used due to the specialised sources and equipment required 
and this tends to involve significant cost and time at specialised central facilities such 
as  ISIS,  RAL,  Oxfordshire,  UK  or  the  ILL  (Institut  Laué  Langevin)  facility  in 
Grenoble, France.  It should also be noted that high intensity X-rays are also available 
at  central  facilities,  at  synchrotron  radiation  sources  such  as  the  Diamond  Light 
Source in Oxfordshire, and previous to that at SRS, Daresbury Laboratory.  The high 
intensity  of  these  synchrotron  sources  allow  the  study  of  very  small  or  weakly 
scattering  samples,  for  example,  that  are  not  amenable  to  study  in  the  home 
laboratory. 
 
X-ray and neutron diffraction are very different to each other because of the different 
mechanism  by  which  they  interact  with  the  crystal.    X-rays  are  electromagnetic 
radiation and interact with the electron clouds of atoms via an electrostatic interaction, 
whereas neutrons interact with the nuclei of atoms via the strong nuclear force.  The 
X-ray scattering factors increase strongly with atomic number (~Z, with intensities 
varying as Z
2), whereas the neutron scattering length shows a fairly random trend of 
value with increasing atomic number; there is a very slight tendency to increase with 
Z, but there is a large amount of fluctuation in the absolute values.  For this reason 
neutron diffraction is highly important with regards to finding precise hydrogen atom 
positions as these can often be poorly resolved, or hidden by the presence of heavier 
atoms when studying by X-ray diffraction especially in the presence of many heavy 
atoms.   
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The hydrogen atom position  found via X-rays  is also generally  not accurate, with 
shortened bond distances due to the electron (from which the X-rays scatter) being 
pulled  into the  covalent  bond.    For this  reason  it  is  recognised  when  considering 
hydrogen  bonds  then  it  is  best  to  use  donor  –  acceptor  distances  from  X-ray 
determinations  rather  than  distances  from  the  calculated  hydrogen  atom  position.  
This is not the case in neutron experiments where the nuclear position is found and 
due to the scattering length of hydrogen being negative for neutrons, hydrogen atoms 
appear as a very distinctive trough in a difference Fourier map rather than the usual 
peaks.  Neutrons also travel much further through crystals than X-rays probing far 
more  of  the  material,  due  to only  weak  interactions  with  matter.    However,  this, 
combined with the fact that the sources have a low flux, means that larger crystals are 
required to be generated before neutron diffraction can be carried out.  Both single 
crystal techniques make use of the same fundamentals of diffraction theory, however 
there are advantages and disadvantages for the use of either. 
 
Single crystal crystallographic techniques are employed to determine details of the 
molecular  and  crystal  structure  of  the  solid  –  bond  lengths,  bond  angles, 
intermolecular interactions – and are the source of some of the most precise data on 
these structural features.   
 
X-ray diffraction is a technique routinely carried out in-house making it a reasonably 
accessible source for crystal structure determination.  It should also be stated that both 
neutron  and  X-rays  have  powder  diffraction  capabilities  and  whilst  X-ray  powder 
diffraction  is  still  routinely  used  for  sample  identification  purposes  there  are  now 
emerging examples of crystal structure determination from powder diffraction alone
77.  
This has been made possible due to high resolution powder data being available and 
also the substantial progress  in the programs available  for solving  structures from 
powder data.   
 
 
2.2: Diffraction Theory 
 
Much  of  the  theory  that  is  fundamental  to  crystallography  and  solving  crystal 
structures  was  known  well  before  it  was  trialled  experimentally  on  a  crystalline 23 
 
material.  The fundamentals rely on the theory of diffracted light and also the use of 
mathematical models describing the geometry of crystal lattices.  This, coupled with 
the discovery of X-rays
78 enabled von Laue to demonstrate that crystals could diffract 
X-rays
79.  The first structure solved was the structure of salt in 1913
80.  From this the 
field  of  crystallography  has  grown  and  become  a  significant  process  in  terms  of 
chemistry, materials science and biology.  Diffraction methods are often used not only 
with  regards  to  crystal  structure  determination  but  also  to  distinguish  between 
different polymorphs of the same material, examine the purity of a product and also to 
closely examine the bonding and interactions within a crystal structure. 
 
2.2.1: The Unit Cell and Crystal Lattice 
 
A crystal is built up of a basic pattern of points repeated in three dimensions; this is 
called the crystal lattice.  A repeating motif can be placed onto each lattice point to 
build up the three dimensional structure by translation, which occurs whether there are 
any other forms of symmetry or not.  If each repeating molecule is represented by a 
single point, the result of this translation will show a regular array of points, which 
indicate the repeating motif.  This array of points is the lattice. 
   
Defining the repeating geometry of the structure, the unit enclosed by lattice points 
that is repeated by translation to produce the crystal is called the unit cell, where the 
unit cell usually contains the equivalent of one lattice point (though this can be more).  
The unit cell can contain either one molecule, or a combination of many molecules.  
In three-dimensions, each unit cell has a shape size defined by six parameters; lengths 
a, b and c and angles α, β and γ (Figure 2.2.1.1). 
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Figure 2.2.1.1: A three dimensional unit cell. 
 
Rotation and reflection symmetry impose restrictions on the unit cell parameters and 
while every three-dimensional lattice has inversion symmetry, the restrictions applied 
result in crystal systems being divided into seven types (Table 2.2.1.2).  In addition to 
these seven crystal systems, the presence of different numbers of lattice points inside 
the  unit  cell  (called  cell  centrings)  generates  the  Bravais  lattices,  and  internal 
symmetry elements present within the unit cell lead to the definition of the space 
group defining the overall symmetry of the crystal contents, which is dependent on 
the crystal system.  The crystal system adopted by a crystal does limit the number of 
space groups available.   
 
Crystal System  Unit Cell Restrictions  Unit Cell Types 
Triclinic  No restrictions  P 
Monoclinic  α = γ = 90
o, β ≠ 90
o  P, C 
Orthorhombic  α = β = γ = 90
o  P, C, I, F 
Tetragonal  a = b, α = β = γ = 90
o  P, I 
Trigonal  a = b, α = β = 90
o, γ = 120
o  R 
Hexagonal  a = b, α = β = 90
o, γ = 120
o  P 
Cubic  a = b = c, α = β = γ = 90
o  P, I, F 
P = primitive, C = centred, I = body – centred, F = face-centred, R = rhombohedral 
 
Table 2.2.1.2: Unit cell types with associated unit cell requirements and possible 
Bravais lattices. 
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A primitive unit cell contains lattice points only at all 8 corners and all of these are 
equivalent, however centred cells are sometimes used, generating a larger cell which 
contains more than one lattice point.  When lattices are described in this manner the 
six primitive lattices must be combined with eight centred lattices and this generates 
the 14 Bravais lattices.  The asymmetric unit is the most basic repeating unit, which 
relates molecules in one unit cell to each other.  This is only usually a small part of the 
unit cell and when the symmetry operations are carried out on the asymmetric unit the 
unit cell contents can be defined and thus the entire crystal can be generated.  Adding 
the symmetry elements to the possible lattices leads to a total of 230 unique space 
groups  into  which  every  regular  structure  must  belong.    The  space  group  is  the 
collection of all symmetry elements for an infinitely repeating pattern. 
 
Molecules can undergo rotation symmetry in crystals, however only certain rotations 
are permitted in the crystal system, these are C2, C3, C4 and C6.  Other symmetry 
elements can be observed in crystals by combining translation symmetry with rotation 
or reflection to generate screw axes and glide planes.  In a simple two-dimensional 
example of glide plane symmetry, this would include a reflection and a displacement 
of  half  the  repeating  unit  pattern.    A  screw  axis  involves  a  rotation  followed  by 
translation along the direction of the axis. 
 
Systematic absences arise when glide planes and screw axes cause particular subsets 
of reflections to have zero intensity, due to patterns of destructive interference of X-
rays that are completely out of phase because of the unit cell symmetry, leading to no 
scattering  being  observed.    These  are  distinct  for  the  various  space  groups.    For 
example the space group P21/n produces a unique set of systematic absences in its 
diffraction pattern.  The screw axis, parallel to the b axis causes reflections 0k0 to be 
absent when k is odd.  The glide plane, perpendicular to the b axis, and with its glide 
plane direction along the ac face diagonal, causes reflections h0l to be absent when 
h+l is odd. 
 
2.2.2: Miller Indices 
 
When the atoms present in a crystal diffract X-rays, a series of spots with defined 
positions and intensities are produced and these relate to the symmetry and specific 26 
 
atoms present in the crystal.  This is to say that a bromine atom would scatter X-rays 
with a greater intensity than that of carbon for example due to the extra electrons 
possessed  by  the  bromine  atom.    The  planes  which  give  rise  to  these  observed 
reflections are called lattice planes and their orientation may be defined by Miller 
indices h, k and l.  The unit cell is bound by the (100), (010) and (001) planes and the 
Miller indices are defined by their intercept with the a, b and c axes respectively.  A 
simple example of this would be to examine the intercepts halfway along each axis.  
The Miller indices would thus be described as a/2, b/2, c/2 = a/h, b/k, c/l and thus 
describing the (2 2 2) plane (Figure 2.2.2.1).   
 
 
Figure 2.2.2.1: Miller indices showing the (222) plane. 
 
These Miller indices then correspond to a reciprocal lattice point in the diffraction 
pattern. 
 
 
2.2.3: Bragg's Law 
 
A diffraction spot of measurable intensity is only generated when the diffracted beams 
from a series of parallel planes are in phase and give constructive interference (Figure 
2.2.3.1).  For this to happen, the path difference between these two diffracted beams 
must be equal to an integral number of wavelengths.   
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Figure 2.2.3.1: Bragg's law. 
 
This leads to Bragg's Law: 
 
Equation 2.1:  nλ = 2d sinθ 
 
In Bragg's law, n is an integer, λ is the wavelength of the incident and diffracted 
beam, d is the spacing between the planes in the crystal and θ is the scattering angle. 
 
2.2.4: The Ewald Sphere 
 
The analysis of X-ray diffraction patterns can be aided by the use of the Ewald sphere.  
This is centred on the crystal (C) and a circle with radius 1/λ is drawn around it such 
that its edge sits on the origin of the reciprocal lattice.  From Bragg's law a reflection 
is superimposed and the reflected beam cuts the sphere at point P.  Figure 2.2.4.1 
indicates that a diffraction spot will be observed if the scattering vector is equal in 
length and in the same direction as the reciprocal lattice vector QP.  Thus to satisfy 
Bragg’s law the reciprocal lattice point must touch the surface of the Ewald sphere. 
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Figure 2.2.4.1: The construction of an Ewald sphere. 
 
Figure  2.2.4.1  shows  a  simplistic  two-dimensional  view  of  an  Ewald  sphere  with 
parallel planes representing Bragg's law and layers of diffraction.  From this it can be 
seen that Bragg's law is only adhered to if scattering from the next layer produces a 
diffracted beam in phase with the one shown and a reciprocal lattice point located on 
the surface of the sphere.   
 
2.3: Structure Determination 
 
2.3.1: Diffraction patterns and Structural Information  
 
The  experimental  diffraction  pattern  collected  for  a  crystal  structure  allows 
determination  of  the  unit  cell  parameters,  the  space  group  and  the  intensity  data 
related to each individual diffraction spot, which each have their unique Miller indices 
corresponding to their positions.  Each individual diffraction spot of intensity I(hkl) 
has  a  related  structure  factor,  F
o
hkl,  where 
2 o
hkl F I ∝ ,  which  results  in  the  phase 
problem.    These  are  converted  via  a  Fourier  transformation  into  the  observed 
scattering density, the problem in carrying out this transformation being that initially 
there is no phase information available in the observed structure factors.  Each Fourier 
component, the structure factors F
o
hkl, can have a different value, which depends on 29 
 
the internal atomic structure of the unit cell.  The structure factor can thus be written 
in terms of scattering from individual atoms making up the crystal structure: 
 
Equation 2.2:   F
o
hkl = ∑ fj exp [2πi(hxj + kyj + lzj)] 
 
where the summation is over j atoms in the unit cell at coordinates (xj, yj, zj).  The 
scattering of each atom in the cell is given by the atomic scattering factor fj. 
 
There are several factors that can affect the structure factor including the temperature 
factor as indicated by the Debye-Waller effect.  This describes the fact that as each 
atom is not in a fixed position and vibrates around their equilibrium position that the 
structure factor will be reduced as a factor of temperature and this affects each atom 
individually.  This amount will depend on the local environment in which the atom 
sits within the structure.  This will be reflected in the scattering factor fj indicated in 
equation 2.2.  
 
The Fourier transformation relating the scattering density to the observed structure 
factors can be expressed as: 
 
Equation 2.3:   ρ(x,y,z) = (1/V) ∑ Fhkl exp[-2πi(hx + ky + lz)] 
 
where  (x,y,z)  represent  the  fractional  coordinates  in  the  unit  cell.    It  is  the 
interpretation of this scattering density, which enables atoms to be identified in the 
crystal structure.  This summation is carried out over all values of h, k and l and 
therefore all reflections in the diffraction pattern contribute towards it. 
 
The Debye-Waller effect reduces the scattering factor as it leads to a reduction in 
intensity due to smearing of the electron density as a function of thermal motion.  This 
leads to a reduction of the structure factor by: 
 
Equation 2.4:   (F
o
hkl)T ~ exp[-BTj(sin
2θ/λ
2) Fhkl 
 
where each atom has a separate temperature factor Bj.  B=8π
2U, where U represents 
the thermal parameters.  This is accounted for in modern refinement programs where 30 
 
the refinement is carried out allowing the average amplitudes of vibration for each 
atom in the structure to vary independently, and in fact these are usually allowed to 
adopt  non-spherical  vibrations,  undertaking  anisotropic  thermal  vibrations.    From 
equation 2.4 it can also be seen that those reflections at smaller Bragg angles will be 
less affected than those at larger Bragg angles.   
 
The atomic form factor reflects the strength of scattering of an individual atom (for X-
rays this is proportional to the number of electrons), and also how rapidly the intensity 
of reflections decrease with increasing diffraction angle.  Figure 2.3.1.1 indicates how 
rapidly this occurs for hydrogen and carbon atoms.  Also shown in this figure is the 
fact that this form, factor fall-off does not occur for neutron scattering. 
 
Figure 2.3.1.1: Atomic form factor drop off with increasing angle for X-ray form 
factors (and absence of fall-off for neutron scattering lengths). 
 
2.3.2: The Phase Problem 
 
To be able to solve a crystal structure it is necessary to know the intensity, 
2 o
hkl F I ∝ , 
and the phase of the individual reflections, however the structure factor can only be 
determined from the observed scattering intensity, thus the phase information is lost.  
The structure factor 2 can be expressed as: 
 
Equation 2.5:   F
o
hkl = | F
o
hkl | exp(iαhkl) 31 
 
 
where | Fhkl | represents square-root of the measured intensity and αhkl is the phase.  
The phase information is not collected experimentally however so only the magnitude 
is known.  This means that a simple Fourier transform will not generate the electron 
density and this is referred to as the phase problem.  There are now several methods 
for solving this phase problem and the most commonly used include: direct methods, 
the Patterson method and heavy atom methods. 
 
2.3.3: Direct Methods 
 
Direct methods is the most commonly used method for solving the phase problem and 
is  incorporated  in  most  structure  solution  programs.    These  can  examine  the 
relationships between the intensities of the reflections and lead directly to solving the 
phase problem.  The mathematical constraints used for direct methods are based on 
fundamental features of electron density, that the integrated electron density must be 
positive and finite, as defined by Sayre.  The methods currently employed can be 
directly related to the work of Karle and Hauptman who received the Nobel Prize for 
Chemistry in 1985.  This is based on the triplet relationship which relates the values 
of the three phases of reflections involved in the triplet for example if the intensities 
of three reflections such as (3 2 1), (–2 –1 0) and (-1 -1 -1), where the sum of the 
indices within the triplet are (0 0 0), are all strong, then it is probable that the sum of 
their phases will be close to zero.  Many of these probabilistic relationships can be set 
up in a diffraction data set and the method performs many trials to generate the best 
set  of  estimated  phases  producing  a  model  with  the  best  figure  of  merit,  which 
subsequently can be used to determine atomic positions from the calculated electron 
density map.  This technique is known to have a high success rate for small – medium 
sized organic compounds. 
 
2.3.4: The Patterson Method 
 
The  Patterson  method  avoids  the  phase  problem  by  making  use  of  the  known 
intensities.  The Paterson method generates a map of interatomic vectors (u, v, w) via 
|F
o
hkl|
2 values.   
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Equation 2.6:   Puvw = 1/V ∑|F
o
hkl|
2. cos[2π(hu + kv + lw)] 
 
The origin of the cell (000) will always have the highest peak as every atom will be 
mapped onto itself.  The Patterson function is a map of vectors between pairs of atoms 
in the structure.  Therefore for every peak seen in the Patterson map (u, v, w), there 
must be two atoms in the structure whose x coordinates differ by u, y coordinates 
differ by v and z coordinates differ by w.  These Patterson peaks show where the 
atoms lie with respect to each other but not with regards to the unit cell origin, which 
is essentially what we are most interested in.   
 
When  an  organic  molecule  containing  many  of  the  same  atoms  is  mapped  via 
Patterson methods the resulting map will be hard to interpret due to the presence of 
many overlapping vectors, however when dealing with structures containing heavy 
atoms these vectors will be strong and the separations of two lighter atoms will give 
much smaller peaks.  Using the phases calculated from the heavy atoms positions now 
determined,  a  subsequent  Fourier  synthesis  should  determine  the  positions  of  the 
lighter atoms. 
 
2.3.5: Heavy Atom Method 
 
The heavy atom method as suggested relies on the presence of one or more heavy 
atoms being present in the unit cell.  These heavy atoms can be found via a map of the 
interatomic vectors and from this position a set of phases can be produced.  This can 
then be built up to generate phase information for the whole structure.  The heavy 
atoms present need to scatter with a significant difference in scattering power from the 
rest of the atoms for this method to succeed.  If such an atom is present the phases can 
be deduced from this atom and a build up of phases for the structure can be generated 
until  such stage that a Fourier  map will  be able to determine the positions of the 
remaining atoms. 
 
2.4: Structure Refinement 
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The aim of a structure refinement is to generate calculated structure factors that best 
fit  the  observed  structure  factors.    It  is  possible  to  map  the  measured  reflection 
intensities by value of an electron density map, also known as a Fourier map. 
 
Equation 2.7: ρ(x,y,z) = ∑ |F
o
hkl| exp(-2πi(hx + ky + lz) + α
c
hkl) 
 
With each Fourier map produced a better model of the structure is produced and this 
improves the phase information to be used in the next cycle of Fourier calculations.  
This creates a cycle that ultimately closes in on the most accurate crystal structure 
available from the measured diffraction intensities. 
 
The positions of the atoms are known to be the peaks on the Fourier map, however to 
model the structure correctly a description of the atoms has to be refined to give a 
model that best fits the observed data.  Varying the positional and thermal parameters 
for each atom using the  least squares  method gives the  best structure refinement.  
Even for small molecule crystallography the number of parameters that can be varied 
is high so during the least squares refinement an R factor is used to rate how good the 
structure model is. 
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The R-factor is used to assess the agreement between the measured amplitudes and 
those  calculated  from  atomic  positions  during  refinement.    If  the  model  and  the 
structure are identical the R-factor would be zero, however this is unlikely to occur as 
there are always errors present throughout data collection and analysis.  The lower the 
R-factor  the  better  and  ideally  the  R-factor  would  be  between  0.02  and  0.08  for 
publication of small molecule structures.  The weighted R-factor (wR) works in the 
same way but is based on the squared structure factor values where each structure 
factor has its own weighting factor.  A better model results in a better R-factor, with 34 
 
the improving phase information generating better Fourier maps and thus generating a 
better model for refinement. 
 
Another important value for evaluating the structure quality is the goodness of fit, S.   
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In terms of refinement, the more successfully collected reflections the better the data 
set providing better information to refine the structure.  The more parameters that are 
refined the more data is required – typically data/parameter ratios of greater than 10 
should be sought.  The value for the goodness of fit for a good data set should be 
roughly 1 though can be marginally below or above. 
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Chapter 3: Techniques and Instrumentation 
 
3.1:  Focussed  Beam  Reflectance  Measurements  and  Attenuated  Total 
Reflectance Ultra Violet 
 
There  has  been  significant  development  in  in-situ  techniques  that  do  not  require 
sampling and give real time data analysis such as  Attenuated Total  Reflectance  – 
Ultra  Violet  (ATR-UV),  Focussed  Beam  Reflectance  Measurements  (FBRM)  and 
Attenuated Total Reflectance – Fourier Transform Infrared (ATR-FTIR).  The theory 
of  attenuated  total  reflectance  is  based  on  light  passing  from  a  material  of  high 
refractive index, for example a crystal, to a material of lower refractive index, for 
example  a  solution.    Light  travels  to  the  reflection  surface  and  can  be  partially 
absorbed by the solute before being reflected back to the probe.  The reflected light is 
therefore attenuated, causing a measurable reduction in the output signal dependent on 
the  absorbance  of  the  solution
54.    Each  probe  has  two  fibre  optic  cables,  one  for 
transmission of the light from the light source to the measuring head of the immersion 
probe, while the second conducts the signal, which is the light that has passed through 
the sample and back to the spectrophotometer.  ATR-UV probes are suitable for the 
direct measurement of strongly absorbing solutions in which the UV absorption of the 
solvent does not mark the solute absorption.   
 
The  main  advantage  of  using  an  ATR-UV  probe  (Figure  3.1.1)  for  measuring 
solubility and crystallisation in solution is that no sampling is required and that this is 
a real time process.  Other advantages are that the probe is relatively insensitive to the 
presence of particles in solution as the probe is based on surface measurements and 
the probe is suitable for an easy set up.  However in deciding to use the ATR-UV 
probe it must also be considered whether the solute has a significant UV absorption 
compared to the solvent in which the process is carried out so that it can be measured 
in  the  presence  of  the  solvent.    The  UV  absorption  of  the  solute  is  directly 
proportional to the concentration of the solution according to the Beer-Lambert law 
and so provides a convenient method for accurate in-situ real time measurement of 
solute concentration when compared to other techniques.  This process comes into its 36 
 
own during cooling crystallisation processes, enabling a significant solubility profile 
to be compiled from solubility to crystallisation. 
 
 
Figure  3.1.1:  The  ATR-UV  probe  showing  the  clear  crystal  window  through 
which all light passes. 
 
ATR-UV  can  also  be  used  in  connection  with  Focussed  Beam  Reflectance 
Measurements (FBRM).  FBRM uses a highly focussed laser beam projected through 
the sapphire window of the FBRM probe to rapidly scan over a small region.  The 
beam is rotated at a fixed high velocity allowing rapid scans across particles flowing 
across the path of the beam.  This high speed scanning movement of the beam is 
significant as this means that the motion of the particles is insignificant.  A particle 
entering  the  beam  path  produces  back  scattered  light,  which  is  picked  up  by  a 
stereoscopic  system.    The  crystal  continues  to  back-scatter  light  until  the  beam 
reaches the other edge of the crystal.  The time period of back-scattering is recorded 
and multiplied by the scan speed of the beam to give the distance between one edge of 
the crystal and the other
53; this is known as the chord length.  These chord lengths that 
are measured are profiled in a chord length distribution (CLD) plot.   
 
The  Mettler  Toledo  Multi  Max  system  (Figure  3.1.2)  installed  in  the  solid  state 
research laboratory in the Strathclyde Institute of Pharmacy and Biomedical Sciences 
(SIPBS)  was  used  to  carry  out  all  experimental  work  using  Attenuated  Total 37 
 
Reflectance – Ultra Violet (ATR-UV) and incorporating Focussed Beam Reflectance 
Measurements.   
 
 
 
 
Figure 3.1.2: The Multi-Max system at SIPBS.  This shows the reactor vessels in 
their independent compartments, the possibility for dilution and also the FBRM 
probe. 
 
The Mettler Toledo Multi-Max system gives a great degree of control over the desired 
reaction conditions mainly involving the temperature of the reactor vessel and the rate 
at which the solution is stirred.  The reactor vessels, by means of the control box, 
allow  simultaneous  reactions  to  be  measured  without  adversely  affecting  either 
reaction, for example one reactor vessel could be heated whilst the other is being 
cooled and the reactor temperatures are maintained independently.  By running the 
ATR-UV probe in parallel with the Multi-Max system, it is possible to see changes in 
UV  absorbance  as  the  reaction  proceeds,  with  an  accurate  knowledge  of  the 
temperature  at  which  any  changes  occur.   This  is  required  during  calibration  and 
subsequent dissolution methods. 
Reactor vessels  Dilution 
Control 
FBRM 
Probe 38 
 
 
This is achieved via an automated set up which enables the Multi-Max, ATR-UV and 
FBRM  to  be  linked.    The  FBRM  and  ATR-UV  measurements  are  all  computer 
controlled  and  independent  of  each  other,  however  the  data  can  be  extracted  and 
comparisons can  be  made as a  function of time, which  leads to knowledge  being 
generated about the crystallisation process under precise conditions.  This enables 
experiments to be carried out in-situ and data collected while experiments are ongoing 
with no need for sampling.  This is of course a huge advantage as with real time 
measurements  and  no  sampling  required,  analysis  can  be  carried  out  while 
experiments are in progress. 
 
For each different part of the liquid studies that had to be carried out as part of the 
present work a distinct method had to be followed.  The three distinct areas that have 
to  be  studied  to  develop  a  reliable  metastable  zone  width  include  calibration, 
dissolution  to  produce the  solubility  curve,  and  finally  the  metastable  zone  width 
experiments themselves.  The calibration procedure, carried out before any sample 
measurements are made, are the same for every compound and it is imperative that 
these are reliable.  These calibrations are compound dependent as each compound has 
differing  solubilities,  and  thus  the  range  of  the  study  has  to  incorporate  this.  
Furthermore, different compounds have different melting points and this does play a 
part in determining the range of temperatures through which the experiments can be 
carried out.  Calibration profiles rely upon a range of solutions being prepared and 
controllably ramped from the low T range to the high T range.  At defined intervals, 
the temperature is kept steady and left to equilibrate for a period.  This ensures that 
the  absorbance  is  constant  and  therefore  a  specific  concentration  at  each  point  is 
calculated.    This  is  subsequently  carried  out  for  the  full  range  of  temperatures 
required. 
 
Dissolution  experiments  are  usually  carried  out  on  pharmaceutically  important 
compounds to determine the rate of uptake into solution, however this is not required 
for the studies  being  carried out by us as chemists.  The  fundamental differences 
between the  interests of pharmacologists and chemists  is that pharmacologists are 
interested in how much can be dissolved into an aqueous medium and how quickly, 
thus adding of the solute is not carried out until the experiment is running.  Whereas 39 
 
from a  chemistry  viewpoint the  important feature  is the concentration, which  is  a 
measure of the amount of material dissolved at a certain point.  For this reason, and 
because  of  the  high  solubility  of  the  compounds  selected,  the  solute  was  already 
present  in  the  reactor  vessel  prior  to  the  experiment  commencing.    Dissolution 
experiments rely on controlled heating to set temperatures and then leaving for long 
periods  to  ensure  that  full  dissolution  has  occurred  at  each  temperature.    This  is 
carried  out  at  a  series  of  temperatures  and  a  full  solubility  curve  can  then  be 
calculated. 
 
Metastable zone width experiments are the only set of experiments that require all 
three  components  of  the  Multi-Max,  ATR-UV  and  FBRM  to  be  linked  together.  
These  experiments  rely  upon  a  solubility  curve  that  is  reliable  and  solutions  are 
prepared according to this.  The solutions prepared correspond to a specific point on 
the  solubility  curve  and  then  controlled  cooling  is  carried  out  while  the  FBRM 
monitors  any  changes  that  are  occurring  in  solution.    Recrystallisation  is  easily 
observed by the sudden increase in particles detected by the FBRM and the sharp 
decrease in UV absorbance.  These experiments have to be repeated many times to 
ensure a reliable point for crystallisation under these conditions has been determined 
and for many different solutions lying on the solubility curve until a supersolubility 
curve can be generated and a metastable zone width defined. 
 
3.2: Synchrotron Radiation 
 
A synchrotron is a huge scientific machine designed to produce very intense beams of 
X-rays, infrared and ultraviolet light, called synchrotron light.  Electrons generated in 
the electron gun are accelerated to very  high speeds by the  linear accelerator, the 
booster synchrotron and finally maintained at high speed in the storage ring.  The 
storage ring (Figure 3.2.1) is made up of bending magnets, which are used to steer the 
electrons around the ring, and in 3
rd generation synchrotrons, insertion devices that are 
more complicated arrays of magnets.  As the electron beam encounters each magnet it 
is accelerated by changing direction and this results in the emission of radiation that 
can  be  channelled  into  each  beamline  in  the  form  of  light.    Light  generated 
by electrons  in  the  storage  ring  passes  into  beamlines,  where  the  experiments  are 
carried out.  Each beamline is optimised for a different kind of experiment, but each 40 
 
beamline contains an optics hutch, where the light is filtered and focussed, and an 
experimental hutch, where the experiments are carried out.  There is also a control 
hutch where the experiment is programmed. 
 
Figure 3.2.1: A schematic showing the process of how synchrotron radiation is 
generated. 
 
The  synchrotron  radiation  generated  has  many  uses  from  chemistry  and  materials 
science to life science and earth science, showing the wide range of studies that can be 
carried out at synchrotron sources.  The original synchrotron radiation source in the 
UK was the Synchrotron Radiation Source (SRS) at the Daresbury Laboratory.  The 
SRS, at which the SAXS studies described here were carried out, operated from 1981 
until 2008, when it was superseded by the development of the new 3
rd generation 
Diamond Light Source synchrotron in Oxfordshire. 
 
3.3: X-ray Diffraction Studies of Liquids – Synchrotron and Lab Based Sources 
 
Station 2.1 at the SRS Daresbury Laboratory (Figure 3.3.1) was a fixed wavelength 
small  angle X-ray  scattering station.  The  station was widely used  in the  field of 
structural biology to obtain structural information relating to the shape and size of 
their compounds.  The wavelength at station 2.1 was fixed at 1.54Å, with a variable 41 
 
camera length between 1 and 8.25m.  This enabled the user to examine a wide range 
of d-spacings. 
 
 
 
Figure 3.3.1 a and b: Station 2.1 at Daresbury showing the beamline (left) and 
the sample holder (right). 
 
Before each experiment, the instrument has to be calibrated and the beam collimated 
and centred without a sample in place.  The sample window is designed to be very 
narrow, and the camera length determines how much scattering is observed and the 
range of scattering angles accessible.  In the experiments carried out during this work, 
liquid samples were used, in which it was hoped to induce nucleation/crystallisation 
assemblies that could be observed.  Scattering from liquids is weak and therefore most 
scattering  is  observed  on  the  detector  in  regions  around  the  beam  stop.    The 
temperature control in the sample holder system used (Figure 3.3.1) was simple and 
experiments had to be paused in between temperature changes to enable heating or 
cooling to be carried out.  As the mica window is in the vertical position, there is a 
potential problem as it cannot be reliably predicted where any crystallisation event 
will occur.  It is thus difficult to ensure that this lies in the path of the beam and not 
around the sides of the sample holder where it will not be detected. 
 
SAXS can also be carried out in the laboratory rather than at the synchrotron.  Prof 
Tim Wess and his group in the Optometry school at Cardiff University have helped 
install and develop the Bruker AXS Nanostar small angle scattering system.  This has 
enabled the highest flux beam that is currently possible for SAXS studies outwith 
synchrotron sources.  The Bruker AXS Nanostar, with its intense, collimated primary 42 
 
beam  and  2-dimensional  detector,  has  a  similar  design  to  a  synchrotron  SAXS 
beamline.  The Nanostar features a strong X-ray source, which combined with multi-
layer optics, provides an  intense  and narrow incident beam upon the sample.   As 
mentioned  in  Chapter  1,  SAXS  yields  information  such  as  particle  sizes  and  size 
distributions  from  dimensions  of  1  to  100  nm,  as  well  as  shape  and  orientation 
distributions in liquid, powders and bulk samples.  The Wess group routinely use such 
techniques for the study of collagen samples to examine the structure and probe the 
mechanical properties. 
 
A further development in the instrumentation for studying liquids that was attempted 
in  work  related  to  this  project  is  the  Rigaku  R-axis/Rapid  Curved  Image  plate 
diffractometer, used as a WAXS instrument in this context.  This contains a large 
curved  image plate, which enables  scattering to  large angles to be  measured  in  a 
single image.   
 
Solutions for SAXS studies of crystallisation must be prepared in a clean place and 
filtered  into  sample  vessels  to  avoid  any  possible  contamination  or  undissolved 
particulate being found in solution.  It is ideal to prepare as concentrated a solution as 
possible that will not recrystallise spontaneously in a sealed solution, or in contact 
with the droppers required to load the sample vessel.     
 
3.4: General Approach to Crystallisations 
 
There are almost endless ways in which crystallisation can occur as it is ultimately a 
random  process  and  still  nearly  impossible  to  control  fully  due  to  the  lack  of 
knowledge about the early stages of crystallisation.  In this sense, the approach to 
crystallisation that is taken is fairly simple.  The main variables that are often changed 
include temperature, whether that be constant temperature or a temperature profile 
involving controlled heating and cooling regimes, or varying fractions of solute, this 
is true for both co-crystals and single component samples and solvents, where there is 
a huge library potentially available. 
 
Recrystallisation can have two meanings in the study of chemistry.  Firstly in the 
organic chemistry field recrystallisation is often incorporated in the purification and 43 
 
synthesis  of  compounds.    This  involves  rapid  precipitation  to  improve  yields  and 
would not be routinely used by crystallographers.  In a crystallographic sense where 
the object is to generate large single crystals the recrystallisation has to be carried out 
slowly  via  a  variety  of  methods.    The  main  methods  used  for  crystal  growth  are 
solution methods.  Recrystallisation from solvents is by far the must widely used via 
slow evaporation, however if the solution dries out crystals can become deformed and 
not single.  Anti-solvents (solvents in which the molecule is not soluble) can also be 
used to help crystal growth as this reduces the solubility and can enable larger crystals 
to  grow.    A  variety  of  methods  exist  for  crystal  growth  from  solution  including: 
cooling from a hot, near saturated solution; convection which relies on the presence of 
a temperature gradient across the solution, and various diffusion techniques.   
 
Following  recrystallisation  to  produce  a  solid,  often  polycrystalline,  sample,  it  is 
generally commonplace to obtain X-ray powder diffraction (XRPD).  For a single 
component  system  this  is  generally  to  see  if  there  has  been  any  polymorphic 
transitions during the recrystallisation or solvent/hydrate formation depending on the 
conditions.  Powder generation can occur naturally in the recrystallisations vial or can 
be produced from grinding of a single crystal.  Grinding is known however to produce 
enough energy to initiate reactions that may not be desired, so must be employed with 
caution.  Other techniques that are routinely used to ascertain whether any changes 
have occurred during a reaction include techniques such as infrared spectroscopy (IR), 
differential  scanning  calorimetry  (DSC)  and  thermal  gravimetric  analysis  (TGA).  
DSC and TGA can be used simultaneously to monitor energy and weight changes as 
the molecule is heated up towards the melting point, often this can show polymorphic 
changes occurring or whether a single phase is present throughout. 
 
Often the use of single crystal diffraction is beneficial to allow structure determination 
and refinement.  There are many novel ways to attempt to grow single crystals, from 
the traditional slow evaporation through to more modern machines such as the React 
Array Microvate used routinely throughout this work.  This instrument allows twelve 
separate rows of independently temperature controlled conditions for crystallisation to 
be trialled simultaneously and with four individual vessels in each row this allows for 
up to 48 different experiments in twelve separate temperature conditions to be carried 
out  simultaneously.    These  are  small  scale  vessels,  typically  containing  mg  of 44 
 
material,  and  can  give  results  in  a  far  shorter  time  period  than  slow  evaporation 
techniques.  The Microvate allows ramping and cooling profiles to be set up in each 
row and can lead to positive identification of the conditions that may lead to the best 
crystal growth.  If a single crystal is grown successfully, it is necessary to examine its 
quality under the microscope to check whether it is single, more than one crystal or 
even whether there are deformations on the surface, prior to running the sample on the 
single crystal diffractometer for structure determination.   
 
3.5: Laboratory Based X-Ray Single Crystal Diffraction 
 
With X-ray diffraction having developed much in recent years it is now routine to 
solve crystal structures from crystals as small as 0.1mm x 0.1mm x 0.1mm, using 
laboratory based single crystal methods (Figure 3.5.1).  Crystal selection is carried out 
using an optical microscope with cross polarisers used to determine the extinction of 
the crystal.  A crystal with clean edges and faces is selected to ensure no cracks or 
defects are present on the crystal.  When a suitable crystal has been selected it is 
necessary to mount  it on a glass  fibre  and onto the pip of the goniometer before 
mounting  on  the  diffractometer.    The  goniometer  head  is  then  attached  onto  the 
diffractometer, which  has screws to adjust the alignment and ensure the crystal  is 
central in the X-ray beam.  This can be viewed using the built in microscope. 45 
 
 
Figure 3.5.1: Chart of requirements prior to publishing crystal structures
81. 
 
The single crystal X-ray diffraction work carried out and reported here was carried out 
on  a  Bruker  AXS  Apex  II  single  crystal  CCD  detector  diffractometer  and  the 
structures  solved  and  refined  using  either  SIR
82  incorporated  in  CRYSTALS
83  or 
SHELXS
84 and SHELXL
84 in the WinGX program
85.   
 
These  programmes,  together  with  the  Apex  II  software  for  data  collection  and 
processing
86,  can  be  used  for  all  single  crystal  structure  determinations.    The 
diffractometer software provides a quick and easy way to assess crystal quality and to 
set up the data collection.  Incorporated in the instrument software, the primitive unit 
cell can be determined using a preliminary set of frames.  The reflections in these 
frames are indexed to generate a primitive unit cell and crystal orientation, which can 
be done manually by selecting the sharpest, best-defined reflections with no sign of 
smearing  or  double  spots, or  automatically  and  then  are  refined.    The  orientation 
matrix  is the  solution which  best  indexes the observed peaks.   At this point  it  is 
important  not  to  overestimate  the  symmetry  of  the  molecule  or  else  not  enough 
reflections may be collected to enable a full crystal structure determination. 
 46 
 
Within the diffractometer software, a strategy  can  be determined to maximise the 
detection of unique reflections corresponding to the crystal system selected and ensure 
a complete dataset as far as it can be reasonably expected.  For example, the more 
symmetry that is present in a crystal structure, the less crystal orientations have to be 
measured, less reciprocal space has to be explored, and thus the data collection will be 
shorter.  This can be illustrated as in the absence of any symmetry (triclinic) a crystal 
would have to undergo an 180
o rotation to collect all the reflections needed, and due 
to Friedel’s law, this will result in a multiplicity of two.  However if there is a four-
fold axis of symmetry present in the crystal, then providing the correct 45
o angle can 
be found, only a 45
o rotation is required.  A data collection strategy can last for a few 
hours to a day or longer depending on the size of the crystal, the strength of the 
diffraction and  its  symmetry.  On  completion of the data collection an hkl  file  is 
produced  after  integrating  the  data  and  introducing  correction  factors  such  as; 
absorption, extinction and Lorentz corrections.  The hkl file is then input into either 
CRYSTALS
83 or WinGX
85 where the structure can be solved by direct methods, and 
refined. 
 
It  is  also  possible  to  carry  out  variable  temperature  single  crystal  data  collection 
making  use  of  the  Oxford  Cryosystems  low  temperature  device  installed  in  the 
diffractometer.  This enables reliable temperature control to 100K in the laboratory 
and  undertaking  data  collections  every  50K  between  100K  and  300K  is  now 
commonplace to monitor any temperature-dependent effects, such as disorder, that 
may occur.  For the study of disorder in hydrogen bonding systems, a common theme 
in the group, this can be used to give supporting evidence in terms of proposals for 
beamtime at a neutron source where the hydrogen atoms will be able to be located 
with less error.  In the case where multiple temperature data sets are collected, the 
sample has to be recentred for each data collection to account for any contraction or 
expansion of the sample during each run. 47 
 
Chapter 4. Liquid Studies on Substituted Aromatic 
Molecules 
 
4. Methyl 4-hydroxybenzoate 
 
4.1: Introduction 
 
Alkyl  hydroxybenzoate  compounds  are  used  in  foods,  drugs  and  cosmetics  as 
preservatives  due  to  their  antimicrobial  properties.    Methyl  4-hydroxybenzoate 
(pMHB; Figure 4.1.1) has also been well studied for many years due to its potential 
use as a nonlinear optical material
87.  Lin Xianti et al first solved the crystal structure, 
using X-ray diffraction, and published it in 1983
21.  It was found to be monoclinic 
with the space group Cc, and unit cell dimensions of a = 13.568(5) Å, b = 16.957(7) 
Å, c = 12.458(6) Å and β = 130.10(3)
o.  Solubility and metastable zone width studies 
had also been carried out varying both pH and temperature
87.  Presented here are the 
new approaches taken to monitor the solubility curve and then subsequently generate 
the metastable zone, for this reason it was imperative to have models for comparison.  
This also made use of techniques outlined previously for a different system
54.  The 
aims were to monitor concentration changes in situ before further nucleation studies 
could be carried out. 
 
 
Figure 4.1.1: Methyl 4-hydroxybenzoate 
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4.2 Dissolution and Metastable Zone Width Studies. 
 
Methyl-parahydroxybenzoate (pMHB) was selected as the initial compound to test 
and develop dissolution methods and to determine the metastable zone width (MZW).  
This work took place in the Department of Pharmaceutical Sciences in the Strathclyde 
Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde where 
analysis of the pure compound was carried out.  X-ray powder diffraction (XRPD) 
was  used  to  identify  the  physical  form  before  and  after  recrystallisation  from 
methanol to ensure that this was a suitable solvent for our studies.  The scan was 
carried  out  over  a  4-40
o  2θ  range  at  room  temperature.    Differential  Scanning 
Calorimetry  (DSC)  was  also  carried  out  on  samples  of  pMHB  before  and  after 
recrystallisation  to  ensure  that  only  one  physical  form  was  present.    The  DSC 
apparatus was programmed to cool to -40
oC then heated past the melting point at 125-
129
oC before being crash cooled back to -40
oC and heated back up to the melting 
point again.  This is used to assess the stability of the compound even in the harshest 
of conditions and to ensure that rapid cooling would not cause transformations in the 
subsequent  liquid  studies.    To  assess  the  stability  of  the  compound,  a  range  of 
recrystallisations were carried out in a wide variety of solvents available in the solvent 
library  at  the  University  of  Strathclyde  solid-state  laboratory.    The  recrystallised 
material was analysed by IR spectroscopy and XRPD to assess any changes that may 
have occurred from the raw material. 
 
4.2.1 X-ray Powder Diffraction 
 
Figure 4.2.1 shows the XRPD pattern collected from the bottle-fresh (pure) pMHB 
and the recrystallised form.  All peaks are found to match and are aligned, thus the 
only slight changes between the two patterns are in the intensity of the peaks.  This 
would indicate that either form would be able to be used in the solubility studies, 
which is necessary as pMHB is found to have very high solubility in methanol, which 
is to be used for the liquid studies. 
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Figure 4.2.1: XRPD data from pure and recrystallised pMHB.  The pure material is 
shown in black and the recrystallised in red. 
 
4.2.2 Infrared Spectroscopy 
 
Recrystallisations were carried out in a wide variety of solvents and analysed by IR 
spectroscopy  to  examine  if  there  were  any  possible  differences  and  potential 
polymorphs being produced.  The IR data (Figure 4.2.2) shows an overlay between 
pMHB pure material (red) and a sample of pMHB recrystallised in methanol (blue).  
This shows that all peaks are present in both spectra and only the reflectance of these 
peaks varies. 
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Figure 4.2.2: IR data collected on pure and recrystallised pMHB.  The pure material 
is shown in red and the recrystallised material in blue. 
 
On comparison of the IR data from the raw material and from the solvents tested, it is 
suggested that the compound did not recrystallise in any other polymorphic forms.   
 
 
4.2.3 Calibrations 
 
A calibration series is necessary to assess dissolution concentrations and was carried 
out  using  the  MT  Multi-Max  system  in  conjunction  with  the  ATR-UV  probe.  
Calibrations were carried out over a constant temperature ramp starting from 25
oC 
and increasing up to 55
oC over a 6 hour time scale, with a stirring rate of 1000rpm.  
This time scale allows gradual heating between temperatures to ensure minimisation 
of temperature errors, which occur when the solutions are heated too quickly.  The 
ATR-UV probe was  blanked  in air above the  solution  before being placed  in the 
solution where readings would  be taken every  minute.  Taking so  many readings 
allows the ability to monitor the absorbance changes of the solution as a function of 
temperature.  Unlike previous solubility work carried out on the compound
87 where 
the temperature range investigated was 20
oC to 50
oC, it was decided that readings 51 
 
would  be taken  at 5
oC  increments  from 25
oC to 55
oC  inclusive thus producing a 
calibration series that is closer to the boiling point of methanol, the solvent to be used 
during the experiments. 
 
To  provide  the  most  accurate  calibration  standard  possible,  five  solutions  were 
prepared; 5%, 12.5%, 20%, 27.5% and 35%w/w (solute/solvent) solutions; this is in 
comparison to only three concentrations that were used in the published method.  All 
weighings were carried out manually and solutions filtered into the reactor vessel to 
try to protect the system from any impurities affecting the results. 
 
A  sample  solution  was  run  under  these  conditions  from  200-700nm  to  determine 
where the maximum absorbance of the solution occurred.  As a result of this, the 
study was focussed over the 200-300nm range and each solution was run individually 
over this scale (Figure 4.2.3).  In this region the absorbance of methanol is negligible 
so  any  change  in  the  UV  spectra  is  solely  due  to  the  presence  of  pMHB  in  the 
solution. 
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Figure 4.2.3: Absorbance changes with wavelength using varying concentrations of 
solutions at a fixed temperature.   
 
The  major  absorbance  peak  at  roughly  260nm  was  used  for  the  concentration 
calculations.  It should also be noted that the UV absorbance for methanol at this 52 
 
wavelength  is  negligible  and  there  is  better  separation  between  concentrations  of 
solution. 
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Figure 4.2.4:  Calculated calibration results using varying concentrations of solutions 
at a fixed temperature. 
 
Figure 4.2.4 shows the results of a calibration carried out at 25
oC.  The darker line is 
the experimental results and as expected there is an increase in UV absorbance with 
increased concentration of solution.  The equivalent values obtained from the Area 
Max  software  for  the  theoretical  absorbance,  calculated  from  a  manually  input 
concentration  of  solution,  gives  an  almost  perfect  agreement.  This  is  vital  before 
carrying out dissolution experiments as at 25
oC this calibration result will be used to 
calculate the concentration of the saturated solution in the presence of excess pMHB. 
 
Similar calibrations were carried out at all the measured temperatures indicated and 
all calibration results showed similar profiles, all with a very high degree of similarity 
to the experimental results.  This indicates that the ATR-UV probe, which is used for 
monitoring  concentrations  in  situ,  is  highly  accurate  and  can  be  used  to  reliably 
calculate solution concentrations. 
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4.2.4 Solubility Studies 
 
Solubility  experiments  are  fundamental  when  investigating  pharmaceutical 
compounds as this is the method by which the solubility of the compound is assessed.  
For  the  purpose  of  this  work  however,  the  solubilities  at  set  temperatures  are 
fundamental for the knowledge of the concentrations of solutions to be prepared for 
the metastable zone width studies.  This is required as a reliable solubility curve must 
be  determined  prior  to  the  generation  of  a  supersolubility  curve  and  thus  the 
metastable zone being determined.  The method again makes fundamental use of the 
MT Multi-Max system and the ATR-UV probe in unison. 
 
Two  solubility  experiments  were  carried  out  to  directly  compare  the  results  and 
increase the reliability of solubility curve for pMHB when compared with previously 
collected data
87.  The experiments were carried out using 150g of methanol as the 
solvent - this allowed results to be produced that could be directly compared against 
the calibrations previously carried out where the ratio used was grams of pMHB per 
100g of methanol. 
 
An experimental protocol was set up to ramp to each of the desired temperatures and 
then held until the maximal absorbance remained stable.  The stirring rate was again 
set at 1000rpm, however unlike most dissolution experiments where the compound is 
added during the experiment, due to the tremendous solubility of the compound in 
methanol, the compound was added directly to the vessel in prepared solution before 
it was sealed.  The first temperature that was used was 25
oC and the solution was held 
at that temperature until the absorbance was stable before being increased by 1
oC 
every 4 minutes to 30
oC where the next absorbance was monitored.  The temperature 
ramp had to be increased very slowly at this stage to minimise any over-shoot in 
reactor temperature when it reached the desired temperature.  Due to the excellent 
control of the Multi-Max system it should be possible at this rate to minimise this 
occurring  and  generate  the  most  accurate  dissolution  profile  possible.    This  was 
carried out at the same seven temperatures as in the calibration sequence increasing 
the temperature  in the  same  manner  by 5
o each time.  During these  experiments, 
especially at higher temperatures, the solution  had to be monitored to ensure that 
there was always an excess of the compound in the solution. 54 
 
 
The ATR-UV absorbance readings, during the dissolution experiments, were taken 
every  30  seconds  as  this  gave  a  continual  monitoring  of  the  UV  absorbance  and 
enabled  the  user  to  see  easily  when  the  absorbance  reached  a  plateau.    When 
analyzing the results from the dissolution, the calibrations were used, in conjunction 
with the Aspect Plus program, to calculate the concentration of the solution at any 
given temperature. 
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Figure 4.2.5: Absorbance changes against wavelength at varying temperatures for a 
fixed concentration of solution. 
 
Figure 4.2.5 shows the ATR-UV data from the solubility experiments and from this it 
is easy to notice the change in absorbance as a function of temperature.  As expected, 
the solubility increases as a function of temperature.  These values were the basis for 
the MZW experiments to aid with the preparation of near supersaturated solutions. 
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Figure 4.2.6: The solubility curves calculated from solubility experiments. 
  
Figure 4.2.6 shows the two solubility curves calculated from the UV absorbance data 
collected at each temperature.  This was carried out using the Area Max program, 
which took the experimental UV absorbance data and used the calibration profile at a 
set temperature to calculate the concentration of the solution at the set temperature.  
This was subsequently used as the solubility curve.  The two curves show a close 
correspondence to each other and to the previously published results
87.  There is a 
slight difference in the two solubility experiments, however, this can be explained by 
the difference between using fresh pMHB and pMHB which had been recrystallised 
from a previous experiment.   
 
 
4.2.5 MZW Studies: 
 
Metastable zone width (MZW) studies monitor the changes in chord length of the 
solution as the temperature is cooled and give a clear idea of the point at which the 
particles start to emerge from solution.  It is important at this stage to note that this 
point need not necessarily be the nucleation point for the molecule: it is simply the 
point at which the probe can detect the presence of particles in the solution and not 
necessarily the formation of a critical nucleus.  This links the MT Multi-Max
TM, the 56 
 
ATR-UV probe and also the FBRM probe, since when the particles start to emerge 
from solution this will result in a decrease in the UV absorbance of the solution.  The 
set up is defined so as to monitor the fine particles in solution, resulting in a highly 
sensitive method that is able to analyse any change in the solution.  The FBRM probe 
can be set up to monitor up to eight different characteristics simultaneously.  For the 
interests of the MZW studies only four were of extreme significance, these were: 
 
1.  number of chords per second, no weighting factor, 9-27 microns 
2.  number of chords per second, no weighting factor, 24-90 microns 
3.  number of chords per second, no weighting factor, 88-102 microns 
4.  number of chords per second, no weighting factor, 93-102 microns 
 
Using these sets of conditions it was expected that as the particles started to emerge 
from the solution the number of chords per second picked up by the probe of the 
smallest  length  would  be  increased  greatly  and  this  would  indicate  where  the 
nucleation  point  occurred.    The  significant  values  to  monitor  during  the  MZW 
experiments  are  shown  above  as  these  clearly  show  the  particles  emerging  from 
solution and the subsequent growth that occurs after nucleation. 
 
To carry out the MZW  studies, saturated solutions, using concentrations obtained 
from  the  dissolution  experiments,  had  to  be  prepared  manually  at  the  relevant 
temperatures.  The first solution was prepared at 25
oC and cooled at 0.25
oC per min 
until the emergence of particles from solution was detected by the FBRM probe.  The 
stirring  rate  was  kept  constant  at  1000rpm  and  this  was  repeated  to  assess  the 
reliability  of  the  results.    The  solutions  were  prepared  by  using  a  hot  plate  with 
stirring function and a sealed container and then filtered into the reactor vessel to 
prevent contaminants entering the system. 
 
The same method was used for all of the seven temperatures before the metastable 
curve  could  begin  to  be  populated.    This  will  be  plotted  against  the  calculated 
solubility  curve  thus  giving  an  indication  of  the  width  of  the  zone  width  of  the 
molecule. 
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Figure 4.2.7: Chord  length distribution profile  of the  crystallisation process  from 
dissolution to recrystallisation.  The temperature profile for the experiment is shown 
in red. 
 
Figure 4.2.7 shows a chord length distribution (CLD) profile collected during MZW 
experiments.  Initially as the temperature is ramped the particles all start to dissolve 
into the solution.  The solution is then maintained at a constant temperature for a 
period of  time  to  ensure  that  all  particles  are  stable  in  solution  and  not  going  to 
emerge without a cooling ramp being applied.  The solution is then cooled at a steady 
rate until particles start to emerge from the solution.  This occurs rapidly for smaller 
particles  (yellow)  then  gradually  for  larger  particles  (green  and  orange).    The 
nucleation point occurs as soon as the first signs of emergence are detected by the 
FBRM probe. 
 
This can be easily observed when looking at small particles in the 9-27µm range.  
Values  are  taken  every  minute  from  the  initial  starting  temperature  until  the 
nucleation point is reached and the particles all emerge  from  solution.  The other 
values that the FBRM were set up to monitor were not as significant when monitoring 58 
 
the emergence of particles from solution and can therefore be ignored when it comes 
to viewing the results graphically.  This is due to nucleation already having occurred 
and therefore only the significant data is shown. 
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Figure 4.2.8: Change in CLD as solution is cooled and crystallisation occurs. 
 
Figure 4.2.8 shows the number of chords that are detected in the 9-27µm and in the 
24-90µm range and how these both grow at a rapid rate from the nucleation point as 
the particles start to emerge from solution.  The solutions were then reheated and the 
process was carried out again to try and duplicate results to assess the reliability of the 
data that is being generated. 
 
From Figure 4.2.8, it is clear that the chord count remains constant until the nucleation 
point, when the chord count then increases rapidly as the particles emerge from the 
solution.  The chord count is not zero due to the stirring of the solution generating 
bubbles which are picked up by the FBRM probe and thus result in a chord count 
even though all the particles are still in solution.  This is the same pattern that is 
noticed when cooling from all temperatures.  After recrystallisation has occurred, the 
profile  for  the  9-27µm  region  starts  to  decrease.    This  is  due  to  crystal  growth 
occurring as a subsequent result of crystallisation.  The profile for the larger chord 59 
 
lengths  will  subsequently  start  to  grow  at  this  point,  though  this  region  is  not 
significant for determining the metastable zone width. 
 
Figure 4.2.9 shows the UV changes as the MZW experiments progress.  When the 
solution  is  cooled  from  the  starting  point,  determined  from  the  dissolution 
experiments, there is an initial small increase in the UV absorbance.  This is due to 
the solvent evaporation that occurs from the solution.  This results in an increase in 
the concentration of the solution and therefore an increase in the UV absorbance as 
determined by ATR-UV.  This is maintained until the particles start to emerge from 
solution  and  at  this  stage  the  absorbance  drops  rapidly  as  crystallisation  and 
subsequent crystal growth occur. 
 
Change in UV Absorbance with Temperature
1.35
1.4
1.45
1.5
1.55
1.6
1.65
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
Temperature (celsius)
a
b
s
o
r
b
a
n
c
e
 
Figure  4.2.9:  UV  absorbance  changes  as  the  metastable  zone  width  experiment 
progresses and temperature is decreased. 
 
Preparing the solutions by using vacuum filtration ensured that the solution had no 
small elements of crystalline material present in the reactor vessel.  The cooling rate 
of the solution and the stirring rate of the solution were maintained at 0.25
oC/min and 
1000rpm respectively.  This has led to the successful generation of the MZW graph, 
Figure 4.2.10. 60 
 
 
The results for the MZW experiments were extremely positive considering nucleation 
is an entirely random process and to attain results of this quality shows that in the 
right conditions it should be possible to control crystallisation from solution.  Having 
to prepare the solutions at set temperatures prior to filtering into the reaction vessels 
leads to a slight decrease in the concentration of the solution present for the reaction.  
This is due to the fact that a small amount crystallises during filtration due to the 
changes in temperature between the solution and the filtering equipment. 
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Figure 4.2.10: The metastable zone width results plotting the dissolution curve and 
the best fit curve for the nucleation points as observed during the MZW experiments. 
 
The significance of the MZW can be understood due to its width.  In this sense the 
wider the metastable zone the easier it would be to control crystallisation within this 
zone via methods such as seeding.  The narrower the metastable zone signifies that 
the  solution  in  itself  is  not  inherently  stable  and  that  if  left  long  enough  then 
crystallisation is likely to be automatic. 
 
 61 
 
4.3 Small Angle X-ray Scattering Studies of Nucleation 
 
The main objectives behind the SAXS studies were to find a range of data for the 
initial nuclei, including their number, size and type, from organic materials that may 
exhibit polymorphism.  This is carried out using SAXS to probe solution studies as 
crystallisation  occurs.    The  particle  size  distribution  in  nucleating  solutions  is 
important in distinguishing the factors involved in competitive crystallisation within 
solutions, while also providing information on particle homogeneity and uniformity.  
The  structural  information  obtained  from  macromolecules  in  solution  obtained  by 
SAXS has been used to provide confirmation of computationally modelled protein 
structure
39  and this  furthers  the  belief  that  vast information  can  be  obtained  from 
SAXS studies. 
 
Two  days  beam  time  on  Station  2.1  at  the  SRS  Daresbury  were  allocated  for  a 
preliminary SAXS study to investigate the pre-nucleation solution scattering of our 
test material methyl p-hydroxybenzoate.  SAXS is generally used to look at larger 
molecules  in  solution,  such  as  proteins,  however  this  project  involved  trying  to 
monitor pre-nucleation of small organic materials and to determine the initial particle 
size, which exist in solution prior to crystallisation and whether these are mono- or 
polydisperse in nature.  It was anticipated that these particles would vary in size as a 
function of temperature as the temperature can significantly affect the formation of 
the crystals (in terms of both their quality and size and in terms of which polymorph 
may form) during the crystallisation experiments. 
 
During the experiment, time was spent developing the techniques required, including 
preparing suitable sample cells.  The low viscosity of the solutions dictated that extra 
care had to be taken to seal the cell and prevent the solution from leaking from the cell 
during the data collection.  This problem was compounded by the ready crystallisation 
of the samples when in contact with a surface as this acts as a nucleation site and 
subsequently promoted crystal growth due to the high concentration of the solution. 
The sample cell used (Figure 4.3.1) had  a  volume of 200µl and the solution was 
injected between two mica windows by syringe.   62 
 
 
 
Figure 4.3.1: Sample cell used with small window for the solution. 
 
The problems with maintaining a fixed concentration of solution and the fact that it 
was hoped to collect data at two camera lengths meant that much of the data were 
collected with a beam  current several orders of  magnitude  lower  in  intensity than 
recorded after the refill and the ring was only operating on one refill per day.  The 
statistics of the data from some of the measurements were therefore not sufficiently 
high and overnight data collections were not effective.  Data were collected at 5
oC 
intervals  between  25
oC  and  5
oC  and  observed  signal  above  the  background  and 
solvent level for all cases.  The data were collected over a minimum of 30 mins at 
each temperature and longer when the beam was becoming weaker.  The solution 
used initially was a 0.8g/ml pMHB / methanol solution, however this recrystallised 
too rapidly around the surfaces of the cell and on the syringe used for injecting the 
solution.  Having learned from this, the rest of the data were collected using a 0.7g/ml 
concentration. 
 
Despite these complications, on correcting the data for solvent and background levels, 
it was possible to observe significant scattering arising from the solute. Our results 
show a significant small angle peak due to the solute and then a return to a flat signal 
as seen in pure methanol solution.  This small angle peak is present throughout the 
data collection even at low temperatures, though the intensity does not appear to vary 
radically.  Significant features in a small angle diffraction pattern do not appear as 63 
 
sharp peaks; rather, subtle changes in the slope of the small angle peak and very broad 
peaks  at  higher  scattering  angle  are  observed.    These  broad  features  may  not  be 
identifiable when looking at the scattering directly, only becoming apparent when a 
Fourier transform of the diffraction data has been calculated.   Determination of the 
particle size in the form of the radius of gyration depends on a number of assumptions 
including the particle shape, which in its simplest case can be modelled as spherical. 
 
 
 
Figure 4.3.2: The detector image of pMHB in methanol at 20
oC. 
 
Figure 4.3.2 shows precisely how difficult analysis from SAXS data can be.  The 
majority of the scattering from the X-rays occurs around the beam stop with only 
minimal scattering seen elsewhere and the intensity of the data away from the beam 
stop is not sufficiently high to enable any significant data analysis of this region.  The 
significant scattering that occurs around the beam stop shows low angle scattering and 
represents interactions between the molecules in solution.  
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Using SAXS specific programs, available through Dmitri Svergun
43and used routinely 
for assessing protein solution scattering it has been possible to analyse the data to a 
basic extent. 
 
 
Figure 4.3.3: Scattering profile of pMHB (blue) and methanol (red) at 20
oC. 
 
Figure  4.3.3  shows  the  change  in  scattering  profiles  between  pMHB  and  pure 
methanol solution.  The significant areas to examine are at the lowest angles as it is 
seen to be that this is the region of scattering where the majority of the signal occurs.  
It should be noted that the scattering from the solute is not highly different from that 
at methanol at the smallest of angles but does lie higher at larger angle.  The slope of 
the small angle peak is also observed to differ.  This does not give the best view to 
changes during the crystallisation process but gives an initial view that scattering from 
the solute is being observed.  It should also be noted that in the pMHB scattering 
profile at 20˚C, a sharp small peak is observed in addition to the main peak.  This is 
likely to be an artefact in the data, as any changes in particle size in solution will give 
rise  to  only  broad  features  in  the  scattering  pattern.    This  sharp  feature  was  not 
observed for any of the other temperature measurements. 65 
 
 
Figure  4.3.4  shows  an  overlay  of  the  pMHB  data  collected  at  the  four  separate 
temperatures.  The data were analysed using the program PRIMUS
43.  The four lines, 
each corresponding to a separate temperature, show a virtually perfect overlay, which 
indicates that the molecule was stable in the solution.  This could be seen during the 
experiment as no crystallisation appeared to be occurring during the cooling process 
or even when the sample was removed at the end of the experiment.  Due to the small 
volume used in the SAXS studies, especially in comparison to the previous solubility 
studies and less nucleation sites, it proved to be a difficult study.  The SAXS study 
uses 200µl of the concentrated solution prepared, whereas the metastable zone width 
experiments that were carried out all require a minimum of 150ml to ensure that the 
FBRM and  ATR-UV probes are  submerged  in the  solution.  This sort of  volume 
change,  as  well  as  the  presence  of  stirring  in  the  MZW  experiments  will  always 
results in major differences between the two techniques.   
 
Due to the nature of the crystallisation being monitored, organic molecules with no 
heavy atoms to increase scattering, the scattering is much weaker than for the proteins 
routinely studied using this technique, however it should be noted as a positive that it 
has  been  possible  to  see  scattering  from  solutions  and  this  will  be  progressed  by 
adding in heavy atoms into the organic molecules being studied.  This theoretically 
will increase the scattering from the solution, for example the presence of bromine 
will increase the scattering of an organic molecule greatly as it is a much larger atom 
than any of the others that are currently involved in the compound.  This works for X-
ray scattering from crystals due to the number of electrons that bromine has so it is 
expected that this will also be the case in enhancing signals in the SAXS studies. 
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Figure 4.3.4: Scattering profile showing an overlay of the data collected at the four 
studied temperatures (5˚C is shown in green, 10˚C in pink, 15˚C in red and 20˚C in 
blue) showing a marginal increase in intensity as a function of temperature. 
 
The scattering profiles for both pMHB and methanol solutions showed similar traits, 
however with an increased scattering coming from the solute.  The intensity of signal 
is maximised at low angle, due to the lack of scattering ability of solutions.  The 
intensity of scattering drops significantly and results in an almost constant level of 
scattering that is the background for the solute.  This range is not as significant as the 
low  angle  region  as  most  of  the  interactions  in  solution  occur  around  this  region 
leading to increased ordering and intensity.  This is clearly visible even in the solution 
scattering that is occurring from such a small molecule.   
 
Figure 4.3.5 shows an overlay of the data collected at each temperature for pMHB and 
for  the  control  experiments  containing  purely  methanol.    This  is  the  best  way  to 
visualise  the  changes  that  occurred  between  the  control  experiments  and  the 
experiments that were carried out containing pMHB.  This clearly shows that there is 
not a significant difference in the scattering in the temperature range studied but does 67 
 
indicate that there is scattering visible from the solute.  This is indicative of broad 
range ordering in the solution. 
 
 
Figure 4.3.5: All the data collected on station  2.1, indicating  increased scattering 
from the solute.  The methanol solutions all show significantly lower scattering at 
higher angles and show very little variation as a function of temperature. 
 
The analysis of this data was not to a sufficient standard due to the weak scattering 
and it was therefore not possible to determine an accurate radius of gyration (Rg) for 
the molecules coming together in solution in spite of a range of attempts to carry this 
our reliably.    This  will  therefore  not  be  reported.    The  data  were  analysed  using 
PRIMUS
43 and GNOM
43 and the scattering pictures available via FibreFix
43, however 
these  programs  are  all  specifically  designed  for  much  larger  molecules  where  the 
observed  scattering  is  significantly  distant  from  the  beam  stop.    To  increase  the 
scattering from the solution it would be necessary to collect data for a much greater 
length of time on a more powerful beam and then it may be possible to progress our 
knowledge  of  the  process  of  crystallisation  by  monitoring  the  interactions  before 
crystallisation occurs. 68 
 
 
SAXS studies were also carried out at the University of Cardiff in collaboration with 
Professor Tim Wess and Dr Donna Lammie using the Bruker AXS Nanostar
TM.  This 
has a similar design to a synchrotron SAXS system, however the intensity of the beam 
is obviously reduced.  This resulted in further reduced scattering from the solute and 
no significant data were produced to augment the Station 2.1 data reported above. 
 
4.4 Conclusions: 
 
Although  initial  liquid  studies  were  successful  in  the  generation  of  a  MZW,  the 
ultimate goal was to attempt to study the nucleation process.  In this sense the model 
compound that was selected was not ideal for the purpose.  Scattering was observed 
due to the pMHB being present, however a more suitable target molecule containing 
heavy atoms would scatter X-rays more strongly and perhaps be able to produce data 
that can be analysed using the available analysis programs.  This study has therefore 
been significant in the development of reliable solubility and the use of MZW data 
that is required for SAXS studies on highly concentrated solutions.  However it is our 
belief that to be able to make significant progress  a target molecule with  heavier 
atoms would be more beneficial. 
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Chapter 5. X-ray diffraction studies of methyl 4-
hydroxybenzoate – an investigation of possible 
conformational polymorphism 
 
 
Methyl 4-hydroxybenzoate (pMHB; Figure 5.1) is a well studied non-linear optical 
material
87.  The crystal structure of pMHB was originally solved by Lin et al. at room 
temperature
21.  It shows no signs of other polymorphic forms.  Given this, it had been 
assumed that the most stable form was already known. However, a recent study, by 
Vujovic et al
22 has indicated the possibility of a low temperature phase transition, 
claiming to have discovered a previously unknown  form at low temperature. This 
study, carried out at 113K, led to the postulation of a new polymorph, although both 
forms crystallised in the monoclinic non-centrosymmetric Cc space group with three 
Z’=3 and Z=12.   
 
 
 
Figure 5.1: pMHB indicating the two torsion angles discussed in relation to possible 
conformational polymorphism 
 
In the low temperature structure, there is a lengthening of the b axis and an apparent 
twist in the ester group (shown by changes in the torsion angles indicated in Figure 
5.1), when compared with the original structure. These factors result in changes in the 
calculated powder X-ray patterns that were deemed to be sufficient enough to indicate 
that  a  conformational  polymorph  had  been  found.  In  the  case  of  pMHB,  any 
conformational polymorphism occurring would be thought to be due to a ‘displacive’ 
phase transition where a small change would not have to overcome significant energy 
barriers
24 and that can be readily reversed. 
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This finding has been disputed by Threlfall et al
23, who argue that, although slight 
differences can accumulate over a large temperature or pressure range to produce a 
substantial structural difference, this does not of itself produce a new phase or new 
polymorph.  He  further states that the slight changes  in  lattice parameters can  be 
justifiably  accounted  for  in  terms  of  minor  conformational  changes.    This  latter 
interpretation  has  been  backed  up  by  the  work  presented  here  using  variable 
temperature X-ray powder diffraction and single crystal studies. 
 
 
5.1 Variable temperature XRPD 
 
To  investigate  these  reported  changes  in  calculated  powder  patterns  a  variable 
temperature XRPD study was carried out to examine any changes that may show up 
as temperature was increased from 100K to 300K.  These experiments were carried 
out using a Bruker-AXS D8 powder diffractometer with temperature control provided 
by  an  Oxford  Cryosystems  low  temperature  Cryostream  device.    Any  significant 
changes in crystal structure will result in changes to XRPD patterns and will easily be 
determined as a function of temperature and the temperature range in which these 
changes occur.  For this reason diffraction patterns were collected every 50K over a 
scattering  angle  range  of  5-55
o  2θ  at  1
o  per  minute.    Figure  5.1.1  shows  that  as 
temperature was increased the peaks at 16.5-18, 25-26 and 27.4-28.4
o 2θ (marked * in 
the Figure) start to get closer together until there is ultimately one single strong peak 
at 300K.  This is a typical process in all powder data in which the unit cell dimensions 
are varying as a function of temperature and should be noted, does not represent a 
significant  change  in  structure.    Throughout  the  variable  temperature  XRPD 
experiment,  all  the  peaks  are  present  throughout or  can  be  accounted  for  by  this 
gradual coalescence of peaks into one single peak at high temperature. 
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Figure 5.2: XRPD patterns collected during VT XRPD study (from bottom to top, 
100K, 150K, 200K, 250K, 300K). 
 
At low temperatures the XRPD thus does not give any supporting evidence for the 
claim of a phase transition reported to occur at 113K, and can merely be explained by 
a thermal expansion of the unit cell as the temperature is increased. 
 
 
5.2 Variable Temperature Single Crystal Studies 
 
Variable temperature single crystal X-ray diffraction studies have been carried out 
using a Bruker AXS Apex II diffractometer and through this it has been possible to 
generate good quality structure determinations at various temperatures between 100K 
and 300K.  It was found that throughout the study that pMHB crystallized  in the 
monoclinic non-centrosymmetric Cc space group with three independent molecules in 
the asymmetric unit and Z=12.  This was in agreement with previous studies and also 
it  was  found  that  the  b-axis  did  elongate  as  temperature  was  decreased.    This  is 
unusual as it is common for all three axes to contract with decreasing temperature, 
however the reason for this elongation is unknown.  The crystal structures shown in 
 * 
 * 
* 
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Figure 5.2.1 were determined at 100K, 200K and 300K.  These are viewed along the 
b-axis and generally show the same characteristics throughout. 
 
 
 
 
Figure 5.2.1: The crystal packing of pMHB as viewed along the b-axis at (top) 100K, 
(middle) 200K and (bottom) 300K. 73 
 
 
Figure 5.2.2 shows the trend in the unit cell parameters determined from the single 
crystal studies as a function of temperature (unit cell determinations were also carried 
out at 140 and 260K).  This further supports the hypothesis that a simple unit cell 
contraction is occurring as the temperature is cooled, and there is no abrupt change 
that would indicate a polymorphic transition. 
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Change in axis c with temperature
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Figure  5.2.2:  The  trend  in  unit  cell  parameters  and  cell  volume  of  pMHB  with 
respect to temperature, from the single crystal experiments. 
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    τ1 
o  Change 
o  τ2 
o  Change 
o 
Molecule 1  100K  -2.8(5)  2.6  0.9(5)  5.0 
  LT  -4.3(2)  1.1  0.7(2)  4.8 
  RT  -5.4    -4.1   
  300K  -3.0(4)  2.4  1.0(4)  5.1 
Molecule 2  100K  2.9(6)  0.2  -0.2(6)  3.0 
  LT  1.5(2)  1.6  1.4(2)  1.4 
  RT  3.1    2.8   
  300K  3.0(5)  0.1  -0.6(4)  3.4 
Molecule 3  100K  -1.6(6)  3.9  -0.2(5)  6.8 
  LT  3.0(2)  0.7  -1.1(2)  5.9 
  RT  2.3    -7.0   
  300K  -2.0(4)  4.3  -1.2(4)  5.8 
 
Table 5.1: Torsion angle data from low temperature form (LT), room temperature 
form (RT), our 100K data and our 300K data.  (See figure 5.1 for a definition of the 
torsion angles.) 
 
Having  produced  single  crystal  structures, the  torsion  angles  were  investigated  to 
assess the likelihood of conformational polymorphism being present.  Comparing the 
torsion angles in the 100K and 300K structures (Table 5.1) showed no significant 
differences, and allied with the continuous nature of the development of the XRPD 
patterns as a function of temperature, argue against this. 
 
 
5.3 Conclusions 
 
These single crystal studies, backed up with XRPD data, enable us to give the opinion 
that there is not a low temperature phase transition as postulated in the literature
22. 
This is merely a contraction of the unit cell occurring as temperature is decreased.  
The results verify that there is an expansion of the b axis as temperature is decreased 
and a contraction of the a and c axis resulting in an overall unit cell contraction. 76 
 
 
Through these studies, the changes in torsion angles between 100K and 300K are not 
as severe as stated in the literature
22.  We have found no overall changes in torsion 
angles of greater than 7
o for torsion two and only one over 4
o for torsion one (Figure 
5.1),  which  was  calculated  to  be  4.3
o.    This  is  therefore  not  believed  to  be  a 
significant change in the crystal structure to allow it to be deemed a conformational 
polymorph and a simpler explanation of a unit cell contraction and minor changes in 
the molecular geometry as the temperature is lowered is justified. 
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Chapter 6. Scattering studies of bromo-substituted 
compounds: towards signal enhancement and halogen 
interactions 
 
6.1: Dissolution and MZW studies of Methyl 2, 5-dibromobenzoate 
 
Following on from the initial liquid studies carried out on methyl 4-hydroxybenzoate 
(pMHB), it was decided to also study a second molecule containing heavier atoms, 
which may scatter X-rays better and potentially lead to distinctive signatures that can 
be identified in liquid scattering studies.  For this part of the work, a related molecule 
containing two bromine atoms was selected, methyl 2,5-dibromobenzoate (MDBB; 
Figure 6.1.1).  
 
 
Figure 6.1.1: Methyl 2,5-dibromobenzoate 
 
An  added  benefit  of  selecting  this  molecule  was  that  its  crystal  structure  was 
previously  unknown,  so  all  studies  on  this  molecule  including  its  initial 
crystallisation, while linking in with previous work would give a new understanding 
of the solution behaviour as well as revealing its solid-state structure and packing.  All 
molecules behave differently in solution so all solution studies on this new system had 
to be carried out as for the first case study presented in Chapter 4, using the same 
techniques and instrumentation, to see any changes in behaviour that may occur.  Due 
to the low melting point value of 48-51
oC for MDBB, dissolution and metastable zone 
width studies were carried out from 20 to 35
oC, at 5
oC  intervals as  before.  This 
resulted in a narrower range of study than before but was carried out to the same 78 
 
accuracy.  It was also decided to study a mixed solvent system, in this case ethanol 
and water, to decrease the concentrations of the solutions used.  MDBB is soluble in 
ethanol but not in water and it was hoped that the presence of this antisolvent would 
help produce good quality crystals for analysis. 
 
The  wavelength  range  used  in  the  ATR-UV  studies  was  200  –  270nm  as  the 
maximum UV absorbance occurs at ~ 237nm.  This  is smaller than that used  for 
pMHB.  For the calibration stage, five solutions were set up; 3%, 7%, 12%, 16% and 
20% w/w MDBB/solvent (Figure 6.1.2).  The temperature was ramped from 20
oC at a 
rate of 1
o every 6 mins up to 35
oC.  This enabled a suitable mixing time and accurate 
measurements using the  ATR-UV could  be taken.  As  before, this was crucial as 
unknown  concentrations  were  assessed  against  these  calibration  results  at  each 
temperature during the dissolution and metastable zone width experiments. 
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Figure 6.1.2: The absorbance changes for each calibration solution as a function of 
temperature. 
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The dissolution experiments were carried out in 150ml of solvent (1:1 v/v, ethanol : 
water), generating solubility curves using  both out of the  bottle  and recrystallised 
MDBB.  The process was changed from that of pMHB due to the lower solubility and 
lower temperature range that could be studied.  In this instance, the MDBB was still 
added before the experiment commenced, however due to the mixed solvent system 
being studied, the solutions were left at the four temperatures for longer to ensure 
complete  dissolution.    Figure  6.1.3  shows  the  two  dissolution  curves  that  were 
produced, where the blue curve is for straight from the bottle MDBB and the pink 
curve is using recrystallised MDBB.  It is noted that as previously, there is no big 
difference  between  these  results  and  therefore  either  can  be  used  for  the  MZW 
determination. 
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Figure 6.1.3: Solubility curves of MDBB from dissolution experiments. 
 
The  concentrations  generated  from  the  mixed  solvent  system  were  also  decreased 
from  the  pMHB  case  and  this  is  highly  beneficial  for  crystallisation  purposes 
considering the large scale of the reactor vessel. 
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Metastable  zone  width  experiments  were  carried  out  based  upon  these  results.  
Solutions were prepared at each of the temperatures and left to sit in the sealed vessel 
for two hours to ensure that crystallisation was not going to be spontaneous.  The 
solutions were then cooled at 0.1
oC min
-1 until the FBRM detected that particles were 
emerging  from  solution.    This  was  noted  as  the  crystallisation  point  for  the 
experiment, and the MZW was then defined as the area between the solubility curve 
and the point where crystallisation occurred (Figure 6.1.4). 
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Figure  6.1.4:  Solubility  and  supersolubility  curves  for  MDBB  indicating  the 
metastable zone. 
 
It should  be  noted that the crystallisation profiles  for the two test compounds  are 
completely unrelated.  The MZW for MDBB is narrower than for that of pMHB, 
which would indicate that the solution is not as stable i.e. that over a shorter time 
period, crystallisation would be more likely to occur within the metastable zone.  This 
can be explained by the simple notion that for any point within the metastable zone, 
the distance to the supersolubility curve is less for MDBB than for pMHB and thus 
any  loss  of  solvent  would  result  in  the  solution  becoming  more  concentrated  and 
spontaneous crystallisation would be more likely to occur.  This, of course, could be 
anticipated  as  no  two  molecules  are  likely  to  have  similar  solution  behaviour 
especially  when  the  crystal  structures  show  them  to  be  completely  unrelated.  81 
 
Crystallisation is a complex process governed by both thermodynamics and kinetics, 
so  therefore  it  is  impossible  to  predict  exactly  how  these  molecules  will  react  in 
solution and is impossible to have a feel for crystallisation profiles before carrying out 
the experiments. 
 
 
6.1.1: Conclusions on MZW Experiments 
 
Throughout the metastable zone width (MZW) experiments, it has been possible to 
monitor  crystallisation  in-situ;  however  it  should  be  remembered  that  this  pre-
crystallisation work is on the micron scale and crystallisation, and its onset, occurs at 
much shorter length scales than this.  The work carried out during these experiments 
has generated a new method for monitoring solubility and concentrations in solution.  
This is a highly advantageous technique that has been developed, as it is now possible 
to calculate concentration changes as experiments are being carried out without the 
need for sampling and trying to maintain the sample at the desired temperature.  This 
is of huge benefit in the pharmaceutical industry especially, where solubility studies 
are  of  vital  importance  during  the  drug  development  stage.    The  complimentary 
techniques of using FBRM and ATR-UV, in-situ, provide the further benefit of being 
able to detect the sizes of particles present in solution, and arguably their shape.  This 
is due to the scanning of the laser over the particles in solution, which detects particle 
sizes of distinct lengths and separates these in a chord length distribution (CLD) plot.  
The theory behind being able to analyse shape relies on the assumption that each 
shape will have varying lengths that will be scanned and identifies the proportionality 
of each length being scanned by the laser.   
 
This theory has been studied in smaller scale crystallisations
51 and is of importance 
when  monitoring  the  possible  changes  in  polymorphs  (and  the  associated  particle 
morphology)  that  can  occur.    These  changes  in  polymorph  that  do  not  affect the 
solubility in solution would go unnoticed using the technique which has been adopted 
in this work, however using purely FBRM and detailed analysis it should be possible 
to determine when relevant shape changes have occurred.  
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6.2 Structural Studies of Methyl 2,5 dibromobenzoate 
 
One  of  the  reasons  that  MDBB  was  chosen  was  that  it  had  an  unknown  crystal 
structure  and  no  studies  had  been  carried  out  to  investigate  polymorphism  via 
crystallisation with other solvents.  A quick solubility study showed that MDBB was 
soluble  in  only  polar  solvents  and  these  results  were  analysed  by  X-ray  powder 
diffraction to see if there was any change caused by recrystallisation from different 
solvents. 
 
Single crystal studies have shown that even though a literature value of the melting 
point is given as 48-51ºC for this compound, it sublimes at room temperature when 
given enough time.  This was observed when carrying out single crystal studies when 
the diffraction from the crystal seemed to ‘disappear’.  When the run was repeated 
with the crystal attached to the pip with superglue, the same thing occurred, indicating 
that the disappearance of the diffraction was not due simply to the crystal merely 
falling off.  To prove what was happening some single crystals of MDBB were left on 
a slide at room temperature and over time these crystals also ‘disappeared’ to indicate 
that sublimation was occurring.   
 
The  diffraction  data  for  MDBB  were  collected  on  the  Bruker  AXS  Apex-II 
diffractometer  at  100K  and  solved  and  refined  using  SHELXS
84  in  the  WinGX
85 
program.  Although it was only possible to collect data on a twinned crystal, from this 
it  was  still  possible  to  deduce  the  crystal  structure.    The  molecule  was  found  to 
crystallise  in  the  triclinic  space  group  1 P ,  and  cell  parameters  a=4(2)Å, 
b=7.1682(9)Å, c=16.0658(16)Å, α=76.995(3), β=89.205(15) and γ=84.943(15), cell 
volume = 433.545Å
3, with Z = 2.   
 
Figure 6.2.1 shows the crystal structure viewed along the a axis and from this it is 
interesting to notice the halogen contacts involved in the crystal packing.  Halogen 
bonding (X···O, X···N) has been known to exist for many years and is commonly 
understood to have the strength of a moderate hydrogen bond (i.e. 4-15 kJ mol
-1)
61.  In 
this molecule, however, as well as the presence of a Br 
. . . O halogen bond, there is 83 
 
also the weaker halogen – halogen (Br···Br) interaction present.  Although this type of 
interaction is weaker, with no hydrogen bonding possible in this particular case, it is 
an  interesting observation that  may  indicate this  interaction  may contribute to the 
packing  in the  crystal structure.  This could  be studied  further  in the presence of 
hydrogen bonds to assess whether this is a significant contribution to the structure of 
the molecule or definitely a secondary interaction. 
 
 
  
Figure 6.2.1: Crystal structure of MDBB viewed along the a axis, with halogen - 
oxygen bonds and halogen – halogen interactions highlighted and the distances shown 
in Å. 
 
While the strength of the interactions were not calculated, by looking at the sum of the 
van der Waals radii these can be determined to be a close contact and likely to be 
significant in the absence of any other stabilising interactions.  The contact distance of 
the halogen bond, Br···O, was measured to be 3.188(2)Å, which corresponds to 94.8% 
of the sum of the van der Waals radii, while the halogen interaction, Br···Br, is found 
to be 3.5(1)Å, corresponding to 95.4% of the sum of the van der Waals radii.  Whilst 
it is recognised that these contacts are not significantly less than the sum of their 84 
 
respective van der Waals radii, they are likely to be important and can be further 
investigated in other studies. 
 
Due to the difficulties in being able to solve the crystal structure from single crystal 
analysis,  XRPD  was  also  carried  out  for  a  direct  comparison  against  the  powder 
pattern calculated from the solved single crystal structure.  This confirms that the 
correct structure had been produced – the calculated powder pattern from the structure 
solved and refined from the twinned crystal at 100K is shown in Figure 6.2.2.  When 
compared with the pattern collected from the powder sample on the Bruker AXS D8 
diffractometer at room temperature, it can  be  seen that the two patterns generally 
match well.  There is some indication of splitting of peaks from the predicted pattern, 
but this is known to occur for some peaks during the temperature range of 100 – 300K 
due to lattice expansion and is not a significant effect in this case.  The first five peaks 
from the predicted pattern correspond almost perfectly with the first five peaks from 
the  pattern  collected  experimentally  and  thus  a  close  correspondence  is  observed.  
This supports the conclusion that the correct crystal structure has been solved even 
though it was from a twinned crystal. 
 
 
 
Figure 6.2.2: Predicted powder pattern of MDBB calculated from the crystal structure 
solved from the twinned crystal at 100K. 85 
 
 
 
 
Figure 6.2.3: Powder pattern of MDBB collected at 300K. 
 
 
6.3 Preliminary SAXS studies of 2-bromobenzoic acid 
 
During the beam time that was granted at Daresbury on Station 2.1, SAXS studies of 
2-bromobenzoic acid were carried out.  This sample was chosen as a substitute to the 
planned  system,  due  to  the  fact  that  the  concentrated  solutions  of  methyl  2,5-
dibromobenzoate that  were  prepared tended  to crystallise  whenever  a  sample  was 
taken  from  the  stock  solution  and  prior  to  SAXS  studies  commencing  on  the 
beamline.    Concentrated  solutions  of  2-bromobenzoic  acid  were  thus  used  as  an 
alternative  sample.    The  choice  of  2-bromobenzoic  as  an  alternative  to  MDBB 
revolves around the fact that the compound is known to crystallise in the carboxylic 
acid dimer motif (Figure 6.3.1) and also contains a heavy (Br) atom, which was the 
prerequisite  following  on  from  the  initial  studies  carried  out  on  methyl  4-
hydroxybenzoate, with the aim of enhancing the X-ray scattering in the system due to 
the presence of the heavier Br atom.   86 
 
 
Figure  6.3.1:  Typical  dimer  of  2-bromobenzoic  acid,  with  hydrogen  bonds  and 
halogen bonds labelled in blue
88. 
 
 
 
 
Figure 6.3.2: Scattering profile of MDBB. 
 
SAXS studies were carried out using the identical method as for pMHB described in 
section 4.3.  Figure 6.3.2 shows the scattering profile from the 2-bromobenzoic acid 
solution.  From this it is easily noticeable that, as before, the scattering produced from 
the solution is focussed at very small angles around the beam stop and for this reason 87 
 
analysis is not easy to carry out.  The programs that are routinely used for the analysis 
of protein solutions were again used, including Fibrefix, GNOM and Primus, which 
are  all  available  on  line  through  the  web-site  of  their  author,  Dmitri  Svergun
43.  
Unfortunately  due  to  the  weak  scattering  that  was  produced  from  the  solutions 
studied,  in  depth  analysis  was  not  possible  using  these  programs,  especially 
considering that such a small molecule system was being investigated. 
 
It was however, possible to notice the overall changes in the scattering being observed 
from the pure methanol solution compared with that from the pMHB (Chapter 4) and 
2-bromobenzoic acid solutions.  Our hypothesis was indeed correct in suggesting that 
increased scattering would be observed from the 2-bromobenzoic acid solution due to 
the heavy atom present.  This is shown in Figure 6.3.3 where the scattering profiles 
are overlaid, with obvious increases in scattering evident for the systems with solute 
present. 
 
 
 
Figure 6.3.3: Scattering profile measured on Station 2.1 showing variations between 
the scattering from solutions of the two molecules investigated (2-bromobenzoic acid 88 
 
in blue, pMHB in red, both in methanol solvent) and the control (methanol solvent-
only) experiment (in pink). 
 
It can be easily observed from this graph that the scattering patterns cannot overlay 
perfectly.  This is due to the increased scatter observed for the solutions with solute 
present.  The profile for the 2-bromobenzoic acid shows differences even at lower 
angle.  The slope of the peak is seen to vary more significantly than for pMHB.  This 
is as expected due to the presence of the bromine atom in the molecule being studied, 
however,  even  with  this  increased  observed  scattering,  attempting  to  deduce  any 
structural information from this was not possible with the analysis tools available. 
 
One  observation  from  the  2-bromobenzoic  acid  study  that  was  not  present  in  the 
pMHB study, was that of a slight temperature effect; it is not clear how important this 
may  be.    One  of  the  initial  hypotheses  underlying  this  work  was  that  prior  to 
crystallisation, the particles in solution would become more ordered and increase the 
scattering from solution – this may be expected to lead to an increase in scattering as 
the temperature is lowered, potentially inducing more crystallisation.  This turned out 
not to be the case  in our experiments, during  which crystallisation did  not occur.  
However  there  is  a  small  change  observed  in  the  scattering  profiles  of  the  2-
bromobenzoic acid solution between 10 and 20ºC.  This is shown in Figure 6.3.4 and 
can  perhaps  be  attributed  to  changes  in  kinetics  and  thermal  motion.    It  is  to  be 
expected that at higher temperatures particles move about a lot more than at lower 
temperatures and although the temperature change in this case is just 10ºC this may 
explain the differences in scattering.   
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Figure  6.3.4:  Scattering  profile  showing  the  variations  in  scattering  of  2-
bromobenzoic acid with temperature, with the increase between 10
oC (red) and 20ºC 
(blue) evident. 
 
6.3.1: Conclusions 
 
Through the SAXS studies that have been carried out it has been possible to observe 
scattering  from  the  solutions  containing  our  test  molecules.    This  is  a  significant 
achievement  considering  the  size  of  the  molecules  involved  in  the  study  and  the 
shortage of studies carried out in this field to date.  It is of course, a disappointment 
that there  has  not  been  an  opportunity  to  get  any  structural  information  from  the 
observed  scattering, however this would require extra specialist analysis programs 
that are not currently available.  Differences in the small angle liquid scattering for 2-
bromobenzoic acid have however been observed as a function of temperature and this 
requires further investigation. 
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Chapter 7: Co-crystals of Brominated Compounds.   
I. Bromanilic acid with picolines 
 
7.1: Methyl 4-bromobenzoate 
 
The  structural  studies  of  methyl  2,5-dibromobenzoate  (Section  6.2),  showed  that 
halogen – halogen interactions and the stronger Br 
. . . O halogen bond were present in 
the crystal structure.  The related methyl-4-bromobenzoate was studied to examine 
whether these interactions were more significant in the absence of other ‘stronger’ 
interactions.   
 
Br
O
C H3
O
 
Fig 7.1.1: Methyl-4-bromobenzoate 
 
The structures of the iodo- and chloro- analogues of methyl-4-bromobenzoate have 
previously been studied, although there are no three dimensional coordinates available 
for  the  chloro  analogue
89,  the  iodo-  has  been  solved  by  means  of  single  crystal 
diffraction
90.  The iodo- substituted derivative was found to crystallise in the Pbca 
space group and was found to contain I···O halogen bonds, but no halogen – halogen 
interactions.  The halogen bonds formed have a length of 3.203(4)Å and a C-I···O 
angle of 172.5(2)
o.  This is equivalent to 91.5% of the sum of the van der Waals radii. 91 
 
 
Fig 7.1.2: Crystal structure of methyl-4-iodobenzoate viewed along the b axis, with 
an O···I halogen bond highlighted. 
 
A systematic recrystallisation study was carried out on methyl-4-bromobenzoate using 
a  variety  of  solvents  and  conditions  and  analysed  using  XRPD  to  assess  the 
possibilities for polymorphism.   
 
Fig 7.1.3: Overlay of representative XRPD patterns of methyl-4-bromobenzoate 
collected from samples recrystallised from different solvents. 92 
 
 
Figure 7.1.3 shows an overlay of two data sets collected on a Bruker AXS D8 powder 
diffractometer.  This clearly shows that although intensities may vary, that each peak 
is accounted for in both patterns.  Only two patterns have been overlaid here to make 
it simple to notice the similarities between the patterns, however many more patterns 
were collected and all contain the same peaks, which would indicate that there is only 
one form present.   
 
Following on from this initial analysis, a variable temperature single crystal X-ray 
diffraction analysis was carried out.  The crystals were grown at room temperature 
using the slow evaporation technique from methanol solvent.  Data were collected on 
a Bruker AXS Apex II diffractometer.  The structure was solved using SIR
82 within 
CRYSTALS
83  and  refined  using  SHELXL
84.    It  was  found  to  crystallise  in  the 
orthorhombic  Pbca  space  group,  with  Z  =  8,  at  all  the  temperatures  that  were 
investigated.    Structures  were  solved  every  50K  between  100  and  300K  so  that 
analysis over a wide temperature range could be carried out. 
 
   
 
Fig 7.1.4 a-c: Crystal structures of methyl 4-bromobenzoate viewed along the b axis 
produced at 100, 200 and 300K respectively, with the halogen bond highlighted. 
a  b 
c 93 
 
 
Figure  7.1.4a  shows  the  crystal  structure  and  packing  of  methyl-4-bromobenzoate 
along the b axis at 100K.  This packing motif is the same across the temperature range 
studied and no phase transition was observed.  The only variation is in the length of 
the bromine – oxygen contact.  In the absence of hydrogen bonding in this system, 
halogen bonding is the strongest interaction present.  At 100K, the Br 
. . . O halogen 
bond measures 3.040(2)Å and represents 90% of the sum of the van der Waals radii, 
and the C-Br 
. .  . O angle was found to be 172.1(1)
o.  The length of this interaction 
varies  as  a  function  of  temperature  and  is  elongated  to  3.122(3)Å  at  300K,  this 
however still represents 92.6% of the sum of the van der Waals radii with the C-Br ··· 
O angle found to be 173.1(1)
o.  
   
 
Figure 7.1.5: The  variation of the thermal  ellipsoids at 100K(a) and 300K(b)  for 
methyl-4-bromobenzoate  indicating  that  although  the  precision  of  the  structure 
remains  similar,  the  thermal  motion,  specifically  around  the  methyl  hydrogens 
increases considerably as would be expected for a librating methyl group. 
 
The crystal structure is isostructural with that of the iodo derivative and shows no 
signs of polymorphism.  During this study the crystal structure was published from a 
determination  at  173K
91  and  is  found  to  be  in  close  agreement  with  the  data  we 
collected at 200K. The published halogen bond distance measures 3.047(3)Å and the 
C-Br ··· O angle is 172.3(1)
o.  This study indicates that in the absence of hydrogen 
bonding, halogen bonding interactions are important intermolecular interactions in the 
stabilising  of  the  crystal  structure.    The  crystallographic  data  from  the  variable 
temperature study is available in Appendix 2. 
(a) (b) 94 
 
 
 
7.2: Co- crystallisations of Bromanilic Acid – potential intermolecular halogen 
interactions 
 
7.2.1: Introduction to bromanilic acid 
 
Bromanilic acid  belongs to a family of widely  used and  studied anilic acids with 
importance  in  organic  synthesis
92  and  also  widely  studied  in  for  its  ferroelectric 
properties
93.  It is the aim of this part of the project to examine the possibilities for 
potential uses in crystal engineering, due to the ability of bromanilic acid to hydrogen 
and halogen bond readily. 
Br
Br
OH
HO O
O
 
Fig 7.2.1: A schematic diagram of bromanilic acid, systematic name: 2,5-dibromo-
3,6-dihydroxyl-1,4-benzoquinone. 
 
Bromanilic acid, unlike other members of its family, is soluble in many solvents and 
crystallises mainly in deep purple cuboidal shapes.  It is possible for bromanilic acid 
to  co-crystallise  with  target  molecules  and  lose  either  one  or  two  protons  to  an 
acceptor on another molecule in a similar way to that seen for the related chloranilic 
acid
92,94.    In  studies  carried  out  to  date,  there  is  only  two  examples  of  complete 
hydrogen  atom  transfer  from  both  hydroxyl  groups  of  the  bromanilic  acid 
molecule
9295.  
 
Robl solved the crystal structure of bromanilic acid from X-ray diffraction data in 
1987
96 and it was found to crystallise in the space group P21/n.  The most interesting 
characteristic of the crystal structure is that each bromanilic acid molecule has four 
hydrogen bonds to four separate bromanilic acid molecules.  This without doubt is the 95 
 
most stabilising interaction in the crystal structure with other weaker interactions such 
as Br ··· Br being formed a result of the former interactions.  The hydrogen bond 
formed is a moderate strength O-H···O interaction and these are formed from each 
oxygen atom in the crystal structure (O···O distance 2.781Å, O-H···O angle 147.55
o).  
The Br···Br close contact of 3.434Å is measured as being 92.8% of the sum of the van 
der Waals radii. 
 
Figure 7.2.2: Crystal structure of bromanilic acid viewed along the c axis showing the 
four hydrogen bonds that are present from each bromanilic acid molecule
96. 
 
Bromanilic acid has high potential for co-crystallisation due to the many routes by 
which  it  could  potentially  form  intermolecular  interactions  to  strengthen  a  crystal 
lattice.  The obvious main routes would be through hydrogen bonding, with the ketone 
and hydroxyl groups present and there is a strong possibility of forming bifurcated 
hydrogen bonds as seen for the related chloranilic acid
97.  The larger halogen atoms 
Br and I are known to form close contacts with themselves or with atoms such as 
oxygen, whereas F and Cl are more likely to interact with hydrogen atoms.  Studies 
have  shown  that  Cl 
.  .  .  Cl  interactions  are  longer  than  Br···Br  interactions
60  thus 
backing this theory.  For this reason it would be suggested that there should be a 
greater deal of halogen bonding, Br···O, and halogen – halogen interactions, Br···Br, 96 
 
than  in  the  associated  chloranilic  acid  co-crystal  compounds.    There  is  also  the 
possibility  of  halogen  bonds  and  many  other  weaker  interactions  including  π  –  π 
stacking  interactions.    Hydrogen  bonds  are  directional  interactions  and  can  be 
distinguished  in  their  strength  in  the  range  of  angles  (∠D-H···A)  between  strong 
(~180
o) and weak cases (>90
o).  Due to the significant hydrogen bonding capability 
there is also the likelihood of solvates, most significantly hydrates, forming during co-
crystallisation studies
98.   
 
There are two instances of bifurcated hydrogen bonding involving bromanilic acid.  
Both of these instances are found in the same study carried out by Zaman et al.
92.  The 
first  of  these,  a  co-crystal  complex  of  bromanilic  acid  with  bis(4-(2-
pyridyl)pyridinum) forms a three molecule interaction in a two to one ratio of the 
pyridinium to bromanilic acid.  This results  in  deprotonation on both sides of the 
bromanilic  acid  and  bifurcated  hydrogen  bonds  forming.    The  second  of  these 
involves a co-crystal of bromanilic acid with ethyne-1-(4-pyridyl)-2-(4’-pyridinium) 
also in a two to one ratio as previously.  This time however deprotonation only occurs 
on one side of the bromanilic acid. 
 
Interestingly, on further examination of the CSD there are also two instances of Br···O 
halogen bond interactions
92,99 with interactions of 3.190 and 3.251Å, which are both 
shorter than the sum of the van der Waals radii of 3.37Å.  Zaman et al.
92 show the 
complex interactions surrounding the anilic acids.  Their study focuses on the co-
crystallisation of 2,2’-bipyrimidine with cyanilic acid, chloranilic acid and bromanilic 
acid.  The chloranilic acid and bromanilic acid co-crystal structures are both stabilised 
by hydrogen bonding from water molecules and interestingly both generate halogen – 
halogen  interactions.  These  studies do  not emphasise the significance of  halogen 
bonding which has been found to be significant in previous crystal structures.   
 
Bromanilic acid is soluble in a wide variety of solvents, which enables a variety of 
conditions to be used throughout the studies.  Many of these trials were set up using 
the Microvate Reactaray™, which allows 12 different temperature conditions to be 
used in parallel.    This enables products to be collected in a much shorter time and 
screened by XRPD before altering conditions to promote the growth of single crystals.  97 
 
Co-crystals  incorporating  bromanilic  acid  can  exist  in  both  1:1  and  2:1  ratios 
depending on the experimental set up in terms of the ratio of starting materials, and 
other factors. 
 
 
7.2.2: Initial studies of Bromanilic acid 
 
A  crystal  structure  is  a  compromise  between  interactions  of  varying  strengths, 
directionalities and distance-dependence properties.  Interactions in an organic crystal 
are numerous and of a range of strengths, therefore can the effect of hydrogen bonds 
and halogen bonds be studied in co-crystals with the possibility to contain both?  For 
many  years  it  has  been  known  that  there  exists  three  separate  types  of  hydrogen 
bonding for small molecules.  The strengths of these interactions are upwards of 15 kJ 
mol
-1 for the very strong hydrogen bond and 4-15 kJ mol
-1 for the moderate hydrogen 
bonds  and  <4  kJ  mol
-1  for  weak  hydrogen  bonds
61.    In  terms  of  small  molecule 
crystallography,  studies  invariably  centre  around  moderate  strength  hydrogen 
bonding.  The hydrogen bonding in these small molecule systems has been studied for 
many years and now has an element of predictability associated with it.  For this 
reason, it is the purpose of this work to examine the effect of additional halogen atom 
interaction capabilities in the construction of the co-crystals studied.  This is a topic of 
great interest in terms of crystal engineering as halogen bonding is known to be a 
significant non-covalent interaction. 
 
The crystallographic studies reported in Chapter 5 on methyl-2,5-dibromobenzoate, a 
material which was used in the metastable zone width studies, showed that there were 
two distinct interactions occurring in the absence of any hydrogen bonding.  These 
were halogen – halogen interactions e.g. Br···Br and halogen bonding interactions e.g. 
O···Br; the latter of these is predominant and known to be comparable in strength to 
that of weak hydrogen bonds
60.   
 
Co-crystallisation of bromanilic acid with a series of co-molecules has been used to 
try and monitor and possibly engineer these close halogen bonding interactions even 
in the presence of hydrogen bonding.  These close halogen contacts have the potential 
to play a significant role in the crystal structure especially where only weak hydrogen 98 
 
bonding is found to occur.  Hydrogen bonding and possible halogen bonding patterns 
were evaluated with the aim of prediction of certain patterns that are likely to occur in 
related crystal structures. 
 
Previous studies involving the related chloranilic acid show a significant number of 
Cl···Cl interactions and also the presence of halogen bonding interactions with both 
nitrogen atoms and oxygen atoms indeed both are found in the co-crystal structure of 
chloranilic  acid  and  piperazine-2,5-dione
100.    Indeed  the  crystal  structures  of  pure 
chloranilic  acid,  and  indeed  the  hydrated  form,  are  found  to  contain  Cl···Cl 
interactions
101,102.  In related studies involving the co-crystallisation of chloranilic acid 
with the family of picolines there appears to exist a relationship between the ratio and 
the packing sequence.  It has been found that the 1:1 chloranilic acid (C) : picoline (P) 
structures  tend  to  form  a  P:C:C:P  type  structure,  whereas  the  1:2  structures  tend 
towards  P:C:P  due  to  the  hydrogen  atoms  being  transferred  from  both  hydroxyl 
groups of the bromanilic acid
94,103. 
 
A  systematic  co-crystal  study  of  bromanilic  acid  and  a  family  of  compounds, 
picolines  and  lutidines  was  thus  completed  in  this  work,  to  see  if  any  halogen 
interactions were present and determine whether there were any cases  in which  it 
could be a short enough contact to compete with any hydrogen bonding involved. 
 
N
CH3
          
N C H3
C H3
 
Fig 7.2.3: An example of a picoline and a lutidine molecule, in this example (a) 4-
picoline and (b) 2,3-lutidine. 
 
The  molecules studied are all related and  it  is  merely the positions of the  methyl 
groups  in  the  isomeric  picolines  and  lutidines  that  vary.    The  main  interactions 
expected  in  these  co-crystal  compounds  would  be  hydrogen  bonding  between  the 
nitrogen of the ring and the hydroxyl hydrogens on the bromanilic acid with only 
weak halogen interactions present if any at all.  This could be altered by the presence 
of a halogen on the secondary molecule to compete for the interaction around the 
(a)  (b) 
 99 
 
hydroxyl group of the bromanilic acid molecule.  Following on from this study it was 
decided to investigate whether the presence of a bromine atom on the 2
nd molecule 
involved in the co-crystal would have any effect on the likelihood of halogen bonding 
or halogen – halogen interactions occurring.  The hypothesis behind this is that by 
involving a halogen atom in the 2
nd molecule this will enable competition between 
hydrogen  bonding  and  halogen  bonding,  with  the  added  possibility  of  halogen  – 
halogen interactions between the bromine atoms.   
 
Picolines, (chemical  formula C6H7N) come  in three  isomeric  forms, 2-, 3- and 4-
picoline.  They are all colourless liquids with a strong smell and have a high affinity 
for protons.  For this reason it was hypothesised that hydrogen bonding would occur 
with  the  hydroxyl  group  after  extracting  a  H  atom  and/or  possibly  forming  a 
bifurcated hydrogen bond with a second interaction to the ketone group as well.  This 
was anticipated to be the major stabilising interaction in the 2:1 co-crystal compounds 
studied, however in the 1:1 co-crystal studies it was suspected to be more likely that 
competing interactions from halogen bonding would occur. 
 
Before  commencing  the  co-crystal  study,  single  crystals  of  bromanilic  acid  were 
grown from  methanol by the slow evaporation method.  Data were collected on a 
Bruker AXS Apex II diffractometer at 100 K and solved using SHELXS
84 using direct 
methods.  The structure was refined using CRYSTALS
83 and found to crystallise in 
the  monoclinic  P21/c  space  group,  with  cell  parameters  of  a=5.4365(5)  Å, 
b=7.3128(6) Å, c=9.5880(8) Å and β=99.435(6)º, and a cell volume of 376.02(6)Å
3.  
This was found to be in agreement with previously published data
96. 100 
 
 
Fig 7.2.4: Crystal structure of bromanilic acid collected at 100K.  Close contacts are 
shown with dashed lines. 
 
Figure 7.2.4 shows the crystal structure of bromanilic acid with the hydrogen bonding 
extended.  The hydrogen bonding is of the moderate variety forming zigzag chains of 
bromanilic acid molecules, which are highly symmetrical.  For this reason, the full 
three-dimensional structure is held together by hydrogen bonding and any other close 
contacts are constrained to be present by these interactions.  This initial survey of 
solvent and temperature crystallisation conditions yielded only one product and this 
indicated that no hydrates should be expected. 
 101 
 
 
 
Figure 7.2.5: XRPD data from recrystallised sample of bromanilic acid 
 
 
7.3: Co-crystallisation Studies of Bromanilic acid and Picolines 
 
Co-crystallisation experiments were carried out using 2-, 3- and 4-picoline using a 
series  of  solvents  and  temperature  regimes.    Co-crystallisations  were  carried  out 
attempting to crystallise in both 1:1 and 2:1, picoline : bromanilic acid ratios.  All 
solid materials were initially characterised by XRPD.  The co-crystallisations in this 
case  used  a  liquid  material  as  a  second  component.    In  spite  of  this,  the  XRPD 
patterns of the initially solid materials are crucial in such studies as this is always the 
first  check  when  assessing  whether  a  new  co-crystal  has  been  produced.    The 
bromanilic acid spectra collected allows initial comparison with powder data collected 
from the co-crystals and this can indicate if bromanilic acid was crystallising out as 
the product, a valid and useful conclusion even in the absence of powder data for the 
other co-crystal molecules.  The screening showed that new molecular complexes had 
been  formed  and  single  crystals  were  selected  from  these  solid  products.    Single 
crystal data were collected from all new complexes.  Higher quality single crystal data 
were collected from the 2:1 co-crystals, however the data collected from the 1:1 co-
crystals also gave rise to some interesting features.  102 
 
 
All crystals unless stated were grown via the slow evaporation method from alcohol 
solvents at room temperature.  These were generated using molar quantities of the two 
components. 
 
For  all  the  reported  structures,  data  were  collected  on  a  Bruker  AXS  Apex  II 
diffractometer with a CCD detector and graphite monochromated Mo Kα radiation (λ 
= 0.7103Å) at 100K.  Structures were solved by direct methods (SHELXS-97
84) and 
refined (SHELXL-97
84) by full matrix least-squares methods, as implemented in the 
WinGX software package
85.  Absorption corrections were applied.  Hydrogen atoms 
were introduced at calculated positions and refined isotropically. 
 
 
7.3.1.  Bromanilic acid 3-picoline co-crystal structures 
 
 
 
 
Figure 7.3.1: Crystal structure of bromanilic acid and 3-picoline in a 1:1 ratio viewed 
down the a axis collected at 100K. 
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Figure 7.3.1 shows the crystal structure of the 1:1 bromanilic acid and 3-picoline co-
crystal collected at 100K.  The crystal was grown from a methanol solution containing 
10mg bromanilic acid and 31mg 3-picoline to account for the 1:1 ratio.  This is a very 
intriguing co-crystal complex as it bears out the complexity of bromanilic acid due to 
the many states in which it can exist.  It was found to crystallise in the  1 P  space 
group,  the  complex  has  crystallised  in  a  one  picoline  to  0.5  fully  protonated 
bromanilic acid to 0.5 completely deprotonated bromanilic acid ratio.  This is possible 
due to the symmetry of bromanilic acid, however this motif has never previously been 
generated.  This also promotes the  idea of salts or co-crystals.  In this co-crystal 
complex one half has been deprotonated and the other remains fully protonated so by 
definition  this  could  be  determined  to  be  a  half  salt,  half  co-crystal.    To  avoid 
confusion,  all  such  structures  will  be  described  as  co-crystals  to  avoid  any 
terminology difficulties. 
 
There is the presence of a bifurcated hydrogen bond between the 3-picoline and the 
fully deprotonated bromanilic acid molecule with N···O distances of 2.724(2)Å and 
2.858(2)Å and angles equal to 148(2)
o and 122(2)
o respectively (Figure 7.3.2).  There 
are also hydrogen bonds formed from the fully protonated bromanilic acid to the fully 
deprotonated measuring 2.587(2)Å with an angle of 152(2)
o and  further  more the 
presence of two Br···O halogen bonds measuring 3.311(2)Å and 3.337(1), which due 
to the distances involved must be considered to be as a result of the stronger hydrogen 
bonding  interactions  rather  than  as  a  contributing  interaction  resulting  in  extra 
stabilisation of the crystal structure. 
 
The three-dimensional structure is linked via these halogen bonding interactions, so 
they  do  play  an  important  role  in  the  crystal  structure.    The  stabilisation  of  the 
deprotonated bromanilic acid molecule comes from the conjugation in the system.  
This  is  evident  when  compared  with  the  C-O  bond  lengths  from  the  protonated 
bromanilic  acid.    In  the  deprotonated  form  the  C-O  hydroxyl  bond  contracts 
(1.251(2)Å)  and  the  carbonyl  C=O  elongates  (1.246(2)Å)  in  comparison  to  the 
protonated form (1.316(2)Å and 1.220(2)Å). 
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Figure 7.3.2: Crystal structure of bromanilic acid and 3-picoline in the ratio 1:2 
viewed down the a axis, collected at 100K. 
 
The crystal structure of bromanilic acid and 3-picoline in the 1:2 form was collected 
at 100K and found to crystallise in the monoclinic form with space group P21/c.  The 
co-crystal was grown from a methanol solution containing 12mg bromanilic acid and 
75mg 3-picoline left to slowly evaporate at room temperature.  Due to the presence of 
two picoline molecules, this can fully deprotonate both sides of the bromanilic acid 
and it is found that the bromanilic acid exists in the fully deprotonated state and all 
picoline molecules have been protonated.  In this instance only N-H···O(O) bifurcated 
bonds were found to be present, once again in a major and minor variety.  The major 
interaction, N···O, measures 2.601(1)Å, with the angle determined to be 168(2)
o.  This 
follows the same hydrogen bonding motif as found for that of chloranilic acid
94 and 
again the bromanilic acid is found to be stabilised through conjugation with C-O bond 
lengths measuring 1.240(1)Å and 1.265(1)Å.  In this 1:2 co-crystal compound, the 
weaker interactions that generate the 3-dimensional crystal structure again appear to 
involve the bromine with a close contact to the carbon atoms of the bromanilic acid 
molecule which lies perpendicular to the bromine atom (Figure 7.3.3).   105 
 
 
 
 
Figure 7.3.3: Close contacts involving bromine and the carbon atoms of the 
bromanilic acid molecule involved in the bifurcated hydrogen bonding with 3-
picoline. 
 
 
 
Figure 7.3.4: XRPD data showing the 1:1 and 1:2 co-crystal products of co-
crystallisations of bromanilic acid and 3-picoline. 
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Figure 7.3.4 shows a cropped selection of the powder patterns collected for both the 
1:1 and 1:2 bromanilic acid : 3 picoline complexes.  These show very little similarity 
as would be expected considering there is no relationship between the two crystal 
structures and that the bulk products of both are different. 
 
7.3.2 Bromanilic acid 2-picoline co-crystal structures 
 
Bromanilic acid and 2-picoline only produced high enough quality single crystals in 
the 1:2 bromanilic acid : 2-picoline form for single crystal X-ray diffraction studies.  
The crystal used was grown from a methanol and water solution containing 8mg of 
bromanilic acid and 50mg 2-picoline.  The solution was left to crystallise at 5
oC and 
crystals were produced.  The single crystal data collected for the 1:1 co-crystal was 
not of high enough quality to prodice a reliable refined structure.  As with the 2:1 3-
picoline  :  bromanilic  acid  co-crystal,  the  bromanilic  acid  was  found  to  be  fully 
deprotonated and found to crystallise in the monoclinic P21/c space group. 
 
 
 
Figure 7.3.5: Crystal structure of Bromanilic acid and 2-picoline in the ratio 1:2 
viewed along the b axis, collected at 100K 107 
 
 
Once again the predominant interactions are bifurcated hydrogen bonds as a result of 
the hydrogen transferring over to the picoline molecule (Figure 7.3.5).  However in 
this instance the dominant bifurcated hydrogen bond measures 2.841(4)Å, at an angle 
of 164(3)
o.  The hydrogen bonding incorporated in this crystal structure results in 
additional halogen bonding, Br···O, being present in the 2-picoline co-crystal structure 
where none was visible in the 3-picoline structure.  This Br···O interaction is of length 
3.357(2)Å and an angle of 162.5(1)
o and again these halogen bonds are found to be 
important  in  producing  the  three-dimensional  crystal  structure  linking  via  halogen 
bonding to the carbonyl group.  The conjugation present again helps to stabilise the 
deprotonated bromanilic acid molecule with C-O bond distances measuring 1.241(6) 
and 1.255(5)Å.  
 
 
 
Figure 7.3.6: XRPD data showing the 1:1 and 1:2 bromanilic acid 2-picoline co-
crystal products. 
 
Figure 7.3.6 shows the XRPD data collected on result of the recrystallisation trials of 
both the 1:1 and 1:2 co-crystallisation attempts.  From this it can be seen that both 
patterns show a great similarity to each other and from this it is understandable why 
only  the  1:2  co-crystal  structure  could  be  obtained.    Though  showing  marginal 108 
 
changes,  mainly  in  intensity,  the  peaks  for  both  the  1:1  and  1:2  crystallisation 
products show enough to indicate that only the 1:2 product was successfully grown.  
This shows that even though crystallisations were prepared in a 1:1 ratio, only a 1:2 
product  was  obtained.    These  trials  were  carried  out  in  sample  vials  and  further 
investigations  using  the  Reactarray  Microvate 
TM  did  not  prove  to  be  any  more 
successful in producing the 1:1 complex. 
 
7.3.3.  Bromanilic acid 4-picoline co-crystal structures 
 
The  final  picoline  molecule  in  the  sequence,  4-picoline,  was  successfully  co-
crystallised in both the 1:1 and 1:2 forms.  Both 1:1 and 1:2 crystals were grown from 
acetone solution at 5
oC using the Microvate
TM.  The 1:1 co-crystal in this instance 
contains all the non-covalent interactions of interest in the study, possibly helped by 
the methyl group being as far away as possible from the nitrogen on the picoline 
molecule.  In this instance, the bromanilic acid molecule remains fully protonated and 
unlike the 3-picoline co-crystal structure there is only one type of bromanilic acid 
present in the crystal structure.  This results in essentially only a O-H···N hydrogen 
bond being present (Figure 7.3.7), however there is also a close contact between the 
nitrogen and the carbonyl oxygen of the bromanilic acid (3.021(9)Å).  The hydrogen 
bond to the hydroxyl group has an N···O distance of 2.771(9)Å and a reduced angle of 
138.1(5)
o.  There is also the presence of Br···O halogen bonding of 3.263(9)Å, angle 
151.1(3)
o, and also for the first time halogen – halogen interactions are also observed, 
Br···Br, of length 3.546(1)Å, representing 95.84% of the sum of the van der Waals 
radii. 
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Figure 7.3.7: Crystal structure of bromanilic acid and 4-picoline in a 1:1 ratio 
determined at 100K 
 
The 1:2 co-crystal complex of bromanilic acid with 4-picoline follows the same trend 
as the other 1:2 complexes studied whereby the bromanilic acid is fully deprotonated 
and hydrogen bonding occurs at both sides of the bromanilic acid molecule.  This is 
the complex in which the nitrogen is nearest the centre of the two oxygen atoms of the 
bromanilic acid, however as can be seen there is still one dominant hydrogen bond in 
this case measuring 2.762(2)Å, with an angle measured to be 142(2)
o (Figure 7.3.8).  
This is in comparison to the longer N···O distance measuring 2.860(2)Å with an angle 
of 137(2)
o.  In comparison to the other bifurcated hydrogen bonds, Table 7.1, this is 
much more of a central bifurcated bond.  This co-crystal complex has no other non-
covalent interactions present.  In this co-crystal structure there are found to be many 
other weaker interactions involved to stabilise the structure in 3-dimensions involving 
the  hydrogen  in  the  2  position  of  the  picoline  generating  close  contacts  with  the 
oxygen, from the shorter of the two C-O bonds, and the bromine atom of another 
bromanilic acid molecule.  The bromanilic acid molecule in this instance has been 
stabilised  significantly  by  the  conjugation  of  the  molecule  with  C-O  distances  of 
1.242(2)Å and 1.245(2)Å. 110 
 
 
Figure 7.3.8: Crystal structure of bromanilic acid and 4-picoline in the ratio 1:2 
viewed along the b axis, collected at 100K. 
 
 
 
Figure 7.3.9: XRPD data showing the 1:1 and 1:2 co-crystal products of bromanilic 
acid with 4-picoline. 111 
 
 
Figure 7.3.9 shows an overlay of the XRPD data for both the 1:1 and 1:2 co-crystal 
complexes of bromanilic acid and 4-picoline.  This is a pure powder pattern where the 
1:1  pattern  (blue)  and  the  1:2  pattern  (red)  have  completely  unique  peaks  thus 
suggesting  that  there  is  only  one  product  in  each  crystallisation  and  there  are  no 
mixtures.  112 
 
Table 7.1: Distances and angles for the bifurcated hydrogen bond in the bromanilic acid (Ba) picoline (pic) complexes and other important close 
contacts.  The angles shown represent the plane of the bifurcated hydrogen bond. 
 
*It should also be noted from the table that there is no bifurcated hydrogen bond for the bromanilic acid : 4-picoline 1:1 cocrystal as the 
hydrogen atom was located on the hydroxyl group. 
 
 
 
 
 
Co-crystal  N – O1 
(Å) 
N – O2 
(Å) 
N – H 
(Å) 
H - - O1 
(Å) 
H - - O2 
(Å) 
Br - - O 
(Å) 
Br - - Br 
(Å) 
N-H- - 
O1 (
o) 
N-H - - 
O2 (
o)  
O- - H- - 
O (
o) 
Overall 
(
o) 
Ba : 2pic 
1:2 
2.841(4)  2.961(4)  0.89(3)  1.98(3)  2.40(3)  3.357(2)    164(3)  121(2)  74(1)  359(3) 
Ba : 3pic 
1:1 
2.724 (2)  2.858(2)  1.07(2)  1.76(2)  2.15(3)  3.311(2) 
3.337(1) 
  148(2)  122(2)  85(1)  355(2.5) 
Ba : 3pic 
1:2 
2.601(1)  3.041(1)  0.83(1)  1.79(1)  2.59(1)      168(2)  116(1)  73.0(5)  357.0(1.8) 
Ba : 4pic 
1:1 
2.771(9)  3.021(9)    0.820(5)*    3.263(9)  3.546(1)         
Ba : 4pic 
1:2 
2.762(2)  2.860(2)  0.76(2)  2.13(2)  2.25(3)      142(2)  137(2)  74.3(8)  353.3(2.4) 113 
 
Table 7.2: The crystallography data produced from single crystal diffraction. 
Compound  Ba:2pic 1:2  Ba:3pic 1:1  Ba:3pic 1:2  Ba:4pic 1:1  Ba:4pic 1:2 
Formula  C12 H9 Br2 N O4  C12 H9 Br2 N O4  C12 H9 Br2 N O4  C12 H9 Br2 N O4  C12 H9 Br2 N O4 
Molecular 
weight (gmol
-1) 
390.51  390.51  390.51  390.51  390.51 
Temperature 
(K) 
100  100  100  100  100 
Space Group  P 1 21 / c 1  P-1  P 1 21 / c 1  C c  P 1 21/c 1 
a (Å)  16.4608(17)  7.6036(4)  8.9526(7)  18.4569(10)  8.1345(8) 
b (Å)  7.8053(8)  8.4569(4)  9.6149(8)  11.1776(6)  6.1517(6) 
c (Å)  14.5632(15)  11.1195(5)  10.4275(8)  14.0787(7)  17.7868(17) 
α (
o)    69.350(2)       
β (
o)  99.593(5)  86.849(2)  103.935(4)  117.532(3)  96.177(7) 
γ (
o)    74.752(2)       
Volume (Å
3)  1844.9(3)  644.96(6)  871.17(12)  2575.6(2)  884.90(15) 
Z  5  2  2  8  3 
θ range (
o)  1.255 – 21.035  1.959 – 34.393  2.344 – 28.870  2.21 – 36.21  2.303 – 32.816 
Reflections 
Collected 
11969  17647   10143  13032  14768  
Independent  1970  4832  2280  3526  3237 
Refln Observed 
I > 2σ (I) 
1610  4144  2050  3040  2516 
Rint  0.0455  0.0393  0.0329  0.0485  0.0460 
No. Parameters  283  199  142  353  142 
GooF on F
2  0.9733  1.0373  1.3223  1.019  0.8521 
R1 (Observed)  0.0393  0.0344  0.0289  0.0588  0.0403 
R1 (all)  0.0746  0.0396  0.0337  0.0731  0.0579 
wR2 (all)  0.0665  0.0750  0.0740  0.1472  0.1004   114
 
7.3.4.  Summary 
 
From  this  study  it  can  be  concluded  that  in  terms  of  predictable  stabilising 
interactions, the bromanilic acid and picolines in the 1:2 form will always result in full 
deprotonation  with  bifurcated  hydrogen  bonding  occurring  at  both  sides  of  the 
bromanilic  acid  molecule.    This  is  entirely  predictable  given  the  knowledge  of 
picolines to have a high affinity for protons.  This is also in complete agreement with 
work carried out previously
94 where a P:C:P structure was generated with picolines 
and chloranilic acid.  This motif stands up here as well with regards to a predictable 
P:B:P structure being produced. 
 
From the crystal structures produced of the 1:1 co-crystals there does not appear to be 
a  predictable  motif  present.    With  regards  to the  bromanilic  acid  :  3-picoline  co-
crystal there is a P:B:P, three molecule interaction present, however as the bromanilic 
acid  crystallises  in  two  different  types  (protonated  and  deprotonated),  this  is  not 
present throughout.  The protonated bromanilic acid produces a O-H···O hydrogen 
bond and a Br···O halogen bond is also found.  The bromanilic acid : 4-picoline co-
crystal crystallises in a completely different space group and the bromanilic acid is 
found to hydrogen bond only to one picoline molecule with other significant halogen 
bonding present.  Hydrogen transfer to the picoline does not occur for this system.  
For this  reason  there  is  currently  no  specific  motif  present  for  the  1:1  structures, 
however these 1:1 structures are more likely to contain additional halogen bonding 
interactions and the only instance of halogen – halogen interactions was with that of 
the 4-picoline co-crystal. 
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Chapter 8: Co-crystals of Brominated Compounds.  II. 
Bromanilic acid with lutidines 
 
8.1: Co-crystallisations of bromanilic acid and the family of lutidine molecules. 
 
Lutidines or dimethylpyridines are commonly found in coal tar and bone oil and are 
strong smelling liquids.  These compounds have been studied routinely in terms of 
organometallic  compounds  where  the  lone  pair  on the  nitrogen  is  attracted to the 
metal centre.  There have been significant studies using a range of lutidine compounds 
in co-crystal studies,  including a  study  by Schmidtmann and  Wilson
64  in  which a 
whole  family  of  co-crystals  with  pentachlorophenol  were  produced.    This  was 
intended to study hydrogen transfer in the series, however attention should be given to 
2,6-lutidine pentachlorophenol co-crystal where hydrogen transfer has occurred from 
one of the two pentachlorophenol molecules in the crystal lattice
64.  Further research 
of structures available on the CSD only provides one further example of a significant 
co-crystallisation  study  using  lutidines  and  fumaric  acid  by  D.A.  Haynes  et  al
104.  
During this work the full family of co-crystals was produced using lutidines with both 
fumaric and succinic acid, which resulted in salt formation.   
 
Ishida et al have also used lutidines to produce co-crystals with chloranilic acid in the 
1:1  ratio
97.    These  structures  all  formed  a  chloranilic  acid  dimer  and  the  lutidine 
molecule interaction with the hydroxyl group of the other half of the bromanilic acid.  
In  only  the  2,5-lutidine  –  chloranilic  acid  structure  can  this  be  described  as  a 
bifurcated hydrogen bond as the other co-crystals appear to be hydrogen bonded from 
the  nitrogen  to  the  hydroxyl  group.    An  interesting  feature  in  this  study  is  the 
importance of the hydrogens on the lutidine ring and also from the methyl group.  For 
the 2,5-lutidine co-crystal the hydrogen on the 6 position of the lutidine develops an 
interaction with the carbonyl group, whereas in the 2,4- and 2,6-lutidine co-crystal 
compounds,  it  is a  hydrogen on the  methyl group that appears to form this close 
contact to stabilise the crystal structure. 
 
The family of lutidine molecules studied involved 2,3-, 2,4-, 2,5- and 3,5-lutidine.  
These present a set of simple molecules to examine structural motifs that may be   116
present and in common between them.  These are similar to the family of picolines 
though containing an extra methyl group on the aromatic ring.  These co-crystals were 
studied  in  the  1:1  form  with  bromanilic  acid.    This  was  due  to the  1:1  picolines 
showing an increased presence of non-covalent interactions in addition to hydrogen 
bonding.   
 
8.1.1: Bromanilic acid 2,3-lutidine 
 
Bromanilic acid and 2,3-lutidine were found to crystallise in the monoclinic P21/n 
space group at 100K.  Crystals were grown from a 2-propanol solution containing 
6mg bromanilic acid and 16mg 2,3-lutidine, by slow evaporation at room temperature.  
Due to the 1:1 ratio it is unsurprising that deprotonation has only occurred on one of 
the hydroxyl groups of the bromanilic acid molecule and this will be the case in all the 
subsequent lutidine co-crystals, however it is the subsequent interactions that are of 
interest.  Due to this deprotonation a  bifurcated hydrogen  bond  is  formed, with  a 
dominant interaction being present (Figure 8.1.1).  The conjugation of the bromanilic 
acid  molecule  changes  with  the  carbonyl  and  hydroxyl  groups  shortening  on  the 
deprotonated side (1.218(3)Å, 1.258(3)Å) and them both elongating on the protonated 
side (1.240(3)Å, 1.335(3)Å).  
   117
Figure 8.1.1: Crystal structure of bromanilic acid and 2,3-lutidine in a 1:1 ratio 
viewed down the a axis, collected at 100K. 
 
All  the  data  from  the  bifurcated  hydrogen  bonds  and  also  the  halogen  bonds  is 
presented  in  Table  8.1.    However,  the  major  N···O  bifurcated  bond  interaction 
measures 2.772(3)Å and has an N-H- - - O angle of 175(3)
o.  This is significant as this 
is similar to that of a strong hydrogen bond even though it is bifurcated and has a 
second significantly weaker interaction (3.039(3)Å, 113(3)
o).  The environment of the 
transferred hydrogen is also interesting as the sum of the three angles involved in the 
bifurcated hydrogen bond N-H···O, N-H···O and O···H···O is roughly equal to 360
o.  
This shows that the bifurcated hydrogen bond is almost planar in this example. 
 
As well as showing a clear distinction between the major and minor interactions for 
the  bifurcated  bonds,  each  bromanilic  acid  molecule  has  a  Br···O  halogen  bond 
present (Figure 8.1.2) measuring 2.895(2)Å from the bromine of one bromanilic acid 
molecule to the carbonyl group adjacent to the protonated hydroxyl group.  This is a 
significant discovery in the study as the aim was to investigate halogen bonding and 
this instance is the first that has been discovered where the interatomic distances have 
been sufficiently close to describe this as a major interaction in the crystal structure.  
This  is  also  the  main  route  by  which  the  three-dimensional  crystal  structure  is 
produced.  Another feature of this crystal structure is the availability of a hydrogen on 
each  bromanilic  acid  molecule  that  is  not  involved  in  any  hydrogen  bonding 
throughout  the  crystal  structure  and  indeed  the  only  close  contacts  involving  the 
hydroxyl group are to a bromine atom as a result of the significant halogen bond it has 
already  formed  to  the  adjoining  carbonyl  group.    As  it  is  known  that  hydrogen 
bonding is the strongest non covalent interaction this would not be expected.   118
 
Figure 8.1.2: All the interactions from one molecule of bromanilic acid in the co-
crystal structure with 2,3-lutidine. 
 
Furthermore as was discovered by Ishida et al
97, the methyl group in the two position 
also forms a close contact with the deprotonated hydroxyl group of the bromanilic 
acid. 
 
 
8.1.2: Bromanilic acid 2,4-lutidine 
 
Bromanilic acid and 2,4-lutidine were found to crystallise in the monoclinic P21/c 
space group and had very little resemblance to the crystal structure of bromanilic acid 
and  2,3-lutidine.    The  crystal  was  grown  from  a  methanol  and  water  solution 
containing 10mg  bromanilic acid and 26mg 2,4-lutidine  left to evaporate at room 
temperature.    The  crystal  structure  in  this  instance  was  found  to  have  undergone 
hydrogen atom transfer to the lutidine molecule at each end to form a four molecule 
unit.    The  bromanilic  acid  forms  centrosymmetric  dimers  joined  by  two  O-H···O 
hydrogen bonds (Figure 8.1.3).  The dimers are linked to the lutidine via bifurcated 
bonds on either side forming this four-molecule unit (Figure 8.1.4).  In this example 
the bifurcated bonding is not as strong, as shown by the bond lengths and angles in 
Table 8.1, however the hydrogen atom is exactly planar between all atoms involved in 
the  bifurcated  bonding.    This  crystal  structure  is  also  layered  and  π-π  stacking 
interactions are also significant in the crystal structure.   119
 
 
 
Figure 8.1.3: (a) shows the existence of the four molecule interaction in bromanilic 
acid 2,4-lutidine and (b) shows that each of these four molecule interactions has 
staggered four molecule interactions layered below it providing π-π stacking 
interactions. 
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Figure 8.1.4: Crystal structure of bromanilic acid and 2,4-lutidine in a 1:1 ratio 
collected at 100K showing the halogen bonding and how it links the four-molecule 
units. 
 
Each  of  these  four-molecule  units  is  linked  to  two  other  four  molecule  units  via 
halogen bonding to the deprotonated hydroxyl group.  Although this may not be as 
short a contact as that of the 2,3-lutidine co-crystal compound, measuring 3.152(2)Å, 
it  is  obviously  a  very  important  stabilising  interaction  as  it  is  fundamental  in 
producing the three-dimensional structure. 
 
 
8.1.3: Bromanilic acid 2,5-lutidine 
 
The co-crystal used was grown from a methanol and water solution left to evaporate 
slowly at room temperature containing 8mg bromanilic acid and 22mg 2,5-lutidine.  
The bromanilic acid and 2,5-lutidine co-crystal complex crystallised in a similar way 
to the 2,4-lutidine co-crystal  in the P21/c space  group and  forming the same  four 
molecule unit, however the subsequent intermolecular interactions vary considerably.  
The  bifurcated  bonds  in  this  co-crystal  do  not  have  as  distinct  major  and  minor 
interactions present as the nitrogen is much closer to the centre of the two oxygen 
atoms.  The four molecule unit with the bifurcated N---O distances of 2.882(2)Å and 
2.983(2)Å    indicating  that  unlike  previous  examples,  this  co-crystal  has  a  nearly 
symmetrical  interaction with  both hydrogens (Figure 8.1.5).  A small twist of the 
lutidine molecule with respect to the plane of the bromanilic acid dimer can also be 
determined, with the torsion angle between the plane of the lutidine and the plane of 
the bromanilic acid measuring 6.6(1)
o, and this slight distortion moves the hydrogen 
atom away from being in an exactly planar position. 
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Figure 8.1.5: Crystal structure of bromanilic acid and 2,5-lutidine in a 1:1 ratio 
viewed along the a axis, collected at 100K. 
 
The  other  main  interaction  present  in  the  crystal  structure  is  the  presence  of  π-π 
stacking  interactions  from  staggered  layers  of  four  molecule  interactions  (Figure 
8.1.6), which encourages the theory that in the four molecule system present there is 
no requirement for further stabilisations via any other interactions.  This is in contrast 
to the first system studied, which did not have the same four molecule motif and 
therefore the halogen bonding present was a significant interaction.   122
 
 
Figure 8.1.6: The layers in the bromanilic acid 2,5-lutidine co-crystal that are present 
as a result of π-π stacking interactions between the four molecule units. 
 
The only other interactions that are present to help generate the three-dimensional 
crystal structure are weaker interactions involving bromine – hydrogen interactions, 
which lie between the layers and link between two lutidine molecules from separate 
layers via interactions with a methyl hydrogen from one lutidine (C-H···Br) and a 
hydrogen  on  the  ring  of  the  other    (π-H···Br).    Whilst  these  interactions  are  not 
thought  to  be  overly  significant  in  terms  of  strength,  they  do  provide  a  role  of 
generating the entire three-dimensional crystal structure. 
 
 
8.1.4: Bromanilic acid 3,5-lutidine 
 
The bromanilic acid and 3,5-lutidine co-crystal that was formed from a 2-propanol 
solution containing 10mg bromanilic acid and 26mg 3,5-lutidine, crystallised in the 
P21/c space group and also follows the same four molecule motif described in the 
structures of 2,4- and 2,5-lutidine (Figure 8.1.7).  In this crystal structure however, the 
O-H- - - O dimer interactions are longer at 2.757(2)Å, which is supplemented by the 
hydrogen  bond  angle  measuring  133(2)
o  indicating  a  weaker  hydrogen  bond 
interaction. The major component of the bifurcated bond however, is clearly present   123
and measures 2.671(2)Å.  This is the shortest N···O interaction found in this co-crystal 
study (Table 8.1).  Br- - - O halogen bonding is also found to be present in the crystal 
structure and plays a significant role in the generation of the three-dimensional crystal 
structure as in the 2,4-lutidine co-crystal complex.  The halogen bonding is from the 
carbonyl group of the deprotonated side of the bromanilic acid molecule and is again 
used to link the central four molecule unit to two other four molecule units. 
 
Figure 8.1.7: Four molecule interaction of bromanilic acid with 3,5-lutidine. 
 
The four molecule interaction shown in Figure 8.1.7 shows a distinct change to the 
others that have been noted in the study.  This is due to a relatively planar O-H - - - O 
interaction  between  the  bromanilic  acid  molecules,  however  as  can  be  seen  the 
lutidine molecule in this instance is nowhere near co-planar with the bromanilic acid 
dimer.  As a result of this there are no π-π stacking interactions present in the crystal 
structure.  In this case the torsion angle between the plane of the lutidine molecule and 
that of the bromanilic acid is found to be 21.5(1)
o, which is considerably higher than 
that of the 2,5-lutidine complex which was found to be 6.6(1)
o.  The conjugation of 
the bromanilic acid molecule is similar throughout with the C-O bond distances found 
to  be  1.219(2)Å  and  1.242(2)Å  for  the  deprotonated  side  and  1.240(2)Å  and 
1.334(2)Å for the protonated side.  This is found to be similar to that of the 2,3-
lutidine co-crystal complex, thus the position of the methyl groups must play a key 
role.  In this case the  methyl groups are on symmetrical positions away  from the 
bromanilic acid molecule and this extra bulk may play a key role in the significant 
change on torsion angle.     124
 
 
 
Figure 8.1.4.2: Crystal structure of bromanilic acid and 3,5-lutidine in a 1:1 ratio 
viewed along the b axis, collected at 100K. 
 
In the 3,5-lutidine co-crystal complex there are also other weaker interactions that 
help generate the 3-dimensional structure (Figure 8.1.8), however the presence of the 
halogen bonding interactions is highly significant and was found to be so in both the 
2,3- and 2,4-lutidine co-crystal complexes as well.   125
 
Table 8.1: Distances and angles for the bifurcated hydrogen bond in the bromanilic acid (ba) lutidine (lut) complexes and brominated 
methylpyridines (mepyr) complexes  and other important close contacts.  The angles shown represent the plane of the bifurcated hydrogen bond. 
 
*It should be noted that there is not bifurcated hydrogen bond in the crystal structure of bromanilic acid : 2-bromo-3-methylpyridine. 
Co-crystal  N – O1 
(Å) 
N – O2 
(Å) 
N – H 
(Å) 
H - - O1 
(Å) 
H - - O2 
(Å) 
Br - - O 
(Å) 
Br - - Br 
(Å) 
N-H- - 
O1 (
o) 
N-H - - 
O2 (
o)  
O- - H- - 
O (
o) 
Overall 
Ba : 2,3lut   2.772(3)  3.039(3)  0.88(3)  1.89(3)  2.59(3)  2.895(2)    175(3)  113(3)  72(1)  360(3.5) 
Ba : 2,4lut  2.839(2)  2.974(3)  0.78(4)  2.07(3)  2.48(4)  3.152(2)  3.6086(6)  167(4)  123(3)  71(1)  360(4)* 
Ba : 2,5lut  2.882(2)  2.983(2)  0.84(2)  2.20(2)  2.32(3)      155(2)  125(2)  72.2(7)  352.2(2.4) 
Ba : 3,5lut  2.671(2)  2.999(2)  1.00(2)  1.79(2)  2.30(2)  3.237(1)    145(2)  126(2)  80.5(8)  351.5(2.4) 
*Ba : 2-
br-3-
mepyr 
2.618(5)    1.75(5)  0.88(5)    2.850(3)           
Ba : 3-br-
4-mepyr 
2.675(3)  2.915(3)  0.78(4)  1.92(4)  2.52(4)  3.114(2) 
3.274(2) 
  164(4)  113(3)  73(1)  350(4)   126
Table 8.2: The crystallography data produced from single crystal x-ray analysis. 
Compound  Ba:2,3lut  Ba:2,4lut  Ba:2,5lut  Ba:3,5lut  Ba:2br3mepyr  Ba:3br4mepyr 
Formula  C13 H11 Br2 N1 
O4 
C13 H11 Br2 N1 
O4 
C13 H11 Br2 N1 
O4 
C13 H11 Br2 N1 
O4 
C12 H8 Br3 N1 
O4 
C12 H8 Br3 N1 
O4 
Molecular weight  
(gmol
-1) 
405.04  405.04  405.04  405.04  469.91  469.91 
Temperature (K)  100  100  100  100  100  100 
Space Group  P 1 21/n 1  P 1 21/c 1  P 1 21/c 1  P 1 21/c 1  P 1 21/c 1  P 1 21/c 1 
a (Å)  4.9786(4)  8.2948(2)  7.7357(4)  11.6766(5)  5.2866(3)  10.2229(4) 
b (Å)  23.181(3)  12.1560(4)  11.1416(6)  10.4926(5)  13.3814(8)  5.5760(2) 
c (Å)  12.2811(13)  13.9544(5)  15.8011(9)  11.5221(5)  20.3576(13)  24.5300(9) 
α (
o)  90  90  90  90  90  90 
β (
o)  100.794(3)  102.966(2)  94.269(3)  98.834(2)  91.556(4)  95.802(3) 
γ (
o)  90  90  90  90  90  90 
Volume (Å
3)  1392.3(2)  1371.17(8)  1358.09(13)  1394.92(11)  1439.61(15)  1391.12(9) 
Z  4  4  4  4  4  4 
θ range (
o)  1.757 – 23.601  2.247 – 35.962  2.239 – 42.111  1.765 – 31.543  1.821 – 27.237  1.669 – 32.153 
Reflections 
Collected 
9997  23034  39052  14464  14783  21156 
Independent  2053  6064  9404  3817  3202  4796 
Refln Observed 
I > 2σ (I) 
1680  4673  6404  3178  2394  3457 
Rint  0.0442  0.0407  0.0557  0.0304  0.0680  0.0537 
No. Of Parameters  214  214  214  225  205  205 
GooF on F
2  0.9544  0.9449  1.0298  0.9901  0.9925  0.9179 
R1 (Observed)  0.0382  0.0381  0.0468  0.0314  0.0513  0.0475 
R1 (all)  0.0568  0.0575  0.0769  0.0423  0.0836  0.0835 
wR2 (all)  0.0873  0.0944  0.0986  0.0588  0.1063  0.1114   127
8.2:  Summary 
 
As can be determined by this study, in the 1:1 crystal structures of bromanilic acid 
with  lutidines, the  main  stabilising  interaction that  is present is the  four  molecule 
interaction involving centrosymmetric dimers joined by two O-H···O hydrogen bonds, 
with each bromanilic acid molecule involved in bifurcated hydrogen bonding to the 
lutidine molecule.  Where this motif is present, these are the most significant non-
covalent  interactions, however as noted this  motif  is  not present across the whole 
family of lutidines.  In the case of 2,3-lutidine and bromanilic acid, there was only one 
type of hydrogen bonding interaction, a weakly bifurcated hydrogen bond showing a 
large  degree  of  asymmetry  and  in  this  instance  the  presence  of  a  halogen  bond 
stabilised the crystal structure.  This however has been the only instance in which 
halogen bonding has had a significant impact on the co-crystallisation behaviour of 
bromanilic acid. 
 
Furthermore the presence of halogen bonding has been found to be significant in three 
of the co-crystal complexes that were produced.  This enables the three-dimensional 
crystal structure to be generated and the absence of this in the 2,3-lutidine co-crystal 
complex  was  noted,  however  this  complex  was  found  to  contain  π-π  stacking 
interactions from staggered layers of four molecule interactions.  Once again however 
the presence of Br···Br interactions was only produced in the 2,4-lutidine co-crystal 
complex  so  it  is  difficult  to  put  any  emphasis  on  this  at  this  stage.  128
8.3: Co-crystals of bromanilic acid and other bromo substituted compounds. 
 
Further research was carried out involving co-crystallisations with related compounds 
incorporating  extra bromine atoms, to examine the  affect these extra bulky atoms 
have on the co-crystal structure involving bromanilic acid. The compounds selected 
were  2-bromo-3-methylpyridine  and  3-bromo-4-methylpyridine;  these  are 
fundamentally similar to the picoline compounds used previously as they contain one 
methyl group on the aromatic ring but also contain a bromine atom to attempt to 
produce halogen bonding interactions with the bromanilic acid molecule. 
 
These co-crystallisation studies were carried out in the same way as the other co-
crystallisation trials, involving dissolving equimolar amounts of both compounds in a 
minimum amount of methanol and left to slowly evaporate.  The co-crystals produced 
were  then  evaluated  by  single  crystal  X-ray  diffraction.    The  aim  was  to  see  if 
crystallisation could be affected by the presence of these heavy atoms, which would 
also act as a possibility for stabilisation as in the case of bromanilic acid and 2,3-
lutidine.  The 1:1 co-crystal structures with picolines reported in Chapter 7 had no 
obvious  motif,  with  the  3-picoline  co-crystal  showing  hydrogen  transfer  onto  the 
nitrogen atom, whereas the 4-picoline co-crystal does not show hydrogen transfer.  In 
the case of the lutidine co-crystal complexes, the most notable motif involved the four 
molecule  interaction  (P:B:B:P).    The  aim  of  this  study  however  was  to  try  and 
encourage the bromine atoms to play a more significant role in the crystal structure. 
 
8.3.1: 2-bromo-3-methylpyridine : bromanilic acid 
 
The 1:1 2-bromo-3-methylpyridine:bromanilic acid co-crystal structure was found to 
crystallise in the monoclinic P21/c space group when recrystallised from a methanol 
solution containing 10mg bromanilic acid and 14mg 2-bromo-3-methylpyridine left to 
crystallise at 5
oC.  In this crystal structure each bromanilic acid molecule is found to 
be  fully  protonated,  each  containing  four  hydrogen  bonded  interactions  and  two 
halogen  bonding  interactions  meaning  each  atom  capable  of  hydrogen  or  halogen 
bonding  is  involved.    Due  to  the  symmetrical  nature  of  bromanilic  acid  these   129
interactions are the same on each side meaning there are three unique non covalent 
interactions (Figure 8.3.1).   
  
Figure 8.3.1 shows the presence of the O-H···N and O-H···O hydrogen bonds and also 
the  presence  of  a  Br···O  halogen  bond,  which  was  found  to  be  crucial  in  the 
generation of the three-dimensional  structure of the  lutidine co-crystal complexes.  
The presence of the bromine atom in the 2 position of the methyl pyridine ring could 
also explain the absence of any hydrogen transfer due to the increased bulk around the 
nitrogen acceptor. 
 
 
Figure 8.3.1: Crystal structure of bromanilic acid and 2-bromo-3-methylpyridine 
showing the interactions present around each bromanilic acid molecule collected at 
100K. 
 
The  findings  from  this  co-crystal  complex  are  once  again  intriguing  due  to  the 
relatively long and weaker O-H- - - O hydrogen bond, 2.793(4)Å, short and strong O-
H- - - N hydrogen bond, 2.618(5)Å with an angle of 171(5)
o, and the presence of a 
relatively strong halogen bond, 2.850(3)Å for only the second time (Table 8.1).   130
 
Figure 8.3.2: The crystal packing of bromanilic acid (ba) and 2-bromo-3-
methylpyridine (mp) showing apparent a-b-a-b type layers, when viewed along the a 
axis. 
 
Figure 8.3.2 shows the build up of the 3-dimensional crystal structure, which shows 
an  apparent  layered  motif  composed  of  ba:mp:ba:mp.    The  layers  of  mp  form  a 
hydrogen bond to a hydroxyl group from the layer below and then the next hydrogen 
bonds to the hydroxyl group from the layer above.  This integrates each layer in the 
crystal structure.  
 
8.3.2: 3-bromo-4-methylpyridine : bromanilic acid 
 
The  3-bromo-4-methylpyridine  –  bromanilic  acid  1:1  co-crystal  was  found  to 
crystallise in the monoclinic P21/c space group when recrystallised from a methanol 
and  water  solution  containing  10mg  bromanilic  acid  and  14mg  3-bromo-4-
methylpyridine  left  to  slowly  evaporate  at  room  temperature.    In  this  structure 
however, the hydrogen atom has transferred onto the nitrogen atom from one half of 
the bromanilic acid molecule, whereas it remains on the oxygen on the other side of 
the molecule to form a similar dimer interaction to that present in the 1:1 bromanilic   131
acid : lutidines complexes (Figure 8.3.3).  As was discussed previously, by moving 
the  bulky  bromine  atom  away  from  the  nitrogen  acceptor  of  the  methylpyridine 
molecule, this frees up the nitrogen to act as an acceptor in the same way as it did 
previously in the case of the lutidines.  This results in a four molecule interaction 
(Figure 8.3.4), which stabilises the compound and the presence of halogen bonding 
interactions, bromine to the carbonyl adjacent to the deprotonated hydroxyl group as 
seen  previously,  measuring  3.274(2)Å.    There  is    also  a  halogen  bond  from  the 
bromine  of  the  methylpyridine  to  the  hydroxyl  oxygen  on  the  bromanilic  acid, 
measuring  3.114(2)Å,  which  is  still  protonated  and  generates  the  3-dimensional 
structure.  The halogen bonding is elongated in this cocrystal in comparison to that of 
the 2-bromo-3-methylpyridine structure (Table 8.1), however it has been possible to 
engineer  a  further  halogen  bonding  interaction  to  generate  the  three-dimensional 
structure by including an extra bromine atom on the methylpyridine ring. 
 
 
 
Figure 8.3.3: Crystal structure of bromanilic acid and 3-bromo-4-methylpyridine in a 
1:1 ratio viewed along the b axis, collected at 100K.   132
 
Figure 8.3.4: Four molecule unit in crystal structure of 3-bromo-4-methylpyridine 
and bromanilic acid 
 
Figure  8.3.4  shows  the  four  molecule  unit  is  highly  similar  to  that  found  in  the 
bromanilic acid and 3,5-lutidine co-crystal structure.  This relies on the bromanilic 
acid molecules being close to planar with the plane of the 3-bromo-4-methylpyridine 
in  this  case  being  close  to  perpendicular  with  the  nitrogen  and  hydrogen  donor 
between  the  two  oxygen  acceptors.    This  is  in  contrast  to  the  2-bromo-3-
methylpyridine  and  bromanilic  acid  co-crystal,  which  does  not  posses  the  four 
molecule interaction and contains chains of bromanilic acid molecules interspaced by 
rows of the 2-bromo-3-methylpyridine constituent of the co-crystal. 
 
8.4:  Conclusions/Summary 
 
During  these  studies  it  has  been  possible  to  engineer  a  further  halogen  bonding 
contact  with  bromanilic  acid  with  the  presence  of  a  bromine  atom  on  the 
methylpyridine  ring  of  the  3-bromo-4-methylpyridine  co-crystal  structure.    This 
resulted in the same four molecule interaction being observed as was in the case of the 
bromanilic acid : lutidine co-crystal complex.  This was further stabilised and the 
three-dimensional  crystal  structure  generated  via  these  halogen  bond  interactions.  
The halogen bond interactions are found to be shorter in the case of the 2-bromo-3-
methylpyridine  cocrystal,  however  this  does  not  generate  the  four  molecule  unit, 
possibly  due  to  the  presence  of  the  bromine  atom  in  the  2  position  preventing 
hydrogen atom transfer from occurring.   133
Chapter 9: Conclusions and Forward Look 
 
9.1 Liquid Scattering Studies 
 
This aspect of the project was funded under an “adventurous chemistry” theme, due to 
its challenging nature from the outset  - to try and monitor small molecule nucleation.  
Progress has been made with a significant increase in knowledge of the requirements 
and associated challenges, which can only be gained by experience.  It has been a 
huge success to be able to monitor scattering from the small molecule solutions that 
were trialled.  However to develop this work still further, it would be more beneficial 
to  trial  solutes  with  heavier  atoms  present  than  the  ones  studied  in  this  work.  
Unfortunately  future proposals  for  beam time were not successful to enhance this 
study.   
 
The metastable zone width work carried out at Strathclyde Institute of Pharmacy and 
Biomedical  Sciences  (SIPBS)  in  developing  new  and  more  practicable  routes  to 
monitor  crystallisation  from  solution  and  carry  out  solubility  studies  yielded  very 
significant results.  These have been generated without the need for sampling and 
concentration changes can be monitored on-line alongside particle size distribution 
plots,  commonly  referred  to  as  chord  length  distribution  (CLD)  plots.    We  have 
successfully produced two robust metastable zone width diagrams by these methods 
with the solubilities of the pMHB from our method in close correspondence with the 
literature values
87. 
 
Carrying out these experiments prior to SAXS studies enabled us to prepare suitably 
concentrated solutions that would encourage an increase in the scattering due to the 
likelihood of the presence of nucleating particles.  This also enabled us to ascertain an 
idea of the behaviour of the solution as it was cooled, albeit on a much larger scale 
than that used for the SAXS studies.  To continue these studies still further it would 
be a possibility to attempt these studies, possibly even in a co-crystallisation situation 
by  selecting  a  complex  with  long  range  ordering  such  as  halogen  –  halogen 
interactions  and  also  short-range  stronger  interactions  such  as  hydrogen  bonding, 
however again it would be recommended to attempt these with molecules containing 
heavy atoms.   134
 
9.2  Structural  studies  of  methylbenzoate  derivatives  and  the  assessment  of 
conformational polymorphism 
 
This  aspect  of  the  project  focused  on  taking  the  original;  target  models  for  the 
dissolution/nucleation  studies  and  carrying  out  crystallographic  studies  on  their 
structres.  These were successful and included the solution of the previously unknown 
structure of methyl 2,5-dibromobenzoate (MDBB), as presented in Chapter 6. 
 
A wide range of variable temperature crystallographic studies were carried out on 
these systems, with a particular focus on the postulated conformational polymorphism 
in methyl 4-hydroxybenzoate (pMHB), as presented in Chapter 4.  By carrying out 
detailed XRPD scans, backed up by accurate molecular geometry determinations by 
single crystal diffraction, it was shown that this was actually due to a gradual change 
in selected torsion angles and an expected unit cell expansion.  The work thus did not 
support the existence of conformational polymorphism in this material. 
 
9.3  Co-crystal  Studies  and  the  Attempts  to  Engineer  Halogen  Bonding 
Interactions 
 
The co-crystal studies involving bromanilic acid and the picolines, lutidines and the 
bromo-substituted pyridines enabled a wide range of structures to be produced and 
their bonding motifs to be examined.  The 1:1 co-crystals with the range of picolines 
did  not,  unfortunately,  produce  any  reproducible,  predictable  motifs,  but  instead 
showed a wide range of possible configurations and a higher occurrence of halogen 
bonding  than  in  the  2:1  complexes.    The  4-picoline  1:1  complex  was  the  most 
anomalous, with no proton transfer from the bromanilic acid to the picoline observed; 
instead, the bromanilic acid remains fully protonated and the only halogen-halogen 
interaction in these systems is induced.  In the 1:2 ratio a P:B:P motif is generated.  
This  results  in  complete  deprotonation  of  the  bromanilic  acid  molecule  and  both 
picolines are fully protonated in the bifurcated hydrogen bond interactions that are 
formed. 
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Following on from this a selection of 1:1 co-crystals were produced with bromanilic 
acid and a range of lutidine molecules.  In all but one of these co-crystal complexes a 
L:B:B:L motif was observed with hydrogen atom transfer occurring on one hydroxyl 
group of the bromanilic acid, and the other being involved in a hydrogen bonded 
dimer with its mirror image on the other molecule.  It should also be noted that in the 
absence  of  this  four  molecule  interaction  such  as  the  case  with  2,3-lutidine,  the 
presence of a short halogen bonding interaction is present.  Although there are other 
instances of halogen bond interactions in all of the lutidine complexes, it is in the 
absence of the four molecule unit that it becomes shortest and it would be expected 
that at this point it plays a key role in the stabilising of the packing of the molecules in 
the unit cell. 
 
To try and produce further  halogen  bonding  interactions,  bromanilic acid was co-
crystallised  with  bromo-substituted  pyridines.    In  the  case  of  the  2-bromo-3-
methylpyridine  co-crystal  complex,  there  is  no  hydrogen  transfer  to  the  pyridine 
group, possibly due to steric hindrance by the presence of the bromine atom in the 2- 
position.  This means that no bifurcated hydrogen bonding takes place and again the 
bromine plays a more prominent role in the crystal structure.  In the second of these 
co-crystals, this time with 3-bromo-4-methylpyridine, hydrogen transfer does occur 
from the bromanilic acid onto the pyridine group.  This enables the generation of the 
four  molecule  unit,  which  once  again  results  in  an  elongated  halogen  bonding 
interaction.  However, due to the presence of the bromine on the methylpyridine ring, 
a second halogen bonding interaction is produced, also to an oxygen of a bromanilic 
acid molecule.  This signifies a success in generating extra stabilising interactions in 
these co-crystal systems. 
 
To probe these interactions further co-crystallisations should be targeted where there 
is  not  the  presence  of  a  stabilising  interaction  such  as  that  of  a  four  molecule 
interaction.  In this instance it could be possible to produce more than one strong 
halogen bonding interaction, even if possible weaker hydrogen bonding is present.   136
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Appendix 1: Crystallography data generated from the single crystal studies of pMHB in chapter 5. 
Compound  pMHB  pMHB  pMHB  pMHB  PMHB 
Formula  C8 H8 O3  C8 H8 O3  C8 H8 O3  C8 H8 O3  C8 H8 O3 
Molecular weight 
(gmol
-1) 
152.15  152.15  152.15  152.15  152.15 
Temperature (K)  100  150  200  250  300 
Space Group  Cc  Cc  Cc  Cc  Cc 
a (Å)  12.9679(8)  13.0278(9)  13.1838(7)  13.4110(11)  13.548(3) 
b (Å)  17.2935(8)  17.2195(11)  17.1399(9)  17.0261(14)  16.963(4) 
c (Å)  10.8438(10)  10.8588(7)  10.9015(6)  10.9589(9)  11.039(3) 
α (
o)  90  90  90  90  90 
β (
o)  119.139(4)  119.288(3)  119.478(2)  119.745(2)  119.857(9) 
γ (
o)  90  90  90  90  90 
Volume (Å
3)  2124.1(3)  2124.6(3)  2144.5(2)  2172.6(3)  2200.1(9) 
Z  12  12  10  12  12 
θ range (
o)  2.149 – 27.476  2.147 - 34.819  2.136 - 28.431  2.119 - 39.502  2.108 - 32.067 
Reflections 
Collected 
21970  35402  1715  22962  44548 
Independent  2428  4588  1664  6385  3792 
Refln observed 
I > 2σ (I) 
1649  3327  1463  3514  2216 
No. Of Parameters  370  370  298  370  370 
GooF on F
2  0.9828  1.2988  1.0405  0.8176  1.0420 
R1 (Observed)  0.0317  0.0336  0.0326  0.0508  0.0374 
R1 (all)  0.0452  0.0431  0.0371  0.0904  0.0592 
wR2 (all)  0.0702  0.0444  0.0639  0.1467  0.1039   143
Appendix 2: Crystallography data generated from the single crystal studies of methyl-4-bromobenzoate in Chapter 7. 
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Appendix 3: 
_atom_site_label 
_atom_site_fract_x 
_atom_site_fract_y 
_atom_site_fract_z 
_atom_site_U_iso_or_equiv 
_atom_site_occupancy 
_atom_site_adp_type 
 
Bromanilic Acid : 3 Picoline, 1 : 1 
C1.  0.4625(2) 0.8771(2) 0.45069(15) 0.0094 1.0000 Uani  
C2.  0.3846(2) 1.0717(2) 0.38450(15) 0.0093 1.0000 Uani  
C3.  0.4335(2) 1.1871(2) 0.43963(15) 0.0095 1.0000 Uani  
Br4.  0.34134(3) 1.43029(2) 0.356445(16) 0.0132 1.0000 Uani  
O5.  0.28228(17) 1.12111(15) 0.28996(11) 0.0141 1.0000 Uani  
O6.  0.42281(18) 0.77526(16) 0.39557(12) 0.0137 1.0000 Uani  
C7.  0.1818(2) -0.0184(2) 0.94923(16) 0.0104 1.0000 Uani  
C8.  0.1504(2) -0.0841(2) 1.09632(15) 0.0100 1.0000 Uani  
C9.  -0.0284(2) -0.0617(2) 1.13586(15) 0.0121 1.0000 Uani  
Br10.  -0.06715(3) -0.13980(2) 1.315021(16) 0.0163 1.0000 Uani  
O11.  0.29247(17) -0.15350(16) 1.16703(11) 0.0142 1.0000 Uani  
O12.  0.34376(17) -0.04253(16) 0.91671(12) 0.0149 1.0000 Uani  
C13.  0.1960(2) 0.5441(2) 0.77057(16) 0.0140 1.0000 Uani  
C14.  0.3195(3) 0.3824(2) 0.81357(17) 0.0146 1.0000 Uani  
N15.  0.3831(2) 0.3102(2) 0.93524(14) 0.0149 1.0000 Uani  
C16.  0.3323(3) 0.3881(2) 1.02311(17) 0.0156 1.0000 Uani  
C17.  0.2067(3) 0.5494(2) 0.98529(18) 0.0176 1.0000 Uani  
C18.  0.1402(3) 0.6278(2) 0.85967(18) 0.0163 1.0000 Uani  
C19.  0.1315(3) 0.6248(3) 0.63220(19) 0.0233 1.0000 Uani  
H161.  0.389(3) 0.318(2) 1.111(2) 0.0206 1.0000 Uiso  
H171.  0.167(3) 0.607(3) 1.040(2) 0.0219 1.0000 Uiso  
H181.  0.048(3) 0.749(3) 0.8266(19) 0.0203 1.0000 Uiso  
H191.  0.129(3) 0.718(3) 0.606(2) 0.0257 1.0000 Uiso  
H192.  0.257(3) 0.587(3) 0.587(2) 0.0257 1.0000 Uiso  
H193.  0.023(3) 0.573(3) 0.609(2) 0.0257 1.0000 Uiso  
H1.  0.366(4) 0.327(3) 0.757(2) 0.0500 1.0000 Uiso  
H5.  0.496(4) 0.197(3) 0.963(2) 0.0500 1.0000 Uiso  
H8.  0.351(4) 0.840(3) 0.314(3) 0.0500 1.0000 Uiso  
 
Bromanilic Acid : 3 Picoline, 1 : 2 
C1.  0.47315(12) 0.11327(11) 0.57957(11) 0.0135 1.0000 Uani  
C2.  0.35756(13) 0.08050(11) 0.46586(12) 0.0134 1.0000 Uani  
C3.  0.38778(13) -0.04363(11) 0.38114(12) 0.0133 1.0000 Uani  
O4.  0.28233(9) -0.07389(8) 0.28055(8) 0.0181 1.0000 Uani  
O5.  0.23310(9) 0.14209(8) 0.42753(8) 0.0181 1.0000 Uani  
Br6.  0.434429(13) 0.263929(11) 0.686095(12) 0.0171 1.0000 Uani  
C7.  1.00763(14) 0.35162(12) 0.59764(12) 0.0160 1.0000 Uani  
N8.  1.01585(12) 0.46308(10) 0.67562(10) 0.0178 1.0000 Uani  
C9.  0.89114(15) 0.53639(13) 0.68119(12) 0.0190 1.0000 Uani  
C10.  0.86846(13) 0.30601(11) 0.52009(12) 0.0135 1.0000 Uani  
C11.  0.73842(13) 0.38217(12) 0.52713(12) 0.0158 1.0000 Uani  
C4.  0.74976(14) 0.49704(12) 0.60731(13) 0.0178 1.0000 Uani  
C5.  0.86173(16) 0.18305(14) 0.43151(15) 0.0212 1.0000 Uani  
H71.  1.0932(15) 0.3027(14) 0.5950(12) 0.0194 1.0000 Uiso  
H91.  0.9073(14) 0.6167(13) 0.7376(13) 0.0238 1.0000 Uiso  
H111.  0.6494(15) 0.3573(12) 0.4777(13) 0.0194 1.0000 Uiso   
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H41.  0.6703(15) 0.5470(13) 0.6152(13) 0.0219 1.0000 Uiso  
H51.  0.7811(16) 0.1769(14) 0.3714(14) 0.0259 1.0000 Uiso  
H52.  0.8585(15) 0.1002(13) 0.4767(13) 0.0259 1.0000 Uiso  
H53.  0.9522(16) 0.1666(14) 0.4108(13) 0.0259 1.0000 Uiso  
H6.  1.1053(18) 0.4864(16) 0.7110(15) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 2 Picoline, 1 : 2 
C1.  0.7783(3) 0.0885(4) 0.1096(2) 0.0344 1.0000 Uani  
C2.  0.7063(3) -0.0042(5) 0.0865(3) 0.0385 1.0000 Uani  
C3.  0.6910(3) -0.0973(5) -0.0098(3) 0.0393 1.0000 Uani  
C4.  0.7484(3) -0.0768(4) -0.0681(2) 0.0374 1.0000 Uani  
C5.  0.8212(3) 0.0193(4) -0.0456(3) 0.0370 1.0000 Uani  
C6.  0.8391(3) 0.1041(4) 0.0533(3) 0.0364 1.0000 Uani  
O7.  0.90612(19) 0.1785(3) 0.07350(16) 0.0513 1.0000 Uani  
O8.  0.87468(18) 0.0408(3) -0.09503(17) 0.0504 1.0000 Uani  
Br9.  0.72794(3) -0.18929(6) -0.18549(2) 0.0556 1.0000 Uani  
O10.  0.62649(19) -0.1856(4) -0.02641(16) 0.0600 1.0000 Uani  
O11.  0.6513(2) -0.0248(3) 0.13430(18) 0.0624 1.0000 Uani  
Br12.  0.79779(3) 0.19975(5) 0.22786(2) 0.0491 1.0000 Uani  
C13.  0.9458(3) -0.2408(5) 0.1371(3) 0.0438 1.0000 Uani  
N14.  0.9780(2) -0.2366(4) 0.0586(2) 0.0407 1.0000 Uani  
C15.  0.9453(3) -0.3239(6) -0.0183(3) 0.0476 1.0000 Uani  
C16.  0.8794(3) -0.4243(5) -0.0176(3) 0.0570 1.0000 Uani  
C17.  0.8447(3) -0.4370(6) 0.0618(4) 0.0624 1.0000 Uani  
C18.  0.8786(3) -0.3472(7) 0.1384(4) 0.0625 1.0000 Uani  
C19.  0.9857(4) -0.1396(6) 0.2167(3) 0.0681 1.0000 Uani  
C20.  0.4680(3) 0.4474(6) -0.1197(2) 0.0472 1.0000 Uani  
N21.  0.4694(2) 0.2795(5) -0.1037(2) 0.0541 1.0000 Uani  
C22.  0.5311(4) 0.1769(7) -0.1188(3) 0.0598 1.0000 Uani  
C23.  0.5959(3) 0.2413(6) -0.1541(3) 0.0574 1.0000 Uani  
C24.  0.5968(4) 0.4119(7) -0.1725(3) 0.0587 1.0000 Uani  
C25.  0.5346(4) 0.5139(6) -0.1549(3) 0.0551 1.0000 Uani  
C26.  0.3963(4) 0.5472(7) -0.1001(3) 0.0746 1.0000 Uani  
H151.  0.978(2) -0.307(4) -0.071(2) 0.0618 1.0000 Uiso  
H161.  0.860(3) -0.482(5) -0.063(3) 0.0730 1.0000 Uiso  
H171.  0.804(3) -0.512(5) 0.066(3) 0.0778 1.0000 Uiso  
H181.  0.861(3) -0.347(5) 0.195(2) 0.0744 1.0000 Uiso  
H221.  0.529(3) 0.063(5) -0.103(2) 0.0729 1.0000 Uiso  
H231.  0.640(3) 0.162(5) -0.171(2) 0.0759 1.0000 Uiso  
H241.  0.644(3) 0.458(5) -0.191(3) 0.0735 1.0000 Uiso  
H251.  0.534(3) 0.619(4) -0.161(2) 0.0678 1.0000 Uiso  
H261.  0.408(3) 0.665(5) -0.120(3) 0.0938 1.0000 Uiso  
H262.  0.384(3) 0.485(5) -0.045(3) 0.0938 1.0000 Uiso  
H263.  0.355(3) 0.515(6) -0.145(3) 0.0938 1.0000 Uiso  
H2.  0.949(2) -0.099(5) 0.245(2) 0.0500 1.0000 Uiso  
H6.  0.423(2) 0.251(4) -0.079(2) 0.0500 1.0000 Uiso  
H8.  1.023(2) -0.174(4) 0.058(2) 0.0500 1.0000 Uiso  
H9.  0.996(3) -0.048(4) 0.206(3) 0.0500 1.0000 Uiso  
H25.  0.998(2) -0.224(4) 0.272(2) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 4 Picoline, 1 : 1 
H1.  0.513(6) 0.525(7) 0.325(8) 0.00(2) 1.0000 Uiso 
H3.  0.208(6) -0.251(8) 0.077(7) 0.00(2) 1.0000 Uiso 
Br1.  0.33421(5) 0.16939(7) 0.33141(6) 0.01589(19) 1.0000 Uani  
Br2.  0.35842(5) 0.60836(7) 0.02358(6) 0.0164(2) 1.0000 Uani  
O4.  0.4682(4) 0.3621(6) 0.3727(5) 0.0195(13) 1.0000 Uani  
C18.  0.3373(5) 0.2915(7) 0.2413(7) 0.0141(17) 1.0000 Uani  
O1.  0.4773(4) 0.5330(5) 0.2589(5) 0.0171(13) 1.0000 Uani  
O2.  0.2214(4) 0.4238(6) -0.0212(5) 0.0165(13) 1.0000 Uani   
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O3.  0.2171(4) 0.2307(6) 0.0901(5) 0.0176(13) 1.0000 Uani  
H3A.  0.1879 0.2524 0.0283 0.026 1.0000 Uiso  
C15.  0.3514(5) 0.4841(6) 0.1110(6) 0.0104(15) 1.0000 Uani  
C16.  0.2787(6) 0.4066(7) 0.0672(7) 0.0155(18) 1.0000 Uani  
C13.  0.4077(5) 0.3674(7) 0.2844(6) 0.0131(16) 1.0000 Uani  
C17.  0.2749(5) 0.3020(7) 0.1344(6) 0.0121(16) 1.0000 Uani  
C14.  0.4088(6) 0.4663(7) 0.2094(7) 0.0153(18) 1.0000 Uani  
Br3.  0.41071(5) 0.07548(7) 0.08688(6) 0.0179(2) 1.0000 Uani  
Br4.  0.35206(6) -0.34572(8) 0.38002(7) 0.0238(2) 1.0000 Uani  
O8.  0.2687(4) -0.1044(5) 0.0353(5) 0.0184(13) 1.0000 Uani  
C21.  0.3140(6) -0.2059(8) 0.1991(8) 0.0193(19) 1.0000 Uani  
O7.  0.2442(4) -0.2643(6) 0.1434(6) 0.0226(14) 1.0000 Uani  
O6.  0.4952(4) -0.1669(6) 0.4411(5) 0.0201(13) 1.0000 Uani  
C22.  0.3668(5) -0.2233(7) 0.2992(7) 0.0138(17) 1.0000 Uani  
O5.  0.5154(4) 0.0147(5) 0.3313(4) 0.0151(12) 1.0000 Uani  
H5.  0.5405 -0.0076 0.3937 0.023 1.0000 Uiso calc R . . 
C19.  0.3972(6) -0.0411(7) 0.1763(7) 0.0148(18) 1.0000 Uani  
C23.  0.4433(6) -0.1523(7) 0.3512(7) 0.0130(17) 1.0000 Uani  
C24.  0.4544(6) -0.0496(7) 0.2826(8) 0.019(2) 1.0000 Uani  
C20.  0.3265(6) -0.1107(7) 0.1282(7) 0.0163(17) 1.0000 Uani  
N1.  0.1484(5) 0.8057(6) 0.3700(6) 0.0168(15) 1.0000 Uani  
C3.  0.1084(5) 0.9045(7) 0.1736(7) 0.0128(16) 1.0000 Uani  
C2.  0.0716(6) 0.7973(8) 0.1827(7) 0.0178(18) 1.0000 Uani  
H2.  0.0327 0.7592 0.1216 0.021 1.0000 Uiso calc R . . 
C4.  0.1641(6) 0.9589(8) 0.2650(8) 0.023(2) 1.0000 Uani  
H4.  0.1891 1.0295 0.2608 0.028 1.0000 Uiso calc R . . 
C6.  0.0843(6) 0.9571(9) 0.0637(8) 0.024(2) 1.0000 Uani  
H6A.  0.0444 0.9065 0.0098 0.036 1.0000 Uiso calc R . . 
H6B.  0.1317 0.9628 0.0525 0.036 1.0000 Uiso calc R . . 
H6C.  0.0615 1.0354 0.0592 0.036 1.0000 Uiso calc R . . 
C1.  0.0934(6) 0.7496(8) 0.2819(7) 0.0180(18) 1.0000 Uani 
H1A.  0.0701 0.6782 0.2881 0.022 1.0000 Uiso calc R . . 
C5.  0.1834(7) 0.9092(9) 0.3637(8) 0.025(2) 1.0000 Uani 
H5.  0.2206 0.9473 0.4260 0.031 1.0000 Uiso calc R . . 
C8.  0.1506(5) 0.4464(7) 0.2346(6) 0.0132(16) 1.0000 Uani  
H8.  0.1872 0.4865 0.2961 0.016 1.0000 Uiso calc R . . 
C7.  0.1319(6) 0.4945(8) 0.1365(7) 0.0182(18) 1.0000 Uani 
H7.  0.1556 0.5659 0.1312 0.022 1.0000 Uiso calc R . . 
C11.  0.0456(5) 0.3320(7) 0.0518(6) 0.0155(17) 1.0000 Uani  
H11.  0.0111 0.2922 -0.0110 0.019 1.0000 Uiso calc R . . 
C9.  0.1163(6) 0.3387(8) 0.2448(8) 0.0192(19) 1.0000 Uani  
N2.  0.0784(5) 0.4364(6) 0.0480(6) 0.0145(14) 1.0000 Uani 
C12.  0.1386(6) 0.2869(8) 0.3525(6) 0.0190(19) 1.0000 Uani  
H12A.  0.1760 0.3396 0.4070 0.029 1.0000 Uiso calc R . . 
H12B.  0.1640 0.2104 0.3587 0.029 1.0000 Uiso calc R . . 
H12C.  0.0903 0.2776 0.3610 0.029 1.0000 Uiso calc R . . 
C10.  0.0634(5) 0.2826(7) 0.1513(7) 0.0165(17) 1.0000 Uani 
H10.  0.0392 0.2107 0.1544 0.020 1.0000 Uiso calc R . . 
 
Bromanilic Acid : 4 Picoline, 1 : 2 
C1.  0.4281(2) 0.5693(3) 0.42464(10) 0.0160 1.0000 Uani  
C2.  0.5455(2) 0.3690(3) 0.43700(10) 0.0150 1.0000 Uani  
C3.  0.6118(2) 0.3196(3) 0.51063(10) 0.0165 1.0000 Uani  
Br4.  0.75109(2) 0.07117(3) 0.524928(11) 0.0189 1.0000 Uani  
O5.  0.57051(16) 0.26725(19) 0.37879(7) 0.0193 1.0000 Uani  
O6.  0.37844(16) 0.61446(19) 0.35800(7) 0.0198 1.0000 Uani  
C7.  0.1119(2) 0.4826(3) 0.66164(10) 0.0179 1.0000 Uani  
C8.  0.1774(2) 0.5631(3) 0.73151(11) 0.0204 1.0000 Uani  
C9.  0.2878(2) 0.4434(3) 0.77733(11) 0.0220 1.0000 Uani   
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N10.  0.3321(2) 0.2450(3) 0.75598(9) 0.0227 1.0000 Uani  
C11.  0.2733(2) 0.1598(3) 0.68921(11) 0.0219 1.0000 Uani  
C12.  0.1630(2) 0.2765(3) 0.64148(11) 0.0205 1.0000 Uani  
C13.  -0.0045(3) 0.6143(4) 0.60942(14) 0.0287 1.0000 Uani  
H81.  0.153(3) 0.702(3) 0.7470(12) 0.0241 1.0000 Uiso  
H91.  0.335(3) 0.494(3) 0.8230(12) 0.0239 1.0000 Uiso  
H111.  0.307(3) 0.019(3) 0.6774(12) 0.0239 1.0000 Uiso  
H121.  0.126(3) 0.220(3) 0.5978(12) 0.0240 1.0000 Uiso  
H131.  -0.082(3) 0.544(3) 0.5879(13) 0.0281 1.0000 Uiso  
H132.  -0.050(3) 0.734(3) 0.6351(12) 0.0281 1.0000 Uiso  
H133.  0.052(3) 0.687(3) 0.5721(13) 0.0281 1.0000 Uiso  
H3.  0.390(3) 0.183(4) 0.7847(15) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 2,3 lutidine 
C1.  0.6262(6) 0.29482(13) 0.0802(2) 0.0149 1.0000 Uani  
C2.  0.6782(6) 0.29436(13) 0.1907(2) 0.0158 1.0000 Uani  
C3.  0.5236(6) 0.33208(13) 0.2596(2) 0.0178 1.0000 Uani  
C4.  0.3186(6) 0.36856(13) 0.2014(2) 0.0171 1.0000 Uani  
C5.  0.2519(6) 0.37124(13) 0.0860(2) 0.0169 1.0000 Uani  
C6.  0.4243(6) 0.33413(13) 0.0197(2) 0.0169 1.0000 Uani  
O7.  0.3839(4) 0.33938(9) -0.08076(16) 0.0226 1.0000 Uani  
O8.  0.0653(4) 0.40101(9) 0.02924(16) 0.0235 1.0000 Uani  
Br9.  0.11293(6) 0.413336(14) 0.28552(2) 0.0238 1.0000 Uani  
O10.  0.5921(4) 0.32669(9) 0.36148(16) 0.0228 1.0000 Uani  
O11.  0.8656(4) 0.25999(10) 0.25003(16) 0.0228 1.0000 Uani  
Br12.  0.81829(6) 0.247085(14) -0.00351(2) 0.0201 1.0000 Uani  
C13.  0.6458(6) 0.43201(13) -0.2236(2) 0.0191 1.0000 Uani  
C14.  0.5128(6) 0.43488(13) -0.3346(2) 0.0170 1.0000 Uani  
C15.  0.5925(7) 0.39735(14) -0.4106(3) 0.0220 1.0000 Uani  
C16.  0.8044(7) 0.35829(15) -0.3772(3) 0.0250 1.0000 Uani  
C17.  0.9300(7) 0.35722(14) -0.2690(3) 0.0218 1.0000 Uani  
N18.  0.8492(5) 0.39346(12) -0.1953(2) 0.0211 1.0000 Uani  
C19.  0.2870(7) 0.47803(16) -0.3709(3) 0.0274 1.0000 Uani  
C20.  0.5753(7) 0.46964(16) -0.1336(3) 0.0253 1.0000 Uani  
H151.  0.492(6) 0.3999(13) -0.484(2) 0.0286 1.0000 Uiso  
H161.  0.861(6) 0.3292(13) -0.427(2) 0.0315 1.0000 Uiso  
H171.  1.068(6) 0.3315(13) -0.241(2) 0.0290 1.0000 Uiso  
H191.  0.200(6) 0.4747(13) -0.447(3) 0.0349 1.0000 Uiso  
H192.  0.353(6) 0.5159(14) -0.349(2) 0.0349 1.0000 Uiso  
H193.  0.134(6) 0.4701(13) -0.330(2) 0.0349 1.0000 Uiso  
H201.  0.679(6) 0.4631(14) -0.068(3) 0.0349 1.0000 Uiso  
H202.  0.564(6) 0.5089(14) -0.159(2) 0.0349 1.0000 Uiso  
H203.  0.393(6) 0.4619(13) -0.119(2) 0.0349 1.0000 Uiso  
H7.  0.928(6) 0.3956(15) -0.125(3) 0.0500 1.0000 Uiso  
H10.  0.862(7) 0.2665(16) 0.309(3) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 2,4 lutidine 
C1.  0.90439(16) 0.19216(11) 0.55354(10) 0.0140 1.0000 Uani  
C2.  1.02992(15) 0.18826(12) 0.49595(10) 0.0144 1.0000 Uani  
C3.  1.00553(15) 0.10940(11) 0.40708(9) 0.0130 1.0000 Uani  
C4.  0.85658(15) 0.05016(11) 0.38354(9) 0.0130 1.0000 Uani  
C5.  0.73824(15) 0.05279(11) 0.44134(9) 0.0125 1.0000 Uani  
C6.  0.77043(15) 0.12613(11) 0.53096(9) 0.0127 1.0000 Uani  
O7.  0.65620(12) 0.12713(9) 0.58358(8) 0.0175 1.0000 Uani  
O8.  0.60470(11) 0.00120(9) 0.42414(7) 0.0182 1.0000 Uani  
Br9.  0.811745(16) -0.039128(12) 0.269616(9) 0.0164 1.0000 Uani  
O10.  1.12007(11) 0.10674(8) 0.36237(7) 0.0161 1.0000 Uani  
O11.  1.15306(12) 0.24636(9) 0.51295(8) 0.0217 1.0000 Uani  
Br12.  0.933870(16) 0.293269(12) 0.657859(10) 0.0193 1.0000 Uani   
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C13.  0.47281(16) 0.23292(13) 0.31099(10) 0.0190 1.0000 Uani  
C14.  0.61209(17) 0.29593(14) 0.30823(12) 0.0231 1.0000 Uani  
C15.  0.67700(17) 0.37022(14) 0.38130(13) 0.0245 1.0000 Uani  
C16.  0.59599(17) 0.38271(13) 0.45804(13) 0.0235 1.0000 Uani  
C17.  0.45777(17) 0.32123(13) 0.45950(11) 0.0197 1.0000 Uani  
N18.  0.39968(14) 0.24881(11) 0.38723(9) 0.0158 1.0000 Uani  
C19.  0.8323(2) 0.43393(18) 0.38094(19) 0.0377 1.0000 Uani  
C20.  0.4001(2) 0.15064(17) 0.23506(12) 0.0277 1.0000 Uani  
H141.  0.655(2) 0.2852(15) 0.2586(13) 0.0298 1.0000 Uiso  
H161.  0.630(2) 0.4290(16) 0.5087(14) 0.0303 1.0000 Uiso  
H171.  0.399(2) 0.3235(14) 0.5103(13) 0.0251 1.0000 Uiso  
H191.  0.823(3) 0.5062(19) 0.4090(16) 0.0492 1.0000 Uiso  
H192.  0.915(3) 0.3983(17) 0.4275(16) 0.0492 1.0000 Uiso  
H193.  0.843(3) 0.4419(19) 0.3260(18) 0.0492 1.0000 Uiso  
H201.  0.476(2) 0.1158(16) 0.2106(14) 0.0354 1.0000 Uiso  
H202.  0.356(2) 0.0848(17) 0.2615(14) 0.0354 1.0000 Uiso  
H5.  0.321(3) 0.2108(18) 0.3893(16) 0.0500 1.0000 Uiso  
H7.  0.313(3) 0.1788(17) 0.1870(16) 0.0500 1.0000 Uiso  
H11.  0.585(3) 0.0879(18) 0.5645(16) 0.0500 1.0000 Uiso  
 
Bromanilic Acid : 2,5 lutidine 
C1.  0.4371(2) 0.16236(14) 0.00087(11) 0.0126 1.0000 Uani  
C2.  0.2819(2) 0.10049(14) -0.01685(10) 0.0123 1.0000 Uani  
C3.  0.2489(2) 0.04872(14) -0.10566(10) 0.0118 1.0000 Uani  
C4.  0.3629(2) 0.06041(14) -0.16561(10) 0.0119 1.0000 Uani  
C5.  0.5272(2) 0.11945(14) -0.14685(11) 0.0126 1.0000 Uani  
C6.  0.5642(2) 0.17565(15) -0.05707(11) 0.0144 1.0000 Uani  
O7.  0.70451(16) 0.22867(14) -0.04458(9) 0.0262 1.0000 Uani  
O8.  0.63916(15) 0.12864(12) -0.19702(8) 0.0192 1.0000 Uani  
Br9.  0.31638(2) -0.007105(16) -0.274220(11) 0.0155 1.0000 Uani  
O10.  0.09935(15) -0.00757(12) -0.12106(8) 0.0178 1.0000 Uani  
O11.  0.16422(16) 0.08354(12) 0.03184(8) 0.0200 1.0000 Uani  
Br12.  0.47839(2) 0.233092(15) 0.109386(11) 0.0153 1.0000 Uani  
C13.  1.0291(2) 0.28269(15) -0.23866(11) 0.0153 1.0000 Uani  
C14.  1.1652(2) 0.36306(16) -0.24366(12) 0.0178 1.0000 Uani  
C15.  1.2332(2) 0.42206(16) -0.17219(12) 0.0182 1.0000 Uani  
C16.  1.1677(2) 0.40251(16) -0.09346(12) 0.0168 1.0000 Uani  
C17.  1.0319(2) 0.32299(16) -0.09112(12) 0.0165 1.0000 Uani  
N18.  0.96688(18) 0.26690(14) -0.16205(9) 0.0154 1.0000 Uani  
C19.  1.2398(3) 0.4662(2) -0.01527(14) 0.0240 1.0000 Uani  
C20.  0.9481(3) 0.21598(19) -0.31251(13) 0.0220 1.0000 Uani  
H141.  1.207(3) 0.3746(19) -0.2973(14) 0.0233 1.0000 Uiso  
H151.  1.320(3) 0.4795(19) -0.1776(13) 0.0231 1.0000 Uiso  
H171.  0.978(3) 0.3044(18) -0.0431(13) 0.0211 1.0000 Uiso  
H191.  1.163(3) 0.454(2) 0.0293(14) 0.0300 1.0000 Uiso  
H192.  1.355(3) 0.424(2) -0.0013(14) 0.0300 1.0000 Uiso  
H193.  1.237(3) 0.553(2) -0.0248(15) 0.0300 1.0000 Uiso  
H201.  1.005(3) 0.232(2) -0.3572(14) 0.0272 1.0000 Uiso  
H4.  0.883(3) 0.221(2) -0.1561(16) 0.0500 1.0000 Uiso  
H13.  0.038(3) -0.010(2) -0.0764(17) 0.0500 1.0000 Uiso  
H17.  0.956(3) 0.135(3) -0.3007(17) 0.0500 1.0000 Uiso  
H19.  0.827(3) 0.258(2) -0.3251(16) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 3,5 lutidine 
C1.  0.15121(18) 0.03215(17) 0.38885(15) 0.0128 1.0000 Uani  
C2.  0.08214(17) 0.14144(17) 0.41329(14) 0.0123 1.0000 Uani  
C3.  0.14290(18) 0.24873(17) 0.49386(15) 0.0131 1.0000 Uani  
C4.  0.25927(17) 0.23342(17) 0.53944(15) 0.0117 1.0000 Uani  
C5.  0.32706(17) 0.12879(17) 0.51171(14) 0.0125 1.0000 Uani   
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C6.  0.26537(18) 0.02854(16) 0.42882(15) 0.0130 1.0000 Uani  
O7.  0.33428(13) -0.06403(12) 0.40040(12) 0.0168 1.0000 Uani  
O8.  0.43042(12) 0.10762(13) 0.55013(11) 0.0166 1.0000 Uani  
Br9.  0.328043(18) 0.354531(17) 0.649864(16) 0.0148 1.0000 Uani  
O10.  0.08038(12) 0.33994(12) 0.51248(11) 0.0176 1.0000 Uani  
O11.  -0.01997(12) 0.15509(13) 0.37328(11) 0.0184 1.0000 Uani  
Br12.  0.075664(18) -0.098738(17) 0.295329(16) 0.0167 1.0000 Uani  
C13.  0.35380(18) 0.67357(17) 0.55162(16) 0.0149 1.0000 Uani  
C14.  0.36248(19) 0.61039(19) 0.44674(16) 0.0159 1.0000 Uani  
C15.  0.26556(18) 0.56721(17) 0.37197(15) 0.0142 1.0000 Uani  
C16.  0.15909(19) 0.59052(18) 0.40496(16) 0.0152 1.0000 Uani  
N17.  0.15033(15) 0.65306(15) 0.50502(13) 0.0140 1.0000 Uani  
C18.  0.24403(19) 0.69348(17) 0.57821(16) 0.0146 1.0000 Uani  
C19.  0.2729(3) 0.4949(2) 0.26181(19) 0.0246 1.0000 Uani  
C20.  0.4571(2) 0.7156(2) 0.6361(2) 0.0233 1.0000 Uani  
H141.  0.4295(16) 0.5989(18) 0.4236(15) 0.005(5) 1.0000 Uiso  
H161.  0.0920(18) 0.5619(19) 0.3589(17) 0.017(6) 1.0000 Uiso  
H181.  0.2290(16) 0.7308(18) 0.6458(16) 0.008(5) 1.0000 Uiso  
H191.  0.215(2) 0.515(2) 0.197(2) 0.032(7) 1.0000 Uiso  
H192.  0.339(2) 0.511(2) 0.239(2) 0.032(8) 1.0000 Uiso  
H193.  0.2689(19) 0.414(2) 0.2700(19) 0.033(7) 1.0000 Uiso  
H201.  0.4561(18) 0.683(2) 0.708(2) 0.028(6) 1.0000 Uiso  
H202.  0.4617(16) 0.810(2) 0.6335(16) 0.014(5) 1.0000 Uiso  
H203.  0.519(2) 0.696(2) 0.615(2) 0.029(8) 1.0000 Uiso  
H7.  0.073(2) 0.667(2) 0.531(2) 0.051(8) 1.0000 Uiso  
H11.  0.403(2) -0.042(3) 0.444(2) 0.064(10) 1.0000 Uiso 
 
Bromanilic Acid : 2bromo, 3methylpyridine 
C1.  0.6948(8) 0.5219(3) 0.45322(19) 0.0138 1.0000 Uani  
C2.  0.6023(8) 0.5989(3) 0.4963(2) 0.0153 1.0000 Uani  
C3.  0.3986(8) 0.5712(3) 0.54446(19) 0.0143 1.0000 Uani  
O4.  0.3254(7) 0.6446(2) 0.58321(17) 0.0247 1.0000 Uani  
O5.  0.6710(6) 0.6861(2) 0.49645(15) 0.0245 1.0000 Uani  
Br6.  0.95526(9) 0.55600(4) 0.39595(2) 0.0184 1.0000 Uani  
C7.  0.3110(8) -0.0742(3) 0.4850(2) 0.0149 1.0000 Uani  
C8.  0.4677(9) -0.0838(3) 0.5434(2) 0.0159 1.0000 Uani  
C9.  0.6650(9) -0.0032(3) 0.5579(2) 0.0147 1.0000 Uani  
O10.  0.8075(6) -0.0120(2) 0.61070(16) 0.0204 1.0000 Uani  
O11.  0.4534(6) -0.1529(2) 0.58290(14) 0.0188 1.0000 Uani  
Br12.  0.06049(9) -0.17269(3) 0.47153(2) 0.0183 1.0000 Uani  
C13.  0.3389(8) 0.1754(4) 0.2549(2) 0.0181 1.0000 Uani  
C14.  0.3287(9) 0.2585(4) 0.2134(2) 0.0206 1.0000 Uani  
C15.  0.1497(10) 0.3298(4) 0.2290(2) 0.0246 1.0000 Uani  
C16.  0.0001(10) 0.3182(4) 0.2827(2) 0.0242 1.0000 Uani  
C17.  0.0311(10) 0.2337(4) 0.3211(2) 0.0234 1.0000 Uani  
N18.  0.1966(7) 0.1618(3) 0.30661(16) 0.0166 1.0000 Uani  
C19.  0.4981(12) 0.2722(5) 0.1567(3) 0.0309 1.0000 Uani  
Br20.  0.56859(10) 0.06826(4) 0.23907(2) 0.0284 1.0000 Uani  
H151.  0.139(9) 0.380(4) 0.200(2) 0.0331 1.0000 Uiso  
H161.  -0.106(10) 0.358(4) 0.297(2) 0.0311 1.0000 Uiso  
H171.  -0.069(9) 0.225(3) 0.355(2) 0.0292 1.0000 Uiso  
H191.  0.477(10) 0.335(4) 0.138(2) 0.0387 1.0000 Uiso  
H192.  0.652(10) 0.262(4) 0.166(3) 0.0387 1.0000 Uiso  
H193.  0.478(11) 0.244(4) 0.126(3) 0.0387 1.0000 Uiso  
H5.  0.382(11) 0.689(5) 0.572(3) 0.0500 1.0000 Uiso  
H15.  0.788(10) -0.062(4) 0.638(2) 0.0500 1.0000 Uiso 
 
Bromanilic Acid : 3bromo, 4methylpyridine 
C1.  0.2393(2) 0.2671(5) 0.91006(9) 0.0158 1.0000 Uani   
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C2.  0.1454(2) 0.1215(5) 0.93341(9) 0.0164 1.0000 Uani  
C3.  0.0750(3) -0.0689(5) 0.89774(10) 0.0166 1.0000 Uani  
C4.  0.1033(2) -0.1087(5) 0.84607(10) 0.0160 1.0000 Uani  
C5.  0.2049(2) 0.0293(5) 0.82352(9) 0.0154 1.0000 Uani  
C6.  0.2692(2) 0.2395(5) 0.85634(10) 0.0154 1.0000 Uani  
O7.  0.34444(18) 0.3719(4) 0.83172(7) 0.0201 1.0000 Uani  
O8.  0.24267(18) -0.0146(4) 0.77845(6) 0.0202 1.0000 Uani  
Br9.  0.01729(3) -0.34999(5) 0.801722(10) 0.0188 1.0000 Uani  
O10.  -0.01434(19) -0.1956(4) 0.92112(7) 0.0219 1.0000 Uani  
O11.  0.11429(17) 0.1393(4) 0.98104(6) 0.0204 1.0000 Uani  
Br12.  0.31928(3) 0.51669(5) 0.954038(10) 0.0194 1.0000 Uani  
C13.  0.7095(2) 0.1138(5) 0.86032(10) 0.0171 1.0000 Uani  
C14.  0.6174(2) -0.0253(5) 0.88456(9) 0.0168 1.0000 Uani  
C15.  0.5526(3) -0.2020(6) 0.85252(10) 0.0201 1.0000 Uani  
C16.  0.5794(3) -0.2373(6) 0.79910(11) 0.0209 1.0000 Uani  
N17.  0.6659(2) -0.0951(5) 0.77742(9) 0.0203 1.0000 Uani  
C18.  0.7321(3) 0.0782(6) 0.80614(10) 0.0189 1.0000 Uani  
C19.  0.5895(3) 0.0144(7) 0.94257(11) 0.0238 1.0000 Uani  
Br20.  0.80540(3) 0.35720(6) 0.899664(11) 0.0233 1.0000 Uani  
H151.  0.494(3) -0.310(5) 0.8652(11) 0.0243 1.0000 Uiso  
H161.  0.538(3) -0.352(6) 0.7737(12) 0.0254 1.0000 Uiso  
H181.  0.785(3) 0.177(6) 0.7910(12) 0.0257 1.0000 Uiso  
H191.  0.530(3) -0.083(6) 0.9494(12) 0.0317 1.0000 Uiso  
H192.  0.665(3) -0.012(6) 0.9677(12) 0.0317 1.0000 Uiso  
H193.  0.558(3) 0.178(6) 0.9488(12) 0.0317 1.0000 Uiso  
H9.  0.678(4) -0.106(7) 0.7466(15) 0.0500 1.0000 Uiso  
H18.  -0.025(4) -0.141(7) 0.9489(15) 0.0500 1.0000 Uiso 
 